VAERS_ID,SYMPTOM1,SYMPTOMVERSION1,SYMPTOM2,SYMPTOMVERSION2,SYMPTOM3,SYMPTOMVERSION3,SYMPTOM4,SYMPTOMVERSION4,SYMPTOM5,SYMPTOMVERSION5,VAX_TYPE,VAX_MANU,VAX_LOT,VAX_DOSE_SERIES,VAX_ROUTE,VAX_SITE,VAX_NAME,RECVDATE,STATE,AGE_YRS,CAGE_YR,CAGE_MO,SEX,RPT_DATE,SYMPTOM_TEXT,DIED,DATEDIED,L_THREAT,ER_VISIT,HOSPITAL,HOSPDAYS,X_STAY,DISABLE,RECOVD,VAX_DATE,ONSET_DATE,NUMDAYS,LAB_DATA,V_ADMINBY,V_FUNDBY,OTHER_MEDS,CUR_ILL,HISTORY,PRIOR_VAX,SPLTTYPE,FORM_VERS,TODAYS_DATE,BIRTH_DEFECT,OFC_VISIT,ER_ED_VISIT,ALLERGIES,condition_type,group,curated_age,curated_sex,curated_onset_days,curated_key_evidence,curated_severity,curated_summary
925542,Electrocardiogram abnormal,23.1,Laboratory test normal,23.1,Pericarditis,23.1,Troponin normal,23.1,,,COVID19,PFIZER\BIONTECH,EK5730,1,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),01/07/2021,NY,30.0,30.0,,M,,"On 1/1/21 (4 days post dose 1), patient developed sudden onset substernal chest pain that resolved and recurred the next day on 1/2/21.  Patient was seen in the emergency department. VS were reported WNL, EKG with diffuse ST elevations and subtle PR depressions consistent with pericarditis. ECHO did not show evidence of effusion or tamponade. CXR and basic labs were unremarkable including troponin WNL. Patient sent home with colchicine and NSAIDS with plan for outpatient cardiology follow up. Of note, patient had COVID-19 in April 2020 with documented positive antibodies at that time.",,,,,,,,,U,12/28/2020,01/01/2021,4.0,"See ""Item 18""",PVT,,,,,,,2,01/07/2021,,Y,Y,Cefprozil (Hives),pericarditis,clean,30.0,M,4,"Chest pain, EKG changes, Echo findings",clean,"On 1/1/21 (4 days post dose 1), patient developed sudden onset substernal chest pain that resolved and recurred the next day on 1/2/21.  Patient was seen in the emergency department. VS were reported "
966794,Troponin normal,24.0,,,,,,,,,COVID19,MODERNA,025J 20-2A,1,IM,RA,COVID19 (COVID19 (MODERNA)),01/22/2021,CA,55.0,55.0,,M,,Severe stabbing chest and back pain radiating to the left axilla. Diagnosed with atypical pericarditis with diffuse ST elevation on EKG but no effusion or pericardial thickening on echo/MRI. Treated with ongoing Colchicine and complete resolution of pain. Spent the night under ER observation. Missed 4 days of work.,,,,,,,,,U,01/08/2021,01/19/2021,11.0,"1/19/21:  CTA w contrast, no aortic dissection  Blood work x 2, negative Troponin and inflammatory markers Echo, no pericardial effusion MRI w contrast, no pericardial effusion and normal pericardial thickness EKG, diffuse ST segment elevation more pronounced than baseline ECG done in 2018 which showed early repolarization",PVT,,"Wixela, Sildenafil",None,"Asthma, hypertension",Cellulitis in injected arm. Age 50y Pneumonia vaccine given around 2016,,2,01/22/2021,,,,None,pericarditis,clean,55.0,M,11,"EKG changes, Echo findings, Pericardial effusion",clean,Severe stabbing chest and back pain radiating to the left axilla. Diagnosed with atypical pericarditis with diffuse ST elevation on EKG but no effusion or pericardial thickening on echo/MRI. Treated w
977955,Prothrombin time normal,24.0,SARS-CoV-2 test negative,24.0,Troponin normal,24.0,White blood cell count increased,24.0,,,COVID19,PFIZER\BIONTECH,EK9231,2,IM,RA,COVID19 (COVID19 (PFIZER-BIONTECH)),01/27/2021,KY,54.0,54.0,,M,,"Pt seen in ED on 1/20 with increasing chest pain - pain in the mid chest, worse with breathing and limited ability to bend over and lay flat.. Troponin negative x2, ProBNP 42.4. Slightly elevated WBC at 11.96 and PTT at 36.7. PT/INR ok at 11 and 1. CT of the chest demonstrates no PE or pericardial effusion. ECG with no significant changes. Pt given ASA 324 mg and Norco 7.25/325 x1 in ED. D/C with Ibuprofen 800 mg TID for pericarditis. Covid test on 1/21 was negative. Pain improved as of 1/26. Per cardiologist review on 1/22 patient with elevated CRP (1.522) suggestive of pericarditis as cause.",,,,,,,,,Y,01/06/2021,01/19/2021,13.0,Troponin negative x2 ProBNP 42.4 WBC 11.96 PTT 36.7 PT/INR 11/1 ECG - no significant changes CT Chest - no PE CRP 1.522,PVT,,Famotidine 20 mg BID Potassium Chloride 20 mEq 2 tab daily Calcium 250 mg caps CoQ10 1 tap daily Levothyroxine 50 mcg daily Olmesartan 40 mg daily Amiloride 5 mg daily Amlodipine 10 mg dail Cholecalciferol 5000 unit weekly Cyanovobalmin 500,Broken wrist 12/25,Premature ventricular contractions Essential (primary) hypertension,,,2,01/27/2021,,Y,Y,Lisinopril Sulfa antibiotics,pericarditis,clean,54.0,M,13,"Chest pain, EKG changes, Echo findings, CRP/ESR, Pericardial effusion",clean,"Pt seen in ED on 1/20 with increasing chest pain - pain in the mid chest, worse with breathing and limited ability to bend over and lay flat.. Troponin negative x2, ProBNP 42.4. Slightly elevated WBC "
983362,Myocarditis,23.1,Pyrexia,23.1,Troponin increased,23.1,,,,,COVID19,MODERNA,025220A,1,IM,UN,COVID19 (COVID19 (MODERNA)),01/28/2021,CA,25.0,25.0,,F,,"7 Days after receiving the vaccine, patient developed generalized myalgia, fever, shortness of breath, and chest pain. Patient admitted to our hospital on 21JAN and diagnosed with myocarditis. Difficult to elucidate whether the myocarditis was secondary to Moderna vaccination or other viral etiologies.",,,Y,,Y,8.0,,,Y,01/08/2021,01/13/2021,5.0,"Troponin: 3.7 CKMB:>27 EKG findings with ST segment depression in III, aVF, V4, V5",PVT,,Tylenol,None,None,,,2,01/28/2021,,,,None,myocarditis,G2,25,F,5,Trop 3.7->3.7 (peak 3.7),Viral etiology,"25yo female presented with chest pain, dyspnea, fever 5 days after vaccination. Workup: Trop 3.7->3.7 (peak 3.7). Confounders: Viral etiology."
1023768,Electrocardiogram ST segment elevation,23.1,Pain,23.1,Painful respiration,23.1,Procalcitonin normal,23.1,White blood cell count increased,23.1,COVID19,MODERNA,012M20A,2,IM,LA,COVID19 (COVID19 (MODERNA)),02/11/2021,WA,86.0,86.0,,M,,"Patient awoke at 1:00 AM on 2/10/2021, five days after his Moderna COVID-19 booster, with chest pain radiating to the back and worse with deep inspiration. Patient arrived in our office on 2/10/2021 at 9:30 AM for an evaluation. Patient was noted to have new EKG changes with new concave-up ST elevation across the precordium. Bedside echocardiogram showed no pericardial effusion and no pericardial friction rub was appreciated. Due to ongoing chest pain, patient was transported to Emergency Department by medics for further workup and evaluation for possible pericarditis.  Formal echocardiogram in ED was normal. Acute myocardial infarction ruled out. ST changes improved. Patient now being discharged in stable condition 2/11/2021.",,,,,Y,2.0,,,Y,02/05/2021,02/10/2021,5.0,"On arrival at ED: CRP elevated on 2/10/2021 at 20.2 mg/L. WBC elevated on 2/10/2021 at 13,600. Echocardiogram 2/10/2021 was normal. CXR normal on 2/10/2021. WBC normalized on 2/11/2021 discharge at 7600. Procalcitonin on discharge was negative (2/11/2021).",PVT,,"omeprazole 20 mg delayed release, fluoxetine 20 mg capsules, aspirin 81 mg",None,Cognitive impairment History of prostate cancer status post XRT in 2003 with biochemical recurrence in November 2011.  History of bladder cancer.,,,2,02/11/2021,,Y,Y,"donepezil (GI upset),  antibiotic (PCN maybe, but Zithromax tolerated without issues).",pericarditis,confounded,86.0,M,5,"Chest pain, EKG changes, Echo findings, CRP/ESR, Pericardial effusion, Friction rub",Cancer,"Patient awoke at 1:00 AM on 2/10/2021, five days after his Moderna COVID-19 booster, with chest pain radiating to the back and worse with deep inspiration. Patient arrived in our office on 2/10/2021 a"
1088210,SARS-CoV-2 test negative,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,EK9264,1,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),03/10/2021,MA,46.0,46.0,,F,,"Patient presented to BIDMC on 02/23/21 with ~5d of sore throat and intractable fever and was found to have fulminant myocarditis.  She required ICU stay with VA ECMO and Impella circulatory support from 02/25/21-03/03/21.  She received a course of hydrocortisone. Cause of myocarditis was unclear but felt to be viral or post-viral versus inflammatory.  As of this submission she has been transferred to the cardiac floor and seems to be recovering.  Symptoms started ~14d after 1st dose COVID vaccine.  She also had self limited COVID infection in early January, 2021.",,,Y,,Y,20.0,,,Y,02/05/2021,02/23/2021,18.0,"02/26/2021 18:00    Adenovirus PCR (see report) serum - negative 02/26/2021 18:00    Cytomegalovirus DNA, Quantitative, Real-Time PCR (see report) serum - negative 02/26/2021 18:00    EBV PCR, Quantitative (see report) serum + at 980 copies 03/03/20: EBV IgG+; IgM - 02/24/20: COVID PCR nasal swab negative; multiplex respiratory viral pathogen panel negative",PVT,,1. Aspirin 81 mg PO DAILY  2. Atorvastatin 10 mg PO QPM  3. Vitamin D Dose is Unknown  PO DAILY  4. Ascorbic Acid Dose is Unknown  PO DAILY,"Experienced mild COVID-19 infection (loss of taste/smell) in January, 2021 - diagnosed January 5th.  Cleared to return to work 01/25/21.",None,,,2,03/10/2021,,,,Clindamycin: skin rash,myocarditis,G3,46,F,18,Limited data,ECMO; Impella; Fulminant,46yo female presented with fever 18 days after 1st dose. Severity indicators: ECMO; Impella; Fulminant.
1090794,Hypotension,24.0,Pyrexia,24.0,Tachycardia,24.0,Troponin increased,24.0,Ventricular hypokinesia,24.0,COVID19,PFIZER\BIONTECH,EL9262,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),03/11/2021,CA,20.0,20.0,,F,,"20 yo female with recent hospitalization for myocarditis. Pt initially Dx with Covid 19 on 31 Dec 2020 and received Pfizer COVID Vaccines on 19 and 09 Feb. Pt reports on 21 Feb developing fevers of 107 and stomach upset, by 25 Feb she developed chest pain, SOB, weakness, continued fevers and diarrhea. She was seen at ER on 25 Feb where she was tachycardic, hypotensive, and hyponatremic with an elevate lactate. She was transferred to another hospital and found to have a Troponin of 0.629. she was admitted from 25 Feb to 04 March. During that time she had an ECHO with an EF of 35-45% with global hypokinesis and peak BNP of 1389. Pt is currently felling well with no chest pain or shortness of breath.",,,,,Y,6.0,,,U,02/09/2021,02/21/2021,12.0,,MIL,,"Nexplanon, Iron, Elderberry Vitamin C + Zinc, Immuneti Advance",Covid 19 infection 31 Dec 2020 (2 months prior),None,,,2,03/10/2021,,Y,Y,None,myocarditis,G3,20,F,12,Trop 0.629; BNP 1389.,Severe (unspecified),"20yo female presented with chest pain, dyspnea, fever 12 days after vaccination. Workup: Trop 0.629. Severity indicators: Severe (unspecified)."
1105807,Troponin I increased,24.0,,,,,,,,,COVID19,MODERNA,,2,IM,AR,COVID19 (COVID19 (MODERNA)),03/16/2021,MO,21.0,21.0,,F,,"Patient received first dose of Moderna COVID-19 vaccine on 2/10/21 and had a large, red, inflamed area on her arm at the injection site for a few days, but otherwise tolerated vaccine well. She received the second dose of the Moderna COVID-19 vaccine on 3/10/21 and the next day (3/11/21) developed fatigue and lightheadedness while exercising, which continued for the next few days. She developed acute onset, sharp chest pain on 3/13/21 AM which did not resolve so she presented to an ED. Vitals were normal but labs notable for troponin I which peaked at 4.36, CK 758, d-dimer 640. CBC/CMP and EKG were unremarkable and initial TTE with EF ~45%. Repeat TTE obtained a few days later with normal LV and RV size/function without any wall motion abnormalities. Cardiac MRI obtained with normal LV function (EF 64%) but late gadolinium enhancement in a subepicardial distribution within the inferolateral wall of the left ventricle at the base most compatible with myocarditis. ESR and CRP were normal. Further workup to determine etiology of myocarditis was negative (ANA, ANCA, RF, hepatitis panel, HIV, full respiratory viral panel, COVID-19 PCR). She was placed on metoprolol succinate 12.5mg XL daily and will follow up with a cardiologist as an outpatient. Family concerned that COVID-19 vaccine was the trigger/underlying etiology of her myocarditis.",,,,,Y,4.0,,,,03/10/2021,03/11/2021,1.0,3/13/21: Troponin I 2.370 -> 4.360 -> 1.290; CRP 8.0; ESR 7;  3/16/21:  Cardiac MRI: Abnormal late gadolinium enhancement and T1 signal hyperintensity in a subepicardial distribution within the inferolateral wall of the left ventricle at the base most compatible with myocarditis. Normal left ventricular ejection fraction (64%) and wall motion.,UNK,,None,None,Hemiplegic migraines,,,2,03/16/2021,,,,None,myocarditis,G3,21,F,1,Trop 2.37; EF 45%; CRP 8.0,EF 45%,"21yo female presented with chest pain 1 days after 2nd dose. Workup: Trop 2.37, EF 45%. Severity indicators: EF 45%."
1128543,White blood cell count increased,24.0,,,,,,,,,COVID19,MODERNA,045A21A,2,IM,LA,COVID19 (COVID19 (MODERNA)),03/24/2021,PA,41.0,41.0,,M,,"41yo male with history of HLD, LBP, and tobacco use who presented to care initially at the with chest pain. He received the second dose of the Moderna vaccine on 18MAR21 at clinic and within 14 hours developed chills and myalgias. He denies any immediate onset of symptoms after receiving the vaccine. The following day he reports experiencing chest pain 24 hours after the vaccine was administered that progressively worsened over the subsequent 36 hours that finally prompted him to seek care. He describes the pain as a central non-radiating squeezing pain that worsened with movement and breathing. He waited to seek care because he reports several of the soldiers in his unit have experienced similar chest pain that eventually resolved.   He reports being at his baseline health prior to receiving the vaccine and denies any fever, cough, rhinorrhea, congestion, malaise, vomiting, diarrhea, or rash.   Upon initial presentation to care at clinic he was noted to have a Tropnon I of 0.9, WBC of 14, elevated CRP (7.3), and temp to 101.4. Patient was given ASA, Plavix, Lovenox, Tylenol, and Ceftriaxone.    Since arriving to clinic and EKG was obtained showing ST elevation in lead 1 and avF concerning for ischemia and underwent a left heart catheterization which was clear of obstruction. Serial high sensitivity Tropnonin levels have been trended to peak of 465. Respiratory viral panel to include SARS COV-2 was negative. Cardiac MRI was consistent with myopericarditis, and show mildly reduced EF for 46%. Blood cultures have not grown any organism. His chest pain has resolved since starting Aspirin and Colchicine.",,,,,Y,4.0,,,Y,02/17/2021,03/18/2021,29.0,"23MAR CBC: 7.2>14.3<317   39N, 47L normal BMP  22MAR CBC: 7.8>15.3<276  47N, 40L Cr: 1.0, eGFR: 90, C3/C4: WNL RPR: nonreactive HCV Ab: negative HBV s Ag and c Ab: negative  21MAR CBC: 12.2>15.7<254  58N, 30L CMP: totally normal Cr: 1.15, eGFR: 79, CRP: 7.3, ESR: 57 Trop: 123->250->350->465->388 C3/C4: WNL TSH: 1.5 A1C: 5.5 HS-Troponin: 123 -> 250 -> 350 -> 465 -> 388 Blood cultures x2: no growth to date Upper respiratory Biofire 2.1 (Upper respiratory PCR panel to include SARS-CoV-2): all negative",MIL,,Naproxen 500mg BID PRN Buproprion 100mg BID Prazosin 1mg QHS Vit D2 50K unit Qweek,None,Bilateral sensory neural hearing loss Chronic low back pain Elevated cholesterol/hyperlipidemia,,,2,03/24/2021,,Y,Y,NKDA,pericarditis,clean,41.0,M,29,"Chest pain, EKG changes, Echo findings, CRP/ESR, Cardiac MRI",clean,"41yo male with history of HLD, LBP, and tobacco use who presented to care initially at the with chest pain. He received the second dose of the Moderna vaccine on 18MAR21 at clinic and within 14 hours "
1147729,Red blood cell sedimentation rate normal,24.0,Sinus tachycardia,24.0,Troponin increased,24.0,White blood cell count increased,24.0,,,COVID19,PFIZER\BIONTECH,,2,IM,UN,COVID19 (COVID19 (PFIZER-BIONTECH)),03/30/2021,IN,18.0,18.0,,M,,"Patient presented to the emergency department early March 28, 2021 after experiencing 5-7 hours of chest pain. The chest started when the patient went to bed the evening of March 27, where he began having substernal non-radiating chest pain with inspiration. The pain was relieved by sitting upright and by taking some acetaminophen. He received his 2nd dose of the Pfizer COVID-19 vaccine on March 25 (first dose was March 5). He was initially treated with ketorolac 15mg IV and given 1 liter of lactated ringer's solution via IV.  His chest pain resolved after this. He was eventually given colchicine 0.6mg twice daily and ibuprofen 600mg 3 times daily due to concern for myopericarditis. He was ultimately found to have no evidence of pericarditis after undergoing a cardiac MRI, thus colchicine and ibuprofen were discontinued. Due to findings of mildly reduced ejection fraction on imaging, he was started on metoprolol XL 25mg once daily at discharge.",,,,,Y,2.0,,,N,03/25/2021,03/27/2021,2.0,"EKG 3/28/21: sinus tachycardia (rate 107 bpm), ST elevation, probably due to early repolarization EKG 3/29/21: normal sinus rhythm, nonspecific T wave abnormality  C-reactive protein 3/28/21: 46.9mg/L (ref. range <9 mg/L) ESR 3/28/21: 9 mm/hr (ref. range <15 mm/hr) D-dimer 3/28/21: 0.42 ug/mL (ref. range <0.50) High sensitivity troponins 3/28/21: 148 ng/L (time 02:45) -> 114 ng/L (time 05:45) (ref. range <19 ng/L) WBC 11.27 k/uL (ref. range 3.7-10.3)  Cardiac MRI 3/29/21:  1. Normal sized left ventricle with mildly reduced global systolic  function (EF 47%).  2. Normal sized right ventricle with mildly reduced global systolic  function (EF 46%). 3. No significant valvular abnormalities. 4. There is no significant late gadolinium enhancement.",PHM,,Lamotrigine 150 mg daily Cotempla XR ODT 25.9 mg daily as needed,None,ADHD,,,2,03/30/2021,,,,No known allergies,pericarditis,clean,18.0,M,2,"Chest pain, EKG changes, Echo findings, CRP/ESR, Cardiac MRI",clean,"Patient presented to the emergency department early March 28, 2021 after experiencing 5-7 hours of chest pain. The chest started when the patient went to bed the evening of March 27, where he began ha"
1219721,Troponin increased,24.0,,,,,,,,,COVID19,MODERNA,032B21A,2,IM,LA,COVID19 (COVID19 (MODERNA)),04/16/2021,IL,44.0,44.0,,M,,"developed chest discomfort presented to hospital ER.  ekg w diffuse st elevations, elevated troponin.  taken for coronary angiogram negative for cad.  normal echo.  diagnosed w myocarditis.  no evident viral prodrome or other inciting cause.",,,,,Y,3.0,,,Y,04/12/2021,04/15/2021,3.0,"ekg, troponin, coronary angiogram, echocardiogram",PVT,,none,none,none,,,2,04/16/2021,,,,none,myocarditis,G2,44,M,3,ST elevation,Viral etiology,44yo male presented with cardiac symptoms 3 days after vaccination. Confounders: Viral etiology.
1259694,Pleural effusion,24.0,Pyrexia,24.0,Rheumatoid factor negative,24.0,Scan with contrast abnormal,24.0,Venous pressure jugular increased,24.0,COVID19,PFIZER\BIONTECH,EN6200,UNK,IM,RA,COVID19 (COVID19 (PFIZER-BIONTECH)),04/26/2021,WA,69.0,69.0,,F,,"Patient is a 69-year-old woman with newly diagnosed pericarditis in March 2021, hypertension, hyperlipidemia, and hypothyroidism, who presented to the Emergency Department (ED) with progressively worsening chest pain, dyspnea, and fatigue. Patient was in her usual state of health until 3/1/2021, when she developed sudden-onset pain ""across the entire chest"".  She shares that her symptoms ""came out of the blue"", as ""suddenly one day, everything just hurt"".  She saw her primary care physician, who initially felt her symptoms were due to acid reflux.  As such, the patient started ""eating antacids and omeprazole like candy"".  However, her chest pain persisted, prompting her to follow up with her primary care physician on 3/16/2021.  At that time, ECG reportedly showed normal sinus rhythm and no acute changes.  CT of the chest, abdomen, and pelvis with contrast showed abnormal enhancement and thickening of the pericardium with trace pericardial fluid, consistent with pericarditis.  The patient was therefore started on colchicine and an ibuprofen taper.   On 4/5/2021, Patient sent a myVM portal message to her primary care physician and cardiologist, expressing her belief that her chest pain has remained unchanged over the past month.  She continues to experience a constant burning sensation throughout her chest, aggravated by deep inspiration and alleviated by lying flat on her back.  She shares that walking up the stairs at home leaves her ""breathless"".  Associated symptoms include subjective fevers, chills, and night sweats.  Given these symptoms, Patient underwent a chest x-ray, which showed findings consistent with an enlarging pericardial effusion.  Patient was then advised to present to the ED for further workup as an inpatient.   At time of hospital admission, patient endorses persistent chest pain during inspiration.  Prior to 3/1/2021, she has never experienced these symptoms and reports no history of pericarditis.  The most strenuous physical activity she has undertaken in the last month include working in the garden and caring light boxes down the stairs.  She is most concerned about the fluid around her heart.  Patient reports no nausea, vomiting, palpitations, constipation, diarrhea, or abdominal pain.  Of note, the patient developed pericarditis 10 days after her second COVID-19 vaccine.  Hospital Course        # Sub-acute pericarditis with enlarging pericardial effusion Pericarditis initially diagnosed in March 2021, thought to be potentially from her COVID-19 vaccine given time course as no other clear etiology apparent.  Pt was hemodynamically stable with an elevated jugular venous pressure at time of admission, with CXR consistent with an enlarging pericardial effusion. Echo 04/05 with small circumferential pericardial effusion but no tamponade physiology.  Cardiac MRI on 4/7 with enlargement of moderate-sized pericardial effusion but otherwise negative exam, with no evidence of myocarditis or infiltrative myocardial process. ANA screen negative, rheumatoid factor and anti-CCP not elevated Blood cultures x 2 with no growth - CRP continued to remain > 160 with ibupofen and colchicine. Prednisone 20 mg PO daily was added on 4/7, with subsequent improvement in patient's symptoms.   - Discharged on regimen of prednisone 20 mg PO daily and colchicine 0.3 mg PO daily (reduced from 0.6 mg daily that she was taking prior to admission). She will also continue using ibuprofen 800 mg BID.  - Follow-up with Dr (cardiology) next week to follow-up on hospitalization and decide upon tapering plan for her medications",,,Y,,Y,4.0,,,N,02/16/2021,03/01/2021,13.0,"CXR 04/05 with enlarged cardiac silhouette that has developed since the March 1, 2021 exam. Given the visible change in one month a pericardial  effusion should be suspected.   TTE 04/05 with small circumferential pericardial effusion but no tamponade physiology, EF normal (68%), CVP mildly elevated at 8    Cardiac MRI 04/07 Impression: 1. Compared to 3/16/2021 there has been enlargement in now a  moderate-sized pericardial effusion. Findings are nonspecific and  could be related to pericarditis but there is no abnormal pericardial  thickening. 2. New small bilateral pleural effusions. 3. Otherwise negative exam. No evidence of myocarditis or  infiltrative myocardial process.",OTH,,As of Jan 28 2021 1. Flonase 1 spray b.i.d. as needed. 2. Levothyroxine 100 mcg daily. 3. Lisinopril 20 mg a day.   4. Omeprazole 40 mg daily. 5. Sumatriptan 25 mg p.r.n. 6. Pravastatin 40 mg daily. 7. Cetirizine 10 mg daily.,Hypertension Alergies Rash,Ongoing  Allergic rhinitis  Anemia  Atopic dermatitis  Chronic rhinitis  Colon adenomas  Contusion of right ankle  Cough  CRP elevated  Fever  GERD without esophagitis  High cholesterol  Hypertension  Hypothyroid  Left-sided chest pain  Localized osteoarthritis of ankle  Low blood potassium  Migraines  NONTOXIC MULTINODULAR GOITER  Oral herpes  Osteopenia  Pericardial effusion  Pericarditis  Pericarditis  Skin lesion of hand  SPRAIN OF MEDIAL COLLATERAL LIGAMENT OF KNEE.  SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES  Tubular adenoma of colon,,,2,04/26/2021,,Y,Y,"ALLERGIES: CODEINE, SULFA DRUGS.",myocarditis,G2,69,F,13,Cardiac MRI+; Pericardial effusion,Rheumatoid,"69yo female presented with chest pain, dyspnea, fever 13 days after vaccination. Confounders: Rheumatoid."
1262194,Chest pain,24.0,Myocarditis,24.0,Troponin,24.0,,,,,COVID19,PFIZER\BIONTECH,EW0162,2,IM,UN,COVID19 (COVID19 (PFIZER-BIONTECH)),04/27/2021,IA,16.0,16.0,,M,,Patient received vaccination on 4/22 and started developing chest pain on 4/24. patient presented to the Emergency Department on 4/25 and was evaluated and found to have a troponin of 1500 and was diagnosed with myocarditis. The source is unknown at this point but may be related to the vaccine.,,,,,Y,,,,N,04/22/2021,04/24/2021,2.0,Troponin 1500,PVT,,,,,,,2,04/27/2021,,,,,myocarditis,G1,16,M,2,Trop 1500.0->1500.0 (peak 1500.0),Classic presentation,"16yo male presented with chest pain 2 days after vaccination. Workup: Trop 1500.0->1500.0 (peak 1500.0). Diagnosed with acute myocarditis, classic post-vaccine profile."
1262397,N-terminal prohormone brain natriuretic peptide increased,24.0,Nodal rhythm,24.0,Troponin increased,24.0,Ventricular extrasystoles,24.0,,,COVID19,PFIZER\BIONTECH,,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),04/27/2021,OR,16.0,16.0,,M,,"Suspected myocarditis. Chest pain with multiple intermittent dysrhythmias including complete heart block, junctional, PVCs. Trop leak. Elevated NT-proBNP. Planning for IVIG.",,,,,Y,,,,N,04/23/2021,04/26/2021,3.0,"Trop elevation 5.38. NT-proBNP 428. EKG/telemetry with complete heart block, junctional rhythm, PVCs. Normal echocardiogram.",PVT,,None,None,Irritable bowel syndrome,,,2,04/27/2021,,,Y,Penicillin (maybe),myocarditis,G3,16,M,3,Limited data,Heart block,16yo male presented with chest pain 3 days after vaccination. Severity indicators: Heart block.
1263276,Cardiac failure congestive,24.0,Magnetic resonance imaging heart,24.0,Myocarditis,24.0,Troponin,24.0,Ventricular tachycardia,24.0,COVID19,PFIZER\BIONTECH,EJ1686,2,SYR,AR,COVID19 (COVID19 (PFIZER-BIONTECH)),04/27/2021,CA,29.0,29.0,,M,,"pt admitted as inpatient with congestive heart failure, myocarditis and non sustained ventricular tachycardia",,,Y,,Y,5.0,,,,12/19/2020,02/07/2021,50.0,troponin 14.69 on 2/7/8  troponin 13/48 2/8/21 cardiac MRI  2/11/22 E 55# delayed gadolinium enhancement of anteroseptum and inferomedial wall c/w myocarditis,PVT,,,tourette's disorder asthma,tourette's disorder asthma,,,2,04/27/2021,,Y,Y,abilify aripiprazole,myocarditis,G3,29,M,50,Trop 13.0->14.69 (peak 14.69); Cardiac MRI+,VT,29yo male presented with cardiac symptoms 50 days after vaccination. Workup: Trop 13.0->14.69 (peak 14.69). Severity indicators: VT.
1280493,Troponin increased,24.0,Viral test,24.0,,,,,,,COVID19,PFIZER\BIONTECH,,2,IM,AR,COVID19 (COVID19 (PFIZER-BIONTECH)),05/02/2021,NC,16.0,16.0,,M,,"MYOCARDITIS.  Patient is a 16 year old boy with ADHD who presented with fever and myalgias for 3 days, that progressed to sharp parasternal chest pain and some SOB. Patient received second dose Pfizer COVID-19 vaccine on 4/26, and after that shot experienced fever to 102 at home and myalgias. Subsequently his symptoms of chest pain have occurred. He underwent workup revealing of elevated Troponin, and EKG with some ST segment elevation, a slightly elevated CRP at 32, and a normal ECHO. Admitted for observation and concern for infectious myocarditis vs MIS-C. Cardiac MRI was done confirming Myocarditis, Troponin I was elevated and peaked at 23, 325pg/mL. Workup unrevealing of SARS. Other testing showed Resp virus panel negative, blood pcr for EBV, CMV, Parvovirus B19, enterovirus, and adenovirus all negative, HIV antigen/antibody testing negative. Patient treated with Ketorolac with steady improvement in symptoms over several hospital days. Discharged home 5/2 with Troponin I well down and symptoms resolved. Given reports in lay press regarding other cases of COVID-19 MRNA vaccine associated myocarditis, we are reporting this as a vaccine associated adverse event.",,,,,Y,4.0,,,Y,04/26/2021,04/26/2021,0.0,"above summary From Hospital records: 4/29 Blood Cx NGTD   4/29 RVP negative   5/1 HIV antigen/antibody negative   4/29 Blood PCR for Adenovirus, CMV, EBV, Enterovirus, Parvovirus B19 all negative.    5/2 Lyme serologies pending     ECHO 4/30   Interpretation Summary Limited follw-up study to assess left ventricular function   Normal left ventricular size and function Normal right ventricular systolic function Normal septal curvature No pericardial effusion   4/30 HEART MRI   INTERPRETATION  1. The left ventricular (LV) size is normal with normal LV wall                            thickness. The indexed LV end diastolic volume is 90 mL/m2. There is                        low normal systolic function of the LV with an ejection fraction of                        50%. There is late gadolinium enhancement involving 50-75% of the                          epicardial inferior and  inferolateral LV myocardium with increased T1                      and T2 signal.                                                                              2. The right ventricle is normal size with normal systolic function.                        3. Normal atrial size bilaterally.                                                          4. No evidence of significant valvular abnormalities.                                      5. Normal pericardium with no pericardial effusion.                                        Conclusion:                                                                                Epicardial late gadolinium enhancement present in the basal and mid                        lateral wall with elevated T1 and T2 values consistent with acute                          myocarditis.",OTH,,ADHD meds,None. This was second dose Pfizer COVID-19 vaccine given. No history COVID-19 disease.,"ADHD, otherwise healthy.",,,2,05/02/2021,,,,None,myocarditis,G3,16,M,0,EF 50%; ST elevation; Cardiac MRI+; Pericardial effusion; CRP 32,EF 50%,"16yo male presented with chest pain, fever 0 days after 2nd dose. Workup: EF 50%. Severity indicators: EF 50%."
1286607,Pericardial effusion,24.0,Scan with contrast,24.0,Vomiting,24.0,,,,,COVID19,PFIZER\BIONTECH,,2,,,COVID19 (COVID19 (PFIZER-BIONTECH)),05/04/2021,WA,35.0,35.0,,M,,"35 year old male without a significant health history, who had his second dose of the Pfizer vaccine 4 days prior to admit on 4/30/2021. Since his second vaccine dose, he started having generalized chest/abdominal aching, chills, body aches, nausea/vomiting. On the day of admission, he awoke with numbness in his right and left upper extremity. In the ED, his ECG showed NSR with anterior and inferior ST elevation. Troponin elevated to 3.99, trended down. Echo  normal. Cardiac MRI suggested myocarditis. He was started on colchicine 0.6 mg BID with resolution of his symptoms.",,,,,Y,1.0,,,N,04/30/2021,04/30/2021,0.0,"5/3/2021 Echocardiogram:  Normal left ventricular size. Normal LV systolic function (LVEF 55%). o Normal right ventricular size. Normal RV systolic function. o No significant valvular abnormalities. o Unable to assess pulmonary artery systolic pressure. o There is a trace circumferential pericardial effusion. o No prior echo for comparison.  5/3/2021 MRI Cardiac with and without contrast 1.  Normal LV size with low normal LV systolic function.  LVEF = 52 %  2.  Normal RV size with normal RV systolic function.  RVEF = 53 %  3.  Normal biatrial size  4.  No morphologic valvular abnormalities  5.  Normal resting perfusion  6.  There is a focus of late gadolinium enhancement at the distal lateral wall. The LGE pattern is subepicardial and is not consistent with a prior infarct.  Given the clinical history this finding is consistent with a myocarditis.  7.  The aortic root (26 mm) is normal in size  8.  Trivial pericardial effusion  9.  There are no prior cardiac MRI's available for comparison    5/3/2021 06:26 Troponin I, POC: 1.83 (HH)  5/3/2021 06:41 NT-proBNP: 1,025 (H)  5/3/2021 10:07 Troponin I, POC: 3.99 (HH)  5/3/2021 16:20 Troponin I: 3.53 (AA)  5/3/2021 22:44 Troponin I: 1.97 (AA)",PVT,,"Vitamin D3, Lexapro 20 mg dialy",None,"Anxiety, depression",,,2,05/04/2021,,,,None,myocarditis,G3,35,M,0,Trop 1.97->3.99 (peak 3.99); EF 55%; ST elevation; Cardiac MRI+; Pericardial effusion,EF 55%,"35yo male presented with cardiac symptoms 0 days after 2nd dose. Workup: Trop 1.97->3.99 (peak 3.99), EF 55%. Severity indicators: EF 55%."
1296631,Fibrin D dimer increased,24.0,Myocarditis,24.0,Red blood cell sedimentation rate increased,24.0,Troponin I increased,24.0,Ventilation/perfusion scan normal,24.0,COVID19,MODERNA,3001654,UNK,IM,LA,COVID19 (COVID19 (MODERNA)),05/07/2021,,71.0,71.0,,F,,Myocarditis   Patient presented to the hospital with one episode of troponin positive chest pain. She was diagnosed with an NSTEMI for which she had a coronary angiogram which showed no significant coronary artery disease. She subsequently had CRP (normal)/ESR (mildly elevated) and DDIMER. Ddimer was elevated thus a V/Q scan was done which showed no pulmonary embolism. She went on to have a cardiac MRI which showed evidence of myocarditis.,,,,,Y,6.0,,,U,04/11/2021,04/16/2021,5.0,hsTroponin I 4685 April 16/2021 Cardiac MRI April 21/2021 Myocarditis Coronary angiogram April 17/2021 No significant coronary artery disease V/Q scan April 20/2021 No pulmonary embolism,PVT,,None,None,Asthma Hypertension Hypothyroidism Osteoarthritis Right knee replacement Breast cancer with mastectomy Liver cysts,,,2,05/07/2021,,,Y,Gadolinium,myocarditis,G2,71,F,5,Trop 4685.0; Cardiac MRI+,Cancer,71yo female presented with chest pain 5 days after vaccination. Workup: Trop 4685.0. Confounders: Cancer.
1299305,Angiogram pulmonary,24.0,Electrocardiogram,24.0,Magnetic resonance imaging,24.0,Myocarditis,24.0,Pericardial effusion,24.0,COVID19,PFIZER\BIONTECH,,2,,,COVID19 (COVID19 (PFIZER-BIONTECH)),05/08/2021,,,,,U,,"This is a spontaneous report from a contactable other HCP who reported for a patient. A patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot number was not reported) on 17Apr2021 via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. Historical vaccine included: bnt162b2 (COMIRNATY, Solution for injection,) dose 1 on 18Feb2021 04:00 PM, for covid-19 immunization. No prior cardiac past medical history. Medical history was not reported. Concomitant medications were not reported. On Patient received 2nd dose of Pfizer COVID-19 vaccine on 17Apr. That evening noticed SOB and chest tightness. Over the next 3 days went to ED with worsening CP. Found to have elevated troponins and EKG changes. CTPE negative. Symptoms improved with pain management, steroids, and colchicine. Cardiac MRI done on 23Apr that showed EF 52% and findings consistent with myocarditis and small pericardial effusion. Patient managed with ACE and colchicine. The clinical outcome of the events was unknown.   Information on lot/ batch number has been requested.; Sender's Comments: Based on the information provided, the contributory role of the suspect product second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot number was not reported) to reported events myocarditis and small pericardial effusion is possible. Case will be reassessed upon receipt of follow-up information.",,,,,,,,,U,,,,Test Name: CTPE; Test Result: Negative  ; Test Name: EKG; Result Unstructured Data: Test Result:changes; Test Name: MRI; Test Result:  52 %; Comments: showed EF 52% and findings consistent with myocarditis and small pericardial effusion,UNK,,,,,,USPFIZER INC2021472270,2,05/06/2021,,,,,myocarditis,G3,?,U,?,EF 52%; Pericardial effusion,EF 52%,Age unknown patient presented with cardiac symptoms unknown interval after 2nd dose. Workup: EF 52%. Severity indicators: EF 52%.
1310544,Myocarditis,24.0,Troponin increased,24.0,,,,,,,COVID19,MODERNA,,UNK,,,COVID19 (COVID19 (MODERNA)),05/12/2021,CA,21.0,21.0,,M,,myocarditis,,,,,Y,1.0,,,U,04/30/2021,05/03/2021,3.0,troponin 5,PVT,,no,no,no,,,2,05/12/2021,,,,no,myocarditis,G1,21,M,3,Trop 5.0,Classic presentation,"21yo male presented with cardiac symptoms 3 days after vaccination. Workup: Trop 5.0. Diagnosed with acute myocarditis, classic post-vaccine profile."
1313197,Arrhythmia,24.0,Palpitations,24.0,,,,,,,COVID19,PFIZER\BIONTECH,EW0161,1,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),05/13/2021,OH,63.0,63.0,,F,,"After four days with no noticeable side effects or problems, I laid down for the night & noticed that my heart seemed to be struggling a great deal as in it seemed to be pounding hard, racing, & along with arrhythmia.  This continued with a severe & continuous struggle around the clock, but more extreme throughout the night.  I at first thought maybe I had some dehydration, but this did not seem to be the case.  I was diagnosed with light Tachycardia in 1987, but have never experienced anything like what has happened since the COVID-19 vaccine.  I searched the internet & noticed there are reports of other people suffering with the same issue & that a country has opened an investigation related to these heart struggles resulting in Myocarditis following the vaccine.  I am under the care of a cardio Dr. in a city who prescribed Metoprolol ER Succinate 50 mg  1 x daily, ordered a 30 day event monitor which just arrived in the mail, & has ordered an MRI, along with some lab work.",,,,,,,,,N,04/17/2021,04/21/2021,4.0,"Tests are not completed at this time:  30 day event monitor which was just received, a heart MRI, & lab work",PHM,,"Bumetanide 0.5 mg 2 x daily,    Potassium CL Micro10 MEQ ER 2 x daily,    Losartan 50 mg 1 x daily,    B12 over the counter 500 mcg daily,  store brand Women's Multi-Vitamin Gummies daily,    Ezetimibe 10 mg 1 x daily,     Deva Vegan Coenz","Fibromyalgia, OA, Rheumatoid Arthritis, Sjogren's Syndrome, Raynaud's Syndrome, Polymyositis, Tachycardia (since 1987 very mild case), Obesity",Listed above,,,2,05/13/2021,,Y,,Slight rash once when taking a Sulfa prescription,myocarditis,G2,63,F,4,Limited data,Rheumatoid,63yo female presented with cardiac symptoms 4 days after vaccination. Confounders: Rheumatoid.
1314908,Pyrexia,24.0,Red blood cell sedimentation rate increased,24.0,SARS-CoV-2 test negative,24.0,Troponin increased,24.0,White blood cell count increased,24.0,COVID19,PFIZER\BIONTECH,,1,SYR,,COVID19 (COVID19 (PFIZER-BIONTECH)),05/13/2021,CA,53.0,53.0,,F,,"shortly after vaccine, experience chest tightness, palpitations, dyspnea, cough, sweating and fever. Admitted to hospital 3 days later, found to have new pericardial effusion, secondary to acute pericarditis from possible vaccine. Pericardiocentesis removed 250ml proteinaceous material. Also experienced flash pulmonary edema which required intubation x1 day but resolved quickly.",,,Y,,Y,3.0,,,Y,05/08/2021,05/08/2021,0.0,"5/10-CT and ECHO with new pericardial effusion, WBC 19, lactate 2.6 and troponin 0.19, ALT, TBili, D-dimer >4, PT>15.4, COVID neg, Chem 10  5/11 CRP 27.9, ESR 117, C3, C4, dsDNA ab, pericardial fluid cytology and culture 5/12 LDH, TP of pericardial fluid",PVT,,"abilify 5mg, plaquenil 200 daily, risperdal 0.5mg, trazodone",no,"Lupus, Bipolar type 1, Raynauds",,,2,05/13/2021,,Y,Y,NKDA,pericarditis,confounded,53.0,F,0,"Chest pain, Echo findings, CRP/ESR, Pericardial effusion",SLE/Lupus,"shortly after vaccine, experience chest tightness, palpitations, dyspnea, cough, sweating and fever. Admitted to hospital 3 days later, found to have new pericardial effusion, secondary to acute peric"
1321207,Angina pectoris,24.0,Chest pain,24.0,Myocarditis,24.0,,,,,COVID19,PFIZER\BIONTECH,,UNK,,,COVID19 (COVID19 (PFIZER-BIONTECH)),05/15/2021,CA,18.0,18.0,,M,,Gave me heart and chest pain (diagnosed with myocarditis),,,,,Y,3.0,,,Y,04/23/2021,04/28/2021,5.0,,PHM,,,,,,,2,05/15/2021,,Y,Y,,myocarditis,G1,18,M,5,Limited data,Classic presentation,18yo male presented with chest pain 5 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1326494,Thyroxine free normal,24.0,Troponin I increased,24.0,White blood cell count increased,24.0,,,,,COVID19,PFIZER\BIONTECH,EW0176,2,SYR,UN,COVID19 (COVID19 (PFIZER-BIONTECH)),05/18/2021,CT,17.0,17.0,,M,,"Patient is a 17 yo male with no hx asthma who presented to medical center ED as transfer from facility with pleuritic chest pain and fever x1 day. Recent history of second covid vaccine on Friday (5/14). Patient reported associated fatigue, headache and muscle aches late Friday into Saturday (5/15). Sunday patient reported a fever (101 F) and chest pain with deep inspiration. No associated SOB, increased work of breathing or abdominal pain. Was seen initially at urgent care and then referred to facility for ""an abnormal EKG.""    Pertinent findings at facility: troponin 0.31, EKG wnl, rapid covid negative, ESR 9, CK 134, D-dimer <150, WBC 12.4 w/ left shift. Transferred to medical center for further workup.   While in medical center ED, troponin 1.59. EKG rSR' leads V1-V3 w/o ST segment elevation. MISC tier 1 studies drawn. Cardiology consulted - admit for observation, myocarditis infectious workup, echocardiogram and  During his time in the ED, patient continued to have pain with deep inspiration as well as when he had to yawn. He other wise felt fine. Vital signs normal throughout out time in ED.  His troponin continued to rise, with max of 14, so decision was made to start IVIG and steroids. His troponin fell over the next day. He remained stable from a clinical standpoint, and symptoms had resolved by the morning of 5/18. At time of filing, patient is still hospitalized at medical center, with further labs and imaging pending.",,,,,Y,2.0,,,N,05/14/2021,05/15/2021,1.0,"Recent Results (from the past 72 hour(s)) EXT COVID-19 PCR  Collection Time: 05/16/21 11:53 AM Result Value Ref Range  EXT SARS-CoV-2 RNA (COVID-19) NOT DETECTED NOT DETECTED Troponin I  Collection Time: 05/16/21  8:00 PM Result Value Ref Range  Troponin I 1.59 (HH) <0.30 ng/mL Respiratory Pathogen PCR Panel  Collection Time: 05/16/21  9:32 PM  Specimen: Nasopharyngeal Swab Result Value Ref Range  Source Nasopharyngeal   Adenovirus Not Detected Not Detected  Coronavirus 229E Not Detected Not Detected  Coronavirus HKU1 Not Detected Not Detected  Coronavirus NL63 Not Detected Not Detected  Coronavirus OC43 Not Detected Not Detected  Human Metapneumovirus Not Detected Not Detected  Rhinovirus/Enterovirus Not Detected Not Detected  INFLUENZA A PCR Not Detected Not Detected  INFLUENZA B PCR Not Detected Not Detected  PARAINFLUENZA 1 Not Detected Not Detected  PARAINFLUENZA 2 Not Detected Not Detected  PARAINFLUENZA 3 Not Detected Not Detected  Parainfluenza 4 Not Detected Not Detected  Respiratory Syncytial Virus Not Detected Not Detected  Bordetella Pertussis Not Detected Not Detected  Chlamydophilia Pneumoniae Not Detected Not Detected  Mycoplasma Pneumoniae Not Detected Not Detected  Bordetella Parapertussis Not Detected Not Detected  SARS Coronavirus 2, NAA Not Detected Not Detected CBC auto differential  Collection Time: 05/16/21 10:00 PM Result Value Ref Range  Comment Specimen clotted.  Test not performed. (A) No comment Hepatic function panel  Collection Time: 05/16/21 10:00 PM Result Value Ref Range  Alkaline Phosphatase 63 52 - 171 U/L  AST 38 10 - 55 U/L  ALT 21 10 - 55 U/L  Total Bilirubin 0.6 0.2 - 1.0 mg/dL  Total Protein 7.1 6.0 - 8.0 g/dL  Albumin 4.2 3.2 - 4.5 g/dL  Bilirubin, Direct <0.2 0 - 0.2 mg/dL  Globulin 2.9 1.5 - 3.9 g/dL  A/G Ratio 1.4 1.0 - 3.0 Ratio Gamma GT  Collection Time: 05/16/21 10:00 PM Result Value Ref Range  GGT 16 11 - 50 U/L Magnesium  Collection Time: 05/16/21 10:00 PM Result Value Ref Range  Magnesium 1.7 1.1 - 2.7 mg/dL Phosphorus  Collection Time: 05/16/21 10:00 PM Result Value Ref Range  Phosphorus 3.6 2.7 - 4.5 mg/dL C-reactive protein  Collection Time: 05/16/21 10:00 PM Result Value Ref Range  CRP 4.46 (H) 0 - 0.49 mg/dL Erythrocyte Sediment Rate (ESR)  Collection Time: 05/16/21 10:00 PM Result Value Ref Range  Sed Rate Specimen clotted.  Test not performed. <15 MM/HR proBNP, N-terminal  Collection Time: 05/16/21 10:00 PM Result Value Ref Range  proBNP, N-terminal 1,433 (H) <125 pg/mL Creatine Kinase, Reflex to CKMB  Collection Time: 05/16/21 10:00 PM Result Value Ref Range  Total CK 243 (H) 24 - 204 U/L CK total and CKMB  Collection Time: 05/16/21 10:00 PM Result Value Ref Range  CK-MB 12.3 (H) 0 - 6.4 ng/mL  RELATIVE INDEX 5.1 (H) 0 - 3.4 % iSTAT CHEM8+ :  Collection Time: 05/16/21 10:03 PM Result Value Ref Range  iSTAT TCO2, Venous 30 (H) 20 - 28 mmol/L  ISTAT Potassium 4.0 3.5 - 5.5 mmol/L  ISTAT Chloride 99 98 - 106 mmol/L  ISTAT Creat (with GFR) 1.0 0.5 - 1.3 mg/dL  ISTAT BUN 5 5 - 18 mg/dL  ISTAT Sodium 140 136 - 145 mmol/L  ISTAT Glucose 87 65 - 99 mg/dL  ISTAT Ionized Calcium 1.29 1.17 - 1.33 mmol/L POCT COVID-19 and Influenza A/B, BOTH Molecular (LIAT)  Collection Time: 05/16/21 10:07 PM Result Value Ref Range  Influenza A Not Detected Not Detected  Influenza B Not Detected Not Detected  SARS Coronavirus 2, NAA Not Detected Not Detected TSH, Highly Sensitive  Collection Time: 05/17/21  6:01 AM Result Value Ref Range  TSH, High Sensitivity 3.01 0.27 - 4.20 mIU/L T4, free  Collection Time: 05/17/21  6:01 AM Result Value Ref Range  Free T4 1.10 0.80 - 1.90 ng/dL C-reactive protein  Collection Time: 05/17/21  6:01 AM Result Value Ref Range  CRP 6.37 (H) 0 - 0.49 mg/dL Erythrocyte Sediment Rate (ESR)  Collection Time: 05/17/21  6:01 AM Result Value Ref Range  Sed Rate 27 (H) <15 MM/HR Lactate dehydrogenase(Serum)  Collection Time: 05/17/21  6:01 AM Result Value Ref Range  LDH 200 120 - 260 U/L CBC auto differential  Collection Time: 05/17/21  6:01 AM Result Value Ref Range  WBC 10.8 4.0 - 11.0 Thou/uL  Platelets 270 150 - 450 Thou/uL  Hemoglobin 13.6 13.0 - 17.7 g/dL  Hematocrit 41.1 39.0 - 54.0 %  RBC 4.70 4.50 - 6.20 Mil/uL  MCV 87 80 - 100 fL  MCH 28.9 25.0 - 35.0 pg  MCHC 33.1 30.0 - 36.0 g/dL  RDW 12.5 11.5 - 14.5 %  MPV 9.5 9.4 - 12.5 fL  Segmented Neutrophil 60 %  Lymphocyte 23 %  Monocyte 12 %  Eosinophil 3 %  Basophils 2 %  Absolute Neutrophil Count, Total 6.5 2.0 - 7.5 Thou/uL  Lymphocyte, Absolute 2.5 1.5 - 4.5 Thou/uL  Monocyte, Absolute 1.3 0.2 - 1.5 Thou/uL  Eosinophil, Absolute 0.3 0.0 - 0.7 Thou/uL  Basophil, Absolute 0.2 0.0 - 0.2 Thou/uL  Cell Count 100   Normochromic Present   Normocytes Present  Troponin I  Collection Time: 05/17/21  6:01 AM Result Value Ref Range  Troponin I 10.43 (HH) <0.30 ng/mL Urinalysis with Reflex to Microscopic  Collection Time: 05/17/21  7:30 AM Result Value Ref Range  Specimen Clean Catch   Color Yellow   Clarity Clear   Specific Gravity, UA 1.008 1.003 - 1.030  pH, UA 8.0 5.0 - 8.0  Leukocytes, UA Negative Negative  Nitrite, UA Negative Negative  Protein, UA Negative Negative  Glucose, UA 0 0 - 99 mg/dL  Ketones, UA Trace (A) Negative  Hemoglobin Urine Negative Negative  Bilirubin Urine Negative Negative  WBC, UA 0 0 - 4 per hpf  RBC, UA 0 0 - 4 per hpf Miscellaneous Lab - HHV-6 PCR  Collection Time: 05/17/21 11:45 AM Result Value Ref Range  NAME     Results: Request credited.   Referral Lab Performed at facility  proBNP, N-terminal  Collection Time: 05/17/21 11:45 AM Result Value Ref Range  proBNP, N-terminal 1,888 (H) <125 pg/mL Troponin I  Collection Time: 05/17/21 11:45 AM Result Value Ref Range  Troponin I 14.62 (HH) <0.30 ng/mL Creatine Kinase, Reflex to CKMB  Collection Time: 05/17/21 11:45 AM Result Value Ref Range  Total CK 746 (HH) 24 - 204 U/L CK total and CKMB  Collection Time: 05/17/21 11:45 AM Result Value Ref Range  CK-MB 50.3 (H) 0 - 6.4 ng/mL  RELATIVE INDEX 6.7 (H) 0 - 3.4 % HIV 1/2 Ag/Ab Rfx Confim  Collection Time: 05/17/21  2:45 PM Result Value Ref Range  HIV 1/2 Ag/Ab CMIA Nonreactive Nonreactive Hep B Surface Ag, Reflex Confirmation  Collection Time: 05/17/21  2:45 PM Result Value Ref Range  Hepatitis B Surface Antigen Nonreactive Nonreactive Hepatitis B surface antibody  Collection Time: 05/17/21  2:45 PM Result Value Ref Range  Hepatitis B, Surface Antibody Reactive (Immune) Reactive (Immune) Hep B Core Antibody Total Reflex IgM  Collection Time: 05/17/21  2:45 PM Result Value Ref Range  Hepatitis B Core, Total Antibody Nonreactive Nonreactive Hepatitis C antibody  Collection Time: 05/17/21  2:45 PM Result Value Ref Range  Hepatitis C Ab 0.19 0.00 - 0.79 S/CO ratio  Hepatitis C Ab, Interp Nonreactive Nonreactive Troponin I  Collection Time: 05/17/21  6:25 PM Result Value Ref Range  Troponin I 6.26 (HH) <0.30 ng/mL Troponin I  Collection Time: 05/18/21 12:00 AM Result Value Ref Range  Troponin I 4.90 (HH) <0.30 ng/mL Troponin I  Collection Time: 05/18/21  6:00 AM Result Value Ref Range  Troponin I 3.30 (HH) <0.30 ng/mL Troponin I  Collection Time: 05/18/21  1:55 PM Result Value Ref Range  Troponin I 1.69 (HH) <0.30 ng/mL   Echo 5/17/2021 Mildly decreased EF at 52%. Decreased GLS, -16.3%.  Cardiac MRI pending, further viral studies pending.",PVT,,None.,None.,"Asthma, remote history.",,,2,05/18/2021,,,Y,None.,myocarditis,G2,17,M,1,Trop 0.31->14.62 (peak 14.62); ST elevation; Cardiac MRI+; CRP 4.46,Viral etiology,"17yo male presented with chest pain, fever 1 days after vaccination. Workup: Trop 0.31->14.62 (peak 14.62). Confounders: Viral etiology."
1327087,Chest pain,24.0,Dyspnoea,24.0,Myocardial infarction,24.0,Myocarditis,24.0,,,COVID19,PFIZER\BIONTECH,ER8731,2,SYR,RA,COVID19 (COVID19 (PFIZER-BIONTECH)),05/18/2021,AR,18.0,18.0,,M,,"He had chest pains and could not breath after 48 hours, rushed to the ER.  Stayed in the hospital for 4 days.  He had a heart attack and was diagnosed with acute idiopathic myocarditis.",,,Y,,Y,4.0,,Y,N,04/30/2021,05/02/2021,2.0,,WRK,,None,None,None,,,2,05/18/2021,,,Y,None,myocarditis,G1,18,M,2,Limited data,Classic presentation,18yo male presented with chest pain 2 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1327571,Headache,24.0,Myalgia,24.0,Pyrexia,24.0,Viral myocarditis,24.0,,,COVID19,PFIZER\BIONTECH,,2,IM,UN,COVID19 (COVID19 (PFIZER-BIONTECH)),05/18/2021,CA,16.0,16.0,,M,,"Patient notes that he about 3d PTA he had his 2nd Pfizer Covid vaccine (received on 5/12/21) after which he had about 24 hrs of myalgias, low-grade fever, headache that all resolved.  Patient was admitted to the hospital on 5/15/21 with likely post-viral myocarditis.",,,,,Y,,,,U,05/12/2021,05/12/2021,0.0,,PHM,,unknown,unknown,unknown,,,2,05/18/2021,,,,none,myocarditis,G2,16,M,0,Limited data,Viral etiology,16yo male presented with fever 0 days after vaccination. Confounders: Viral etiology.
1333399,Pain in extremity,24.0,Pain in jaw,24.0,Red blood cell sedimentation rate increased,24.0,Troponin increased,24.0,,,COVID19,MODERNA,,2,IM,AR,COVID19 (COVID19 (MODERNA)),05/20/2021,TX,25.0,25.0,,M,,"The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol",,,,,Y,2.0,,,Y,04/21/2021,04/24/2021,3.0,"4/24 EKG- diffuse ST elevations Troponin- peaked at 12.8 CRP- 25.8 Sed rate- 19 UDS- negative Lipid panel- wnl A1C- 5.o% CMP, CBC- wnl  4/25 Echo- normal  4/26 Cardiac catheterization with no evidence of CAD",PVT,,None,None,None,,,2,05/20/2021,,,,None,myocarditis,G1,25,M,3,Trop 2.24->12.8 (peak 12.8); ST elevation; CRP 25.8,Classic presentation,"25yo male presented with chest pain 3 days after vaccination. Workup: Trop 2.24->12.8 (peak 12.8). Diagnosed with acute myocarditis, classic post-vaccine profile."
1333796,Pericarditis,24.0,Troponin increased,24.0,,,,,,,COVID19,PFIZER\BIONTECH,,UNK,,,COVID19 (COVID19 (PFIZER-BIONTECH)),05/20/2021,WA,81.0,81.0,,F,,Presented on 4/27/21 (5 days after 2nd dose of Pfizer COVID vaccine) with acute onset of chest pain around 7am the same morning.  Testing ultimately confirmed the diagnosis of acute pericarditis.,,,,,Y,2.0,,,Y,04/22/2021,04/27/2021,5.0,"EKG demonstrated minimal ST elevation, 4/27/217 Coronary angiogram demonstrated normal coronary arteries, 4/27/21 CTA chest was negative for pulmonary embolism, demonstrated small pericardial effusion, 4/27/21 Echocardiogram demonstrated small to moderate pericardial effusion, with normal LV function 4/27/21 Troponin was minimally elevated with peak value of 0.032, 4/28/21 CRP was <0.5 on 4/27/21 and rose significantly to 9.6 on 4/28/21 Cardiac MRI on 5/18/21 confirmed findings of acute pericarditis with pericardial thickening (5-6 mm), increased T2 pericardial signal, and pericardial late gadolinium enhancement.  Minimal pericardial effusion.",PVT,,Armour Thyroid,,Hypothyroidism,reported prior reaction to flu vaccine,,2,05/20/2021,,Y,Y,Reported prior reaction to flu shot,pericarditis,clean,81.0,F,5,"Chest pain, EKG changes, Echo findings, CRP/ESR, Pericardial effusion, Cardiac MRI",clean,Presented on 4/27/21 (5 days after 2nd dose of Pfizer COVID vaccine) with acute onset of chest pain around 7am the same morning.  Testing ultimately confirmed the diagnosis of acute pericarditis.
1341730,Rheumatological examination,24.0,Viral test,24.0,,,,,,,COVID19,PFIZER\BIONTECH,,UNK,,,COVID19 (COVID19 (PFIZER-BIONTECH)),05/23/2021,KS,18.0,18.0,,M,,"Chest pain  episodes 1-3 days after vaccine, Cardiac MRI shows small area of acute myocarditis",,,,,Y,2.0,,,Y,05/18/2021,05/19/2021,1.0,Cardiac MRI 5/22 shows small area of acute myocarditis ESR and CRP normal viral and rheumatologic labs pending,UNK,,none,none,none,,,2,05/23/2021,,,,,myocarditis,G2,18,M,1,Cardiac MRI+,Viral etiology,18yo male presented with chest pain 1 days after vaccination. Confounders: Viral etiology.
1343980,Nausea,24.0,Troponin increased,24.0,Urine analysis normal,24.0,Vomiting,24.0,,,COVID19,JANSSEN,043A21A,1,IM,LA,COVID19 (COVID19 (JANSSEN)),05/24/2021,WA,22.0,22.0,,M,,"Myocarditis with elevated cardiac biomarkers and decreased EF.  Patient had chest pain on admission along with nausea, vomiting and diarrhea.",,,,,Y,6.0,,,Y,04/10/2021,05/06/2021,26.0,"Elevated troponin, EF 30% normalized at discharge, negative urine toxicology",PVT,,None,COVID-19 PCR (+) 3/31/21,None,,,2,05/24/2021,,,,None,myocarditis,G3,22,M,26,EF 30%,EF 30%,22yo male presented with chest pain 26 days after vaccination. Workup: EF 30%. Severity indicators: EF 30%.
1347238,Coronary artery dissection,24.0,Magnetic resonance imaging heart,24.0,Myocarditis,24.0,Pain,24.0,Troponin increased,24.0,COVID19,MODERNA,032B21A,2,IM,RA,COVID19 (COVID19 (MODERNA)),05/25/2021,NY,25.0,25.0,,M,,"Pt developed upper body pain 5/17, then back and chest pain 5/18.  + Troponin.  CT showed LMCA and RCA SCAD.  Cardiac MRI showed active myocarditis.",,,Y,,Y,6.0,,,N,05/14/2021,05/17/2021,3.0,5/19/21- Troponin peaked to 1945 5/19/21- Cardiac CTA LM and RCA SCAD 5/20/21- cMRI- myocarditis,PVT,,He took Claritin on 5/12 & 13/ 2021,None besides seasonal allergies.,None,,,2,05/25/2021,,,Y,"No food or drug allergies.  Only seasonal allergies- ""Claritin for 2 days after mowing the lawn.""",myocarditis,G1,25,M,3,Cardiac MRI+,Classic presentation,25yo male presented with chest pain 3 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1347846,Troponin increased,24.0,White blood cell count increased,24.0,,,,,,,COVID19,MODERNA,unknown,2,IM,UN,COVID19 (COVID19 (MODERNA)),05/25/2021,MN,31.0,31.0,,M,,"Patient is a very pleasant 31-year-old white male who previously healthy, he works with a maintenance crew, he was in his usual state of health last week, he did receive his 2nd dose of the COVID-19 Moderna vaccine on Thursday.  Over the next 24-48 hours he began experiencing myalgias malaise and fatigue, he self treated with ibuprofen and Tylenol as needed.  He felt a little bit better on Sunday and went to assist in picking up a brush more.  During the process he became  short of breath as well as midsternal chest discomfort. He presented to the ED.    Evaluation found a CRP of 112, elevated troponins and a  leukocytosis of approximately 20,000 along with elevated neutrophils.  His influenza a and influenza B testing have been negative and his SARS COVID the PCR was negative.  Given his elevated troponins, he was started on IV heparin and admitted for further evaluation.   On admission to the floor, he was chest pain free. We were concerned for potential myo/pericarditis given his history and laboratory study findings. Cardiac MRI was performed which suggested active myocarditis with biventricular systolic dysfunction (LVEF 34%, RVEF 37%). Given his new LV dysfunction he was started on low dose lisinopril and metoprolol succinate.  It is unclear whether this is atypical viral myocarditis or whether it potentially could be vaccine related, the MRI is consistent with that of myocarditis. We did not proceed with cardiac biopsy unless since there was no evidence for clinical decompensation, unstable heart rhythm or other worrisome features. He will plan to follow up with Dr. 1 week post hospitalization with repeat echocardiography and blood work.  If at that time there are any signs of instability we would proceed with more aggressive workup at that time.    Infectious disease was consulted who recommended infectious work up including serology testing for: parvovirus IgG and IgM was positive, Herpes Virus type 6, EBV, CMV (undetected) adenovirus, enterovirus (negative) and HIV (negative) .    He does not have any family history of cardiomyopathy.  There is no family history of sudden cardiac death, he states that his family has been quite healthy from a cardiac standpoint he was previously healthy before this episode.",,,,,,,,,Y,04/15/2021,04/18/2021,3.0,see item 18,PVT,,none,none,none,,,2,05/25/2021,,,,none,myocarditis,G3,31,M,3,EF 34%; CRP 112,EF 34%,31yo male presented with chest pain 3 days after 2nd dose. Workup: EF 34%. Severity indicators: EF 34%.
1349546,Pyrexia,24.0,Viral myocarditis,24.0,,,,,,,COVID19,PFIZER\BIONTECH,EW0153,2,,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),05/26/2021,FL,22.0,,,M,,"Bleeding; Shortness of breath; Chest pain; Fever of 102; Viral myocarditis; This is a spontaneous report from a contactable consumer (parent). A 22-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration assuming left arm, at age 22 years, on 05May2021 (Batch/Lot Number: EW0153) as 2ND DOSE, SINGLE for COVID-19 immunization. The patient's medical history was reported as no. Concomitant medications were not reported. Patient historically took first dose of BNT162B2 at age 22 years on 14Apr2021 for COVID-19 immunization. Reporter's son unfortunately appeared was hospitalized for adverse reaction (bleeding) and the physician told reporter to report this. Patient had has viral myocarditis of heart on an unspecified date on May2021 after he got his second dose on 05May2021. On 06May2021, patient started having symptoms of  shortness of breath, chest pain and fever of 102 (unit: unknown) after the second dose, so he went to emergency room. Then on Friday , 07May2021, he ended up with bleeding, so admission date is 07May2021 and he is still in the hospital at the time of reporting, they don't know how long. Patient also underwent lab test and procedure that includes laboratory test on May2021, 2 weeks before, patient was fine until the second dose.  The outcome of the events was unknown.",,,,,Y,,,,U,05/05/2021,05/01/2021,,Test Date: 20210506; Test Name: Fever; Result Unstructured Data: Test Result:102; Test Date: 202105; Test Name: laboratory test; Result Unstructured Data: Test Result:Unknown result,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none,,USPFIZER INC2021523017,2,05/21/2021,,,Y,,myocarditis,G2,22,M,-4,Limited data,Viral etiology,"22yo male presented with chest pain, dyspnea, fever -4 days after 2nd dose. Confounders: Viral etiology."
1350637,Respiratory viral panel,24.0,Troponin increased,24.0,Viral myocarditis,24.0,Viral test negative,24.0,,,COVID19,PFIZER\BIONTECH,,2,IM,,COVID19 (COVID19 (PFIZER-BIONTECH)),05/26/2021,VA,16.0,16.0,,M,,"Previously healthy 16 year old male presenting to hospital as a transfer for chest pain and elevated Troponin levels concerning for myocarditis. Patient has otherwise been healthy. Two days ago he received his second dose of COVID vaccination. He initially felt fine, but later that day had some body aches. The next day he felt feverish off and on and had dull left upper sternal border chest pain intermittently. Today, he reports sharp 7/10 mid sternal chest pain, lightheadedness, sweating, chills, and intermittent non-productive cough. He presented to original hospital for evaluation. The patient admits to tactile warmth since Sunday with no documented temperatures. He recently received his second dose of Pfizer just before onset of these symptoms. He reports difficulty sleeping since Sunday, but no shortness of breath, rashes, syncope, nausea, or vomiting. He has not had any other recent illness, fevers, or known COVID-19 exposures. He denies any history of prior cardiac disease and there is no known family history of cardiac disease, arrhythmias, or sudden death in the child or adolescent period. He denies illicit or recreational drug use. In the ED, he was well appearing with pain now 1 out of 10. POC troponin was 16.8 ng/mL. He had labs pertinent for ESR 10, CRP 3.0, BNP 24. RP2 PCR was negative. UDS was negative except for opiates (s/p morphine). IV was placed and patient was started on IV fluids. EKG was obtained and showed questionable left atrial enlargement per ED read. Cardiology was consulted and performed Echocardiogram in the ED at bedside and was within normal limits. Cardiology resident team contacted for admission. Past Medical History: No major medical diagnoses Past Surgical History: Orchiopexy, T&A Family History: No cardiac family history Social History: Lives at home with mother. Has two healthy siblings not living at home Immunizations: Up to date Medications: None Allergies: NKDA Etiology of likely myocarditis remains unclear at this time. In his age group, this would most likely represent a viral myocarditis. He would likely benefit from cardiac MRI during this admission for further evaluation of myocarditis. His EKG findings with his age group are unlikely to be secondary to myocardial infarct. No arrhythmias or heart block noted on EKG at time of admission or telemetry in ED. There is no family history of autoimmune disease or cardiac disease to suggest an autoimmune component or genetic etiology.",,,,,Y,2.0,,,N,05/23/2021,05/24/2021,1.0,"for ESR 10, CRP 3.0, BNP 24. RP2 PCR was negative. UDS was negative except for opiates (s/p morphine). IV was placed and patient was started on IV fluids. EKG was obtained and showed Outside hospital Labs & EKG:  5/25/21 @ 16:33: BNP=661, EKG shows normal sinus rhythm, with possible left atrial enlargement.  No evidence of arrhythmia or heart block.   At current hospital: 5/25/21 @ 20:10 ECHO: normal, EKG: normal sinus rhythm, with possible left atrial enlargement, ST elevation. Troponin 16.8 ng/mL.  BNP 24 pg/mL.  ESR 10, CRP 3.0.  RP 2 PCR negative.  Urine drug screen positive only for opiates, which was expected given morphine administered at outside facility.",PVT,,None,None,None,,,2,05/26/2021,,Y,Y,None,myocarditis,G3,16,M,1,Trop 16.8->16.8 (peak 16.8); ST elevation; Cardiac MRI+; CRP 3.0; BNP 24.,Heart block,"16yo male presented with chest pain, dyspnea, fever 1 days after 2nd dose. Workup: Trop 16.8->16.8 (peak 16.8). Severity indicators: Heart block."
1350946,Rhinovirus infection,24.0,Troponin I increased,24.0,Ventricular hypokinesia,24.0,,,,,COVID19,PFIZER\BIONTECH,,2,IM,OT,COVID19 (COVID19 (PFIZER-BIONTECH)),05/26/2021,MA,26.0,26.0,,M,,"A 26-year-old male with no past medical history presents to the emergency department (ED) with an acute episode of chest pain. He reports initially mild dull substernal chest pain for a day prior to an episode of acute sharp chest pain that radiates to his left neck and left shoulder accompanied by diaphoresis leading him to present to the ED. He had received the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine three days prior to presentation and reported myalgia and weakness beginning within 24 hours of vaccination. His blood pressure on arrival was 126/83 mmHg and pulse was 61 bpm. Electrocardiogram (ECG) on admission showed diffuse upsloping 2mm STE, no reciprocal changes, and PR elevation in aVR. Troponin-I on admission was 6.03 ng/ml prior to peaking at 21 ng/ml while initial CRP was 56.8 mg/L. Transthoracic echo (TTE) showed left ventricular ejection fraction (LVEF) of 55-60% with hypokinesis of the basal lateral wall. Cardiac magnetic resonance imaging (CMR) was consistent with myocarditis showing subepicardial late gadolinium enhancement (LGE) in the basal inferior wall, no edema on T2 sequences, and a mildly reduced left ventricular systolic function with an LVEF of 51%. He was started on colchicine, low dose beta blocker and losartan and improved symptomatically along with resolution of the EKG findings prior to being discharged with plan for close outpatient follow-up and repeat imaging.  In addition, a respiratory viral PCR panel was obtained which was positive for Rhinovirus/Enterovirus on nasal swab. Although it is possible that his presentation was secondary to enteroviral myocarditis, the temporal relationship to the second dose of Pfizer-BioNTech mRNA COVID-19 vaccine suggests the possibility of myocarditis secondary to immunologic response to COVID-19 vaccine itself.",,,,,Y,2.0,,,Y,04/22/2021,04/23/2021,1.0,See above,PVT,,None,Possible URI/sinusitis 2 to 3 weeks but return to baseline after 3 to 5 days,None,,,2,05/26/2021,,,,None,myocarditis,G3,26,M,1,EF 51%; CRP 56.8,EF 51%,26yo male presented with chest pain 1 days after 2nd dose. Workup: EF 51%. Severity indicators: EF 51%.
1354460,Troponin,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,,UNK,,,COVID19 (COVID19 (PFIZER-BIONTECH)),05/27/2021,CA,19.0,19.0,,M,,"Chest pain, palpitations. Diagnosed with myocarditis at hospital. (admitted 5/14/21-5/16/21).",,,,,Y,3.0,,,U,05/11/2021,05/14/2021,3.0,Troponin 23 echocardiogram normal cardiac catheterizatoin normal,PVT,,"Lorazepam, lithium carbonate, fluvoxamine",Bit by a venomous catfish one week prior,"OCD, anxiety, depression",,,2,05/27/2021,,,,"Risperidone - dry mouth, restlessness",myocarditis,G2,19,M,3,Trop 23.0,Lithium,19yo male presented with chest pain 3 days after vaccination. Workup: Trop 23.0. Confounders: Lithium.
1354522,Pleuritic pain,24.0,Pyrexia,24.0,Tachycardia,24.0,Troponin,24.0,,,COVID19,PFIZER\BIONTECH,ew0185,2,,,COVID19 (COVID19 (PFIZER-BIONTECH)),05/27/2021,CT,38.0,38.0,,F,,"Patient is a 30-year-old previously healthy Mediterranean woman complaining substernal squeezing chest pain for 2 days in the setting of 2nd Pfizer COVID vaccine 2 days ago.  The chest pain is pleuritic but otherwise has no exacerbating or relieving factors.  It does not radiate.  She has never had this pain before.  The patient is worried about myocarditis or blood clot as she has heard the can be reactions from the vaccine.  The pain is associated with shortness of breath.  She denies vomiting, diarrhea.  She has had some fever, chills and myalgias over the past few days.  She denies cough.  She denies history of VTE, hemoptysis, history of immobilization or trauma, estrogen birth control.  She denies family history of early cardiac death or MI.   38y/o woman with no significant past medical history who had her second Pfizer vaccine on Monday and later that day developed low grade fever/ diffuse myalgias/ pleuritic and positional central dull 5/10 chest pain. On Tuesday and Wednesday she remained bedridden with same sx. Thursday morning felt improved except had persistent chest pain for which she presented to the ED for evaluation. She had tachycardia, +troponins, and +DDimer. EKG was negative for acute changes. She was admitted to the cardiology service for suspected myocarditis. She was started on colchicine, standing ibuprofen, and metoprolol.  Echocardiogram complete on 5/21 was normal with an EF of 60%. She was evaluated again after her echo. She continued to feel significantly improved on medical therapy and was discharged home on 05/21/21. She will continue medical therapy as listed. She will follow-up with as arranged on 5/25/21.",,,,,Y,,,,N,05/17/2021,05/20/2021,3.0,"trop 0.39, EKG ECHO MRI",PVT,,none,none,none,,,2,05/27/2021,,Y,Y,none,myocarditis,G3,38,F,3,EF 60%,EF 60%,"38yo female presented with chest pain, dyspnea, fever 3 days after vaccination. Workup: EF 60%. Severity indicators: EF 60%."
1357322,COVID-19,24.0,SARS-CoV-2 test,24.0,Vaccination failure,24.0,,,,,COVID19,PFIZER\BIONTECH,EH9899,2,OT,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),05/28/2021,MA,29.0,,,M,,"Breakthrough COVID infection; Breakthrough COVID infection; This is a spontaneous report from a contactable Nurse. This Nurse reported in response to HCP letter. A 29-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EH9899 and expiry date: unknown), dose 2 via intramuscular, administered in Deltoid Left on 07Jan2021 as 2nd DOSE, SINGLE for Covid-19 immunization. The patient medical history and concomitant medications were not reported.  The patient experienced breakthrough Covid-19 infection on 17Feb2021. The patient underwent lab tests and procedures which included an asymptomatic COVID test (COVID 19 PCR-done of state) prior to visiting elderly family on 17Feb2021 which was positive. The patient was then re-tested using SARS-CoV-2 on 22Feb2021 and 23Feb2021, both of which were negative. The patient was not hospitalized and not admitted to an Intensive Care Unit. The patient did not display clinical signs at rest indicative of severe systemic illness. The patient did not require supplemental oxygen (including high flow or ECMO) or receive mechanical ventilation. The patient did not experience respiratory symptoms like Dyspnea, Tachypnea, Hypoxemia, COVID-pneumonia, Respiratory failure, Acute Respiratory Distress Syndrome (ARDS) and cardiovascular symptoms like Heart failure ,Cardiogenic shock, Acute myocardial infarction, Arrhythmia , Myocarditis and Gastrointestinal/Hepatic   symptoms like Vomiting, Diarrhea ,Abdominal pain, Jaundice, Acute liver failure and vascular symptoms like Deep vein thrombosis, Pulmonary embolism, Limb ischemia, Vasculitis and  any other thromboembolic events) and renal symptoms like acute kidney injury, Renal failure and Neurological  symptoms like Altered consciousness, Convulsions/seizures, Encephalopathy, Meningitis, cerebrovascular accident and Hematological symptoms like thrombocytopenia, Disseminated intravascular coagulation and dermatological  symptoms like Chillblains, Erythema multiforme and other symptoms like multisystem inflammatory syndrome. The patient did not receive any additional therapies for COVID-19.  On an unknown date in Feb2021 the outcome of the events was recovered.  Follow up attempts are needed. Further information has been requested.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 or comirnaty to the reported event vaccination failure and covid-19 cannot be ruled out.",,,,,,,,,Y,01/07/2021,02/17/2021,41.0,Test Date: 20210222; Test Name: Abbott Alinity; Result Unstructured Data: Test Result:Negative; Comments: Negative; Test Date: 20210223; Test Name: Abbott Alinity; Result Unstructured Data: Test Result:Negative; Comments: Negative; Test Date: 20210217; Test Name: covid-19 PCR done of state; Result Unstructured Data: Test Result:positive; Comments: positive,PVT,,,,,,USPFIZER INC2021550444,2,05/24/2021,,,,,myocarditis,G3,29,M,41,Limited data,ECMO; Cardiogenic shock,29yo male presented with dyspnea 41 days after 2nd dose. Severity indicators: ECMO; Cardiogenic shock.
1361389,Troponin increased,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,,UNK,IM,,COVID19 (COVID19 (PFIZER-BIONTECH)),05/29/2021,MD,43.0,43.0,,F,,"Patient developed sharp substernal chest pain that was worse when lying down ~36h after her second dose of the Pfizer COVID vaccine in addition to typical side effects including subjective fever and malaise. Pain became constant on the second day post vaccination, and patient presented to the ED and was admitted to the Cardiac Progressive Care Unit. Laboratory data suggested acute pericarditis. PE was ruled out by CTA. The CTA also revealed normal appearing coronary arteries without calcification (a coronary event is unlikely). Her echo was normal, suggesting no significant myocardial involvement. No pericardial rub was heard. She was treated with high dose aspirin and became asymptomatic rapidly.",,,,,Y,1.0,,,Y,04/19/2021,04/20/2021,1.0,"ESR 49, CRP 10.3 (4/22/2021) Troponin  0.40 -> 0.68 -> 0.91 -> 0.99 -> 0.89 (4/21/21 to 4/22/21) ProBNP 1000 (4/21/21 ) Lactate 0.9 (4/21/21 ) D-dimer 0.32 (4/21/21 )  CXR: No acute cardiopulmonary findings (4/21/21) CTA: 1.  No pulmonary embolism. No CT evidence of acute abnormality in the chest. 2.  Multiple enlarged left axillary lymph nodes, nonspecific and can be seen in the setting of recent COVID vaccine to the left arm. 3.  Multiple tiny pulmonary micronodules in the bilateral lungs. (4/21/21) TTE: Normal left ventricular cavity size.  Normal global left ventricular  systolic function.  EF estimated at 60-65%.  Normal diastolic filling    pattern for age.  Normal right ventricular size.  Normal right ventricular global  systolic function.  RVSP (PA systolic pressure from tricuspid    regurgitation jet) is estimated at 16 mmHg. Normal pulmonary  artery systolic pressure. No pericardial effusion. (4/22/21)",PVT,,sumatriptan 25 mg as needed for migraines,None,BMI 32. No other chronic conditions or pertinent past medical history.,,,2,05/29/2021,,Y,Y,Amoxicillin causes skin rash,pericarditis,clean,43.0,F,1,"Chest pain, Echo findings, CRP/ESR, Pericardial effusion, Friction rub",clean,Patient developed sharp substernal chest pain that was worse when lying down ~36h after her second dose of the Pfizer COVID vaccine in addition to typical side effects including subjective fever and m
1382523,Chest pain,24.0,Echocardiogram normal,24.0,Magnetic resonance imaging heart,24.0,Myocarditis,24.0,Troponin increased,24.0,COVID19,PFIZER\BIONTECH,ER8729,1,IM,RA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/08/2021,GA,19.0,19.0,,M,,"Patient presented with severe crushing chest pain and was found to have elevated troponin levels. He was diagnosed with myocarditis. Echo showed normal heart function. Cardiac MRI was also done and showed normal heart function with a faint scar suggestive of myocarditis. Overall, findings suggested post vaccine related myocarditis.",,,,,Y,2.0,,,Y,04/28/2021,05/01/2021,3.0,Abnormal troponin- 2.82,PVT,,None,None,None,,,2,06/08/2021,,,Y,Penicillin,myocarditis,G1,19,M,3,Trop 2.82->2.82 (peak 2.82); Cardiac MRI+,Classic presentation,"19yo male presented with chest pain 3 days after vaccination. Workup: Trop 2.82->2.82 (peak 2.82). Diagnosed with acute myocarditis, classic post-vaccine profile."
1382634,SARS-CoV-2 test negative,24.0,Troponin increased,24.0,,,,,,,COVID19,PFIZER\BIONTECH,EW0186,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/08/2021,MA,13.0,13.0,,F,,Patient received her second Pfizer vaccine on Friday (6/4). She developed CP and SOB on Saturday (6/5) evening which resolved after sleeping. She then developed return of her chest pain and shortness of breath this morning (6/7) which prompted her to present to  ED. She was found to have elevated troponins and was diagnosed with myocarditis.   Treatment was supportive with NSAIDs/Tylenol for chest pain PRN and encouraged PO hydration. Troponins and EKGs trended every 8 hours to ensure troponins were down-trending and EKGs remained normal. No sign of CHF or pulmonary edema.,,,,,Y,,,,N,06/04/2021,06/05/2021,1.0,"Elevated troponin; mildly elevated CSR and ESR. All other labs unremarkable (normal EKG, BNP, CXR, CBC, negative viral panel, TSH, BMP,  negative COVID)",OTH,,none,none,none,,,2,06/08/2021,,,,apples,myocarditis,G2,13,F,1,Limited data,Viral etiology,"13yo female presented with chest pain, dyspnea 1 days after vaccination. Confounders: Viral etiology."
1382955,Electrocardiogram normal,24.0,Fatigue,24.0,Insomnia,24.0,Pain in extremity,24.0,SARS-CoV-2 test negative,24.0,COVID19,PFIZER\BIONTECH,EW0187,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/08/2021,CA,15.0,15.0,,M,,"My 15-year-old son received dose #2 of Pfizer?s Covid-19 vaccine at 10:30am on 6/6/21. At 1:00am on 6/8/21 he was struggling to breathe due to pain in the center of his chest upon inhalation. Nothing like this has ever happened to him before. His chest pain was worse lying down and he could not lie down or sleep and wanted to stay standing on his feet. He felt pain in both forearms too. He was crying from the pain and the difficulty of breathing, and was very tired but unable to recline in order to sleep. I called the advice nurse, who checked with the doctor on call at his pediatrician?s office, and she told us to go to the ER due to concern it may be myocarditis or pericarditis.",,,,,,,,,U,06/06/2021,06/08/2021,2.0,"The doctor said: ?You most likely have muscle aches, not likely myocarditis.? EKG normal. Ultrasound of heart normal. C-Reactive Protein was elevated at 18 but the doctor said that was a normal result of my son receiving his second dose of the Pfizer Covid-19 vaccine. Covid-19 test negative. The cardiologist said it was okay for my son to go home and continue taking ibuprofen as needed to control the chest pain.",PHM,,None,None,None,,,2,06/08/2021,,Y,Y,None,myocarditis,G1,15,M,2,Limited data,Classic presentation,15yo male presented with chest pain 2 days after 2nd dose. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1386123,Chest X-ray abnormal,24.0,Chest pain,24.0,Myocarditis,24.0,Pyrexia,24.0,Troponin increased,24.0,COVID19,PFIZER\BIONTECH,EW0176,1,IM,UN,COVID19 (COVID19 (PFIZER-BIONTECH)),06/09/2021,CA,15.0,15.0,,M,,"15 yo M with chest pain, fever found to have likely myocarditis secondary to likely COVID vaccine (Pfizer) with elevated troponin at OSH of 660 ng/L. Repeat here noted to be 58,513 mg/L but patient otherwise stable, not complaining of chest pain after Toradol and eating more currently.",,,Y,,Y,2.0,,,N,06/06/2021,06/08/2021,2.0,"Troponin, CXR",PHM,,,None,None,,,2,06/09/2021,,Y,Y,NKDA none,myocarditis,G1,15,M,2,Limited data,Classic presentation,"15yo male presented with chest pain, fever 2 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile."
1394458,Chest pain,24.0,Computerised tomogram,24.0,Costochondritis,24.0,SARS-CoV-2 test negative,24.0,Sleep disorder,24.0,COVID19,PFIZER\BIONTECH,,2,SYR,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/12/2021,TX,25.0,25.0,,M,,"Woke up in the middle of the night with sharp chest pain. Went to the ER and was diagnosed with costochondritis. I recovered within a few days just medicating with advil and tylenol. I am reporting this incident because I have seen reports from the CDC about cases of myocondritis occuring after vaccination, and symptoms very similar to what I experienced.   https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html",,,,,,,,,Y,04/24/2021,05/11/2021,17.0,"Tested positive for COVID-19 with a rapid test, but also had a PCR test which came back negative. 5/11/21  I also received a CT scan to look for blood clots. 5/11/21",OTH,,,,,,,2,06/12/2021,,,Y,,myocarditis,G2,25,M,17,Limited data,COVID-19 positive,25yo male presented with chest pain 17 days after vaccination. Confounders: COVID-19 positive.
1395737,SARS-CoV-2 antibody test positive,24.0,Troponin increased,24.0,,,,,,,COVID19,PFIZER\BIONTECH,EW0165,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/14/2021,NC,15.0,15.0,,M,,"Got second dose of vaccine 6/2.  Same day had chills, myalgia, fatigue and soreness at injection site.  6/3 developed substernal chest pain and dyspnea.  Admitted to hospital for suspected myocarditis given elevated troponin and mildly elevated inflammatory markers 6/4.   No treatments given.  Symptoms resolved and troponins improved prior to discharge 6/8.  He remains well today 6/14.",,,Y,,Y,4.0,,,Y,05/13/2021,06/02/2021,20.0,"Troponin (6/4) 56, (6/6) 1097, 6/8 (98) EKG (6/4,5,6) wnl ECHOcardiogram (6/5), (6/7) wnl CBCd, CMP (6/4) wnl ESR (6/4) 30 CRP (6/4) 98,  (6/6) 34 mg/L ID work up (6/7):   1. Respiratory viral panel negative  2. COVID Ab positive 3. Enterovirus, adenovirus, parvovirus B19 Qual PCR blood neg 4. Quant PCR EBV, CMV blood PCR neg 5. Lyme serologies neg",PVT,,None,None,Autism Epistaxis Ehlers Danlos hypermobility Von Willebrands disease type 1,,,2,06/14/2021,,,,Sulfa,myocarditis,G2,15,M,20,CRP 6,Viral etiology,"15yo male presented with chest pain, dyspnea 20 days after 2nd dose. Confounders: Viral etiology."
1396077,Angina pectoris,24.0,Electrocardiogram normal,24.0,,,,,,,COVID19,PFIZER\BIONTECH,EW0217,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/14/2021,WA,17.0,17.0,,M,,"Within 24 hours of receiving his 2nd vaccination, my son began complaining about heart pain. He described them as sporadic, and mild in nature - mostly an annoyance. The pain was not associated with increased heart rate or increased/labored breathing.  He has never experienced anything similar in the past and is in exceptionally good health (He runs long distance cross country and track for his high school). Three days from his vaccination, I took him to his primary care physician where the performed and ECG which the doctor interpreted as ""normal"", and most likely not Myocarditis. He recommended Advil (3 tablets up to 4 times a day) for a few days, to reduce any potential inflammation, which he began immediately.   Once he began the Advil regiment, his conditions ceased to come back and he has not experienced any further episodes even after he stopped taking Advil. Is is now exactly 7 days after his 2nd vaccine.",,,,,,,,,Y,06/04/2021,06/05/2021,1.0,"ECG as noted above; interpreted as ""normal"" by the doctor",PHM,,one-a-day gummy vitamins,none,none,,,2,06/14/2021,,Y,,none,myocarditis,G1,17,M,1,Limited data,Classic presentation,17yo male presented with cardiac symptoms 1 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1397727,Ventricular dyskinesia,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,,2,IM,,COVID19 (COVID19 (PFIZER-BIONTECH)),06/14/2021,NH,12.0,12.0,,M,,"Patient presented to emergency room on 6/7/21 with chest pain, chills and fatigue. His troponin was noted to be elevated concerning for myocarditis. He was hemodynamically stable. He was admitted to Pediatric ICU for close monitoring and remained stable on admission. Initial echo was concerning for low normal function, however cardiac MRI showed normal function. His troponins trended down with ibuprofen therapy for anti-inflammation and he was discharged to home on 6/9/21.",,,,,Y,2.0,,,Y,06/05/2021,06/06/2021,1.0,"6/8/21 @ 0140 - Troponin 8.23ng/ml (<0.03ng/ml) 6/8/21 @ 0435 - Troponin 9.13ng/ml 6/8/21 @ 0843 - Troponin 8.22ng/ml 6/8/21 @ 1405 - Troponin 5.79ng/ml 6/9/21 @ 0537 - Troponin 5.06ng/ml 6/9/21 @ 1207 - Troponin 3.62ng/ml  06/08/21: Echocardiogram: The intracardiac anatomy is normal. Technically difficult imaging due to patient body habitus. Global LV function appears to be normal shortening fraction is 32%, however, there is septal dyskinesia. There is a trivial posterior pericardial effusion. 06/08/21: Cardiac MRI; Global LV function is within normal limits, The sf = 36% and the EF by Simpson's is 58%. This is improved from study 15 hours ago. There is no mitral regurgitation. There is a trivial posterior pericardial effusion.There is trace tricuspid regurgitation. The right ventricle systolic pressure is 20-24 mmHg above the right atrial pressure. Normal coronaries.",PVT,,Albuterol PRN,None reported,Asthma Obesity,,,2,06/14/2021,,,Y,None,myocarditis,G1,12,M,1,Trop 3.62->9.13 (peak 9.13); Cardiac MRI+; Pericardial effusion,Classic presentation,"12yo male presented with chest pain 1 days after vaccination. Workup: Trop 3.62->9.13 (peak 9.13). Diagnosed with acute myocarditis, classic post-vaccine profile."
1400188,Myocarditis,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,EW0151,2,IM,,COVID19 (COVID19 (PFIZER-BIONTECH)),06/15/2021,IL,15.0,15.0,,M,,Myocarditis,,,,,Y,,,,,06/11/2021,06/13/2021,2.0,,PVT,,,,,,,2,06/15/2021,,,,,myocarditis,G1,15,M,2,Limited data,Classic presentation,15yo male presented with cardiac symptoms 2 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1400232,Troponin increased,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,,UNK,,,COVID19 (COVID19 (PFIZER-BIONTECH)),06/15/2021,IL,14.0,14.0,,M,,"Chest pain two days after receiving vaccine. Labs obtained were troponin elevated to 21.8 BNP 230, diagnosis of myocarditis. Troponin levels are down trending. Echocardiogram obtained and plan for cardiac MRI. EKG obtained overall unremarkable.",,,,,Y,2.0,,,,06/12/2021,06/14/2021,2.0,,UNK,,,,,,,2,06/15/2021,,,,No known allergies,myocarditis,G1,14,M,2,Trop 21.8; Cardiac MRI+; BNP 230,Classic presentation,"14yo male presented with chest pain 2 days after vaccination. Workup: Trop 21.8. Diagnosed with acute myocarditis, classic post-vaccine profile."
1400865,Fatigue,24.0,Fibrin D dimer,24.0,Full blood count,24.0,Metabolic function test,24.0,Myalgia,24.0,COVID19,PFIZER\BIONTECH,EW0162,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/15/2021,MO,23.0,23.0,,M,,"Around 3:30 am on 4/17/21 typical vaccine side effects started: muscle aches, fatigue, temp. Symptoms continued through day time 4/17. Highest temp 102, took tylenol every 4 hours to help with fever and aches. At 9:30 pm began with continuous strong chest pain/shortness of breath. Nothing made it feel better. 9:45 PM Called after hour line of primary physician, who recommended going to ER. Left for ER at 10 PM. Chest pain had eased somewhat on the way to ER. Was seen at ER. Received EKG, lab work, CT scan, IV fluids and toradol. Chest pain was mild in ER and felt better by discharge around 3:30 AM.  Felt normal by 4/19/21 and returned to work. Have seen a few reports in news about myocarditis/pericarditis in males which seem to fit patients experience, so wanted to report the incident.",,,,,,,,,Y,04/16/2021,04/17/2021,1.0,"4/17/21 EKG, CBC, CMP, Troponin, D-Dimer, Chest CT Received IVF's and toradol.",PVT,,None,None,None,,,2,06/15/2021,,,Y,None,myocarditis,G1,23,M,1,Limited data,Classic presentation,"23yo male presented with chest pain, dyspnea, fever 1 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile."
1403701,Magnetic resonance imaging heart,24.0,Myocarditis,24.0,Ventricular hypokinesia,24.0,,,,,COVID19,MODERNA,,2,IM,AR,COVID19 (COVID19 (MODERNA)),06/16/2021,MA,25.0,25.0,,M,,"The patient presented 3 days after receiving the 2nd dose of Moderna vaccine with chest pain. Initially, the patient was started on Heparin drip, a beta-blocker, high-intensity statin, and aspirin.  Cardiac MRI showed evidence of myocarditis with normal biventricular systolic functions. An echocardiogram showed a normal Ejection fraction with apical hypokinesis. The patient was discharged on aspirin only. In the last follow-up visit, the patient denies any recurrence of chest pain.",,,,,Y,3.0,,,,04/07/2021,04/10/2021,3.0,,UNK,,,,,,,2,06/16/2021,,,Y,,myocarditis,G1,25,M,3,Cardiac MRI+,Classic presentation,25yo male presented with chest pain 3 days after 2nd dose. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1412506,White blood cell count,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,,2,,,COVID19 (COVID19 (PFIZER-BIONTECH)),06/19/2021,,,,,M,,"This is a literature report from the Pediatrics, 2021, entitled Symptomatic Acute Myocarditis in Seven Adolescents Following Pfizer BioNTech COVID-19 Vaccination with DOI: 10.1542/peds.2021-052478. Additionally reported in Pediatrics, 2021, entitled Myocarditis after SARS-CoV-2 Vaccination: True, True, and Related? with DOI: 10.1542/peds.2021-052644 via contactable Physicians. This Physician reported similar events for seven patients. This is the sixth of seven reports. Introduction: On 11Dec2020, the FDA issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 mRNA vaccine for prevention of COVID-19 for individuals 16 years of age and older.1. On 10May2021, the FDA revised the EUA for this vaccine to include children 12 years and older. The Pfizer vaccine remains the only vaccine with an EUA for 12-to 17-year-old children. This vaccine demonstrated 94-95% efficacy in preventing COVID-19 infection in 16- 55-year-old participants, and 100% efficacy in the 12-15 years old age group. Systemic reactogenicity occurred more commonly in younger patients and after the second dose of vaccine. Post-immunization myocarditis is a known rare adverse event following other vaccinations, particularly following smallpox vaccination. Recently the news media has highlighted reports of myocarditis after COVID-19 mRNA vaccination involving United States (US) military patients and patients from Israel. The Israeli cohort identified a male predominance with an incidence of 1/20,000 (men aged 18 to 30 years old). However, a conclusive causal link to vaccination has not been confirmed at this time. Additionally, two recently published European case reports describe myocarditis after COVID-19 mRNA vaccination in a 56-year-old man with previous COVID-19 and a 39-year-old man with no history of COVID-19. This report summarizes case histories of 7 healthy male adolescents 14 to 19 years of age who developed acute myocarditis or pericarditis within 4 days after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, none of whom met criteria for MIS-C. All 7 patients were vaccinated in April and May of 2021 and have been reported to VAERS. Patient 6: A 16-year-old previously well male was admitted with a chief complaint of chest pain. His initial symptoms began 3 days after the second Pfizer-BioNTech COVID-19 vaccine with malaise and subjective fever. He had no recent or remote history of viral illness, and no known COVID-19 exposures. The night prior to admission he developed acute midsternal chest pain that lasted for approximately 18 hours. Evaluation in the ED showed an elevated troponin T (0.66 ng/mL, normal range, <0.01 ng/mL), ST-elevation on ECG but normal function and structure on echocardiogram. Cardiac MRI demonstrated diffuse edema and subepicardial late gadolinium enhancement. A nasopharyngeal SARS-CoV-2 PCR was negative and antibody testing showed positive spike and negative nucleocapsid antibodies for SARS-CoV-2. He was treated with 70 grams IVIG and started on prednisone 30 mg orally twice daily with a gradual taper over 4 weeks. He did not receive any non-steroidal anti-inflammatory drugs (NSAID). Troponin T climbed after admission and remained elevated throughout the hospitalization. Chest pain resolved after administration of 6 mg of morphine in the initial ED evaluation. Telemetry was normal throughout hospitalization. He was discharged 3 days after admission. He had not yet returned for follow-up visit at the time of this submission. Exposure to COVID-19 in 14 days prior to illness onset was None. The patient underwent lab tests and procedures which included activated partial thromboplastin time prolonged: 27.9 seconds, alanine aminotransferase: 22 (units/L), antibody test negative: negative, antibody test positive: antibody testing showed positive spike and negative nucleocapsid antibodies for SARS-CoV-2, aspartate aminotransferase: 59 (units/L), blood albumin: 3.8 g/dl, body mass index: 22, brain natriuretic peptide increased: 149 pg/ml, c-reactive protein: 1.5 mg/dl, c-reactive protein increased: 1.8 mg/dl, cytomegalovirus test negative: negative, echocardiogram: normal, electrocardiogram: st-elevated, ST-elevation on ECG but normal function, enterovirus test negative: negative, epstein-barr virus antibody negative: negative, International Normalized Ratio INR: 1.06, Other diagnostics: Negative Lyme serology, negative Mycoplasma serum PCR, negative Parvovirus serum PCR, Absolute lymphocyte count: 1.4/mm3, Absolute neutrophil: 2.8 /mm3, Platelet count: 189, Mycoplasma serum PCR: Negative, Respiratory pathogen panel PCR: Negative, Prothrombin time: 11.4 seconds, Erythrocyte sedimentation rate: 3 (mm/hr), COVID-19 spike antibody: Positive, Ferritin: 65 ug/L, Highest troponin: 0.82 ng/ml, Lowest troponin prior to Discharge: 0.01 ng/ml, Peripheral white blood cell count: 5.0. Discussion: Author report 7 cases of clinical myocarditis or myopericarditis that developed in 14 to 19-year-old males within 4 days of receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine with no evidence of acute SARS-CoV-2 infection and who did not fulfill criteria for MIS-C. Extensive diagnostic evaluation for other myocarditis etiologies was negative, including respiratory pathogens from nasopharyngeal swabs, serum PCR tests, and infectious serologies. Additionally, all cardiac MRIs were diagnostic for myocarditis based on the modified Lake Louise criteria rather than MIS-C characteristics described by (withheld) et al (diffuse myocardial edema without evidence of late gadolinium enhancement). There was some suggestion of abnormal left ventricular myocardial echocardiographic strain corresponding to regions of myocardial necrosis on cardiac MRI. All patients in this series had myocarditis or myopericarditis, which is the term for diagnosis of both myocardial and pericardial inflammation. These terms are often used interchangeably, which can make surveillance of these diseases challenging. Myocarditis and pericarditis are rare diseases. The true baseline incidence of myocarditis is unknown and varies by season, geography, and age: it has been reported to occur in 1.95/100,000 person- years in children <15 years of age in Finland and in 2.16 cases per 100,000 US military service members in a 30-day period. It is more common in males, and among children demonstrates a bimodal incidence pattern, with peaks at <2 years of age and in adolescence. An evaluation for potential viral causes is recommended, although a cause is usually not found. There have been prior reports of myocarditis following smallpox vaccination10. In patients with myocarditis, restriction from competitive sports is recommended for at least 3 months until cleared by a cardiologist in order to avoid sudden cardiac events while the heart muscle recovers. Less is known about the true incidence of pericarditis. Pericarditis can occur in the setting of a variety of infectious and non-infectious illnesses. In a study of patients more than16 years of age in Finland, the incidence rate of hospitalizations for acute pericarditis was 3.32/100,000 person-years, with males at higher risk than females and in 2007, the incidence of acute pericarditis in one study was 27.2 cases per 100,000 per year. Treatment for myocarditis and pericarditis may vary considerably depending on the patient characteristics, clinical condition, underlying cause, and physician preference. Consistent with a known male preponderance of myocarditis and pericarditis, all seven of our cases were male. The Pfizer-BioNTech clinical trials demonstrated an increased systemic reactogenicity and immunogenicity in younger study participants following mRNA vaccine. For example, 41.5% of adolescents developed chills after dose #2, compared to 35.1% of subjects 18-55 years of age. In terms of immunogenicity, an analysis of SARS-CoV-2 50% neutralizing titers 1 month after dose#2 demonstrated higher geometric mean titer (GMT) in children 12-15 years of age (GMT=1,239.5), compared to subjects 16-25 years of age (GMT=705.1). Adverse events often occurred more frequently after dose #2 and within 2 days following vaccination and included injection site pain, fatigue, myalgia, chills, arthralgia, fever, injection site swelling or redness, nausea, malaise, and lymphadenopathy. It is possible that myocarditis or myopericarditis may be an additional rare adverse event related to systemic reactogenicity, but currently no causal association has been established between this vaccine and myopericarditis. In our case series, 6 patients received non-steroidal anti-inflammatory drug (NSAID) treatment. Four patients received IVIG and oral prednisone; one of these four patients also initially received high-dose methylprednisolone. The recognition of a possible temporal relationship of COVID-19 vaccine and myocarditis is critical, because the correct diagnosis may spare healthy adolescents and young adults presenting with chest pain and ECG ST elevation from undergoing unnecessary invasive medical procedures such as cardiac catheterization. It is unclear if treatment with intravenous immunoglobulin and/or corticosteroids, in the absence of MIS-C criteria, is warranted with all cases of myocarditis that develop temporally after COVID-19 vaccination. Notably, 3 patients recovered with NSAID therapy alone. Myocarditis and myopericarditis after COVID-19 vaccination appear rare. As of 23May2021, the Centers for Disease Control and Prevention (CDC) reports that 1,560,652 people <18 years of age have completed a two-dose series of COVID-19 vaccine17. Of these, 652, 758 adolescents received their second dose more than fourteen days ago17. Currently, the Pfizer-BioNTech COVID-19 vaccine is the only COVID-19 vaccine authorized for children <18 years of age in the US. We urge physicians and healthcare providers to consider myocarditis in the evaluation of adolescents and young adults who develop chest pain after COVID-19 vaccination. All cases of myocarditis in patients with recent COVID-19 vaccination should be reported promptly to VAERS. Our case series has inherent limitations. We compiled cases through personal communications between colleagues rather than using a systematic surveillance system to identify cases. It was not possible to exclude all alternative etiologies including idiopathic and other infectious etiologies, and there was not a systematic diagnostic evaluation for other viral etiologies. Cardiac biopsy was not performed on any patients, because they were all clinically stable during hospitalization. However, no patient had evidence of a preceding or concurrent symptomatic viral illness to implicate as an etiology of myocarditis, and the lack of eosinophilia dissuades a hypersensitivity reaction. The pathophysiology of myocarditis in these patients is indeterminate and we do not know if it is the same or different than classic myopericarditis or myopericarditis following other vaccines, associated with acute COVID-19, or MIS-C. Given the nature of a case series, we cannot determine the incidence rate of myocarditis/myopericarditis following COVID-19 mRNA vaccination. Finally, a negative nucleocapsid antibody does not conclusively rule out the possibility of natural infection. This report summarizes a series of US cases of myocarditis and myopericarditis following the Pfizer BioNTech COVID-19 mRNA vaccine in adolescent males. All cases in this report occurred after the second vaccine dose. Fortunately, none of our patients was critically ill and each was discharged home. At present, there is no definite causal relationship between these cases and vaccine administration.  Information on the lot/batch number has been requested.; Sender's Comments: Based on chronological connection to the vaccine causality between reported event acute myocarditis and Pfizer-BioNTech COVID-19 mRNA vaccine cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021665013 Same reporter, drug, event but different patient",,,,,Y,3.0,,,U,,,,"Test Name: Partial thromboplastin time; Test Result:  27.9 s; Test Name: Alanine transaminase; Result Unstructured Data: Test Result:22 IU/l; Comments: (units/L); Test Name: COVID-19 nucleocapsid antibody; Test Result: Negative  ; Test Name: Antibody test; Test Result: Positive  ; Comments: antibody testing showed positive spike and negative nucleocapsid antibodies for SARS-CoV-2; Test Name: Aspartate transaminase; Result Unstructured Data: Test Result:59; Comments: (units/L); Test Name: Albumin; Result Unstructured Data: Test Result:3.8 g/dl; Test Name: BMI; Result Unstructured Data: Test Result:22; Test Name: NT pro-BNP; Result Unstructured Data: Test Result:149 pg/mL; Test Name: C-reactive protein; Test Result:  1.5 mg/dl; Test Name: Highest C-reactive protein; Test Result:  1.8 mg/dl; Test Name: Cytomegalovirus Disagnostics; Test Result: Negative  ; Test Name: Echocardiogram; Result Unstructured Data: Test Result:Normal; Test Name: ECG; Result Unstructured Data: Test Result:ST-Elevated; Comments: ST-elevation on ECG but normal function; Test Name: Enterovirus diagnostics; Test Result: Negative  ; Test Name: Epstein-Barr virus Diagnostics; Test Result: Negative  ; Test Name: International Normalized Ratio INR; Result Unstructured Data: Test Result:1.06; Test Name: lab test; Result Unstructured Data: Test Result:Negative Lyme; Comments: Other diagnostics: Negative Lyme serology, negative Mycoplasma serum PCR, negative Parvovirus serum PCR; Test Name: Absolute lymphocyte count; Result Unstructured Data: Test Result:1.4 /mm3; Test Name: MRI; Result Unstructured Data: Test Result:demonstrated diffuse edema; Comments: Cardiac MRI demonstrated diffuse edema; Test Name: Absolute neutrophil; Result Unstructured Data: Test Result:2.8 /mm3; Test Name: Platelet count; Result Unstructured Data: Test Result:189 /mm3; Test Name: Mycoplasma serum PCR; Test Result: Negative  ; Test Name: Respiratory pathogen panel PCR; Test Result: Negative  ; Test Name: Prothrombin time; Test Result:  11.4 s; Test Name: Erythrocyte sedimentation rate; Result Unstructured Data: Test Result:3; Comments: (mm/hr); Test Name: COVID-19 spike antibody; Test Result: Positive  ; Test Name: Nasopharyngeal SARS-CoV-2 PCR; Test Result: Negative  ; Test Name: Ferritin; Result Unstructured Data: Test Result:65 ug/L; Test Name: Highest troponin; Result Unstructured Data: Test Result:0.82 ng/ml; Test Name: Lowest troponin prior to Discharge; Result Unstructured Data: Test Result:0.01 ng/ml; Test Name: Elevated troponin T; Result Unstructured Data: Test Result:0.66 ng/ml; Comments: Evaluation in the ED showed an elevated troponin T (0.66 ng/mL, normal range, <0.01 ng/mL); Test Name: Peripheral white blood cell count; Result Unstructured Data: Test Result:5.0 /mm3",UNK,,,,,,USPFIZER INC2021665019,2,06/18/2021,,,,,myocarditis,G2,?,M,?,Trop 0.82->0.82 (peak 0.82); ST elevation; Cardiac MRI+,Viral etiology,"Age unknown male presented with chest pain, fever unknown interval after 2nd dose. Workup: Trop 0.82->0.82 (peak 0.82). Confounders: Viral etiology."
1412996,Pyrexia,24.0,Sleep disorder,24.0,,,,,,,COVID19,PFIZER\BIONTECH,EWO191,UNK,,,COVID19 (COVID19 (PFIZER-BIONTECH)),06/19/2021,TX,15.0,15.0,,M,,"Starting from the night of the second day (i.e., June 10th), the patient feels chest pain. The pain also extends to neck and left shoulder. Deep breath aggravates the pain. The patient could not fall asleep. He had a light fever at the night of vaccination day but the fever was gone before the chest pain.  Single lead ECG with Watch has been measured and sent to a friend of the parents' who is a physian, and no abnormal sign was shown from ECG. 400 mg Advil (ibuprofen) was given in the coming morning around 7 AM and the patient was able to fall asleep and symptons were gradually relieved. Another two doses of 200 mg Advil were given with six hours apart on the same day. The pain was gone by the following morning (i.e., June 11th) and no ibuprofen has been given afterwards. We suspect that this is related to myocarditis or pericarditis.  This was the second dose of Pfizer COVID-19 vaccine. There was no symptons for adverse effect after the first dose.",,,,,,,,,Y,06/09/2021,06/10/2021,1.0,No tests have been conducted.,UNK,,No,No,No,,,2,06/19/2021,,,,No,myocarditis,G1,15,M,1,Limited data,Classic presentation,"15yo male presented with chest pain, fever 1 days after 2nd dose. Diagnosed with acute myocarditis consistent with classic post-vaccine profile."
1413266,Tremor,24.0,Troponin,24.0,Urine analysis,24.0,Wheezing,24.0,,,COVID19,PFIZER\BIONTECH,EW0158,2,IM,,COVID19 (COVID19 (PFIZER-BIONTECH)),06/20/2021,GA,21.0,21.0,,M,,"Overnight after shot just typical symptoms, some slight chills and next day just a little tired Day 2 after shot, April 11th.  Chest pain, squeezing in chest. Unusual but manageable and didn?t feel terrible otherwise,maybe slightly tired.  Tried leaning forward to make feel better.  Day 3 and 4 chest pain/heart squeezing continued and was bothersome and, went to Urgent Care this day  April 13th. EKG was a little abnormal and told to follow up with a cardiologist and take Advil.  The heart squeezing feeling continued.  Early morning hours April 14th very sick, excessive shaking (no fever), extreme nausea, faint feeling, dry cough (laying on bathroom floor).  Not much, if any chest pain at the time.  Went to ER.  Not much chest pain during ER visit but nauseous and shaking etc. Test were run.   Told that the symptoms were a delayed reaction to the vaccine and to follow up with a cardiologist because possible abnormal EKG and to take Advil as needed.  Overnight at home, no chest pain but an hour of the shaking and nausea returned but not as bad as before.  Over next couple days the chest pain/squeezing, slightly shakes and  light headedness would come and go and by 4-16 feeling pretty great.  The heart feeling mildly at most in the background but not debilitating.  Starting week of April 20th maybe 4-5 flare ups with chest pain and no pattern but not debilitating.  Could happen at rest.  April 27th bigger flare up more debilitating, had to lie down, heart squeezing  pain and maybe some wheezing when breathed in but not tightness in throat.  Lasted about 30 minutes.  Was just doing schoolwork with friends at the time so not under any physical or emotional stress at the time.  After this from April 20 to May 3rd feeling heart symptom mildly but not debilitating and could resume normal active life.  Had cardiology appt. May 3rd with nurse practitioner.  According to NP the 12 Lead EKG run that day correlated with abnormal EKG from ER.  Normal sinus rhythm with sinus arrhythmia Rightward axis Pulmonary disease pattern.  Incomplete right bundle branch block Abnormal ECG.  Given 4 lead heart monitor to wear for a week.  Also ordered a CV CT angiogram coronaries with calcium scoring.  The test could not be scheduled through them until July.  Also told could go on hiking trip out west and to stop and rest if felt pain.  For parents reassurance about hiking trip, had a second opinion over teleconference call with Dr., myocarditis specialist to confirm would be safe on hiking trip. Dr. said he should be good to go.  He said these heart symptoms related to the second vaccine could fade over time.  Hiking trip May 20th to May 30th.  Did fine with exertion and just a few small episodes of the chest pain, light headedness and maybe a little shaking but these were at rest.  Also, 4 lead heart monitor report was good.  Returned from trip May 30th and no chest pain or symptoms for approximately 3 weeks through June 17th.   June 18th went to urgent care for sore throat and ear.  Prescribed amoxycillin.  Took the amoxycillin and one Advil sinus, that evening had a heart squeezing episode return.  This was the first time in almost 3 weeks.  Did not take any more Advil sinus in case that caused the episode. Had another slight episode that evening.  Hiked next day June 19th and fine.  Then felt it slightly again after eating that afternoon of the 19th, also chest did feel a little tight all day.  Then felt it again that evening.  Still taking Amoxycillin as of today.",,,,,,,,,N,04/09/2021,04/11/2021,2.0,"Urgent Care. April 13 EKG abnormal ER April 14th; CBC w/diff, CMP, CRP, D-dimer (PE), Lipase, Troponin, U/A w/reflex  Cx-Clean Catch, EKG-CR, Echo, portable CXR- Chest Pain,  EKG Abnormal Health Center 12 Lead ECG Normal sinus rhythm with sinus arrhythmia Rightward axis Pulmonary disease pattern.  Incomplete right bundle branch block Abnormal ECG.  4 Lead Heart Monitor one week normal CV CT Angiogram w Calcium scoring has not been done yet",SCH,,Zyrtec for seasonal allergies,None,"None.  Very healthy, active and healthy weight",,,2,06/20/2021,,Y,Y,None,myocarditis,G1,21,M,2,Limited data,Classic presentation,"21yo male presented with chest pain, fever 2 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile."
1413465,Procalcitonin,24.0,Pyrexia,24.0,Tachycardia,24.0,Troponin increased,24.0,Ventricular tachycardia,24.0,COVID19,PFIZER\BIONTECH,ER8731,2,IM,RA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/20/2021,OH,15.0,15.0,,M,,"15 yo male with myocarditis following 2nd dose of pfizer COVID-19 vaccine.  He reports that he received the Pfizer COVID-19 vaccine on 6/16/21. In the 1-2 days following the vaccine he experienced fatigue, body aches, and fever to Tmax 101F. Family treated this with anti-pyretics. On 6/18 he started having a pain in his left chest. He was again febrile at that time. On the day of admission his chest pain was worse and he was experiencing pain all over his body.   He was noted to be tachycardic in the ED. His initial labs showed a modestly elevated BNP to 593 with a markedly elevated troponin to 1233. CRP was mildly elevated at 3.8. Electrolytes were unremarkable as were LFTs. CBC w/ diff showed an absolute lymphopenia with ALC of 1000 but was otherwise unremarkable. D-Dimer was normal. He was admitted initially to hospital medicine and then was transferred to the ICU due to concern for risk of developing a cardiac arrhythmia. An echocardiogram done showed trace mitral regurgitation but was otherwise normal with normal LV function. CXR was fairly unremarkable. Coags are normal. Repeat electrolytes showed a slight bump in his creatinine. LFTs largely unchaged and procalcitonin of 0.16.    He does have a past medical history of PCR proven COVID-19 disease in December 2020.",,,,,Y,,,,U,06/16/2021,06/18/2021,2.0,Initial testing showed elevated and rising troponin levels and BNP with beats of Vtach on telemetry. see above for results. Multiple tests ordered upon transfer to ICU as part of work up.,PUB,,melatonin 10 mg gummy at bedtime,none,none,,,2,06/20/2021,,,Y,none,myocarditis,G1,15,M,2,Trop 1233.0; BNP 593,Classic presentation,"15yo male presented with chest pain, fever 2 days after 2nd dose. Workup: Trop 1233.0. Diagnosed with acute myocarditis, classic post-vaccine profile."
1415281,Chest pain,24.0,Myocarditis,24.0,Troponin increased,24.0,,,,,COVID19,PFIZER\BIONTECH,EW0217,2,,RA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/21/2021,CA,15.0,15.0,,M,,chest pain 2/2 myocarditis,,,,,,,,,Y,06/16/2021,06/19/2021,3.0,"elevated troponin over two days, 24,000 at admission and 221 at time of discharge",PVT,,None,None,"None Asthma in childhood, no albuterol needed after age 8",,,2,06/21/2021,,,,None,myocarditis,G1,15,M,3,Limited data,Classic presentation,15yo male presented with chest pain 3 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1419924,Myocarditis,24.0,SARS-CoV-2 test,24.0,,,,,,,COVID19,PFIZER\BIONTECH,EW0186,2,,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/23/2021,CA,15.0,,,M,,"Sent to ER and placed in ICU for 7 days with Myocarditis; This is a spontaneous report from a contactable consumer (parent). A 15-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 04Jun2021 09:00 AM (Batch/Lot Number: EW0186) (at age of 15 years old) as 2ND DOSE, SINGLE for covid-19 immunisation at Hospital. The patient medical history was not reported. No known allergies for the patient. The patient did not have COVID prior vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient previous took first dose of Pfizer COVID 19 vaccine on 14May2021 at 09:00 AM administered in left arm (lot number=ER8736) for covid-19 immunisation and no reaction on previous exposure to drug. The patient was sent to ER and placed in ICU for 7 days with myocarditis on 06Jun2021 with outcome of not recovered. The event was resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The treatment for event included IV prednisone. Since the vaccination, the patient performed Nasal Swab covid test on 07Jun2021 with negative result. The reporter classified the event as serious for seriousness criteria-Life threatening and Caused/prolonged hospitalization.",,,Y,,Y,7.0,,,N,06/04/2021,06/06/2021,2.0,Test Date: 20210607; Test Name: Covid test type post vaccination=Nasal swab; Test Result: Negative,PVT,,,,,,USPFIZER INC2021702216,2,06/21/2021,,Y,Y,,myocarditis,G1,15,M,2,Limited data,Classic presentation,15yo male presented with cardiac symptoms 2 days after 2nd dose. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1423060,Myocarditis,24.0,SARS-CoV-2 test,24.0,Troponin,24.0,Ventricular tachycardia,24.0,,,COVID19,MODERNA,,2,OT,,COVID19 (COVID19 (MODERNA)),06/24/2021,MN,22.0,,,M,,"myocarditis; NSVT episodes; chest pain; This literature-non-study case was reported in a literature article and describes the occurrence of MYOCARDITIS (myocarditis), VENTRICULAR TACHYCARDIA (NSVT episodes) and CHEST PAIN (chest pain) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.      No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (myocarditis) (seriousness criteria hospitalization prolonged and medically significant), VENTRICULAR TACHYCARDIA (NSVT episodes) (seriousness criteria hospitalization prolonged and medically significant) and CHEST PAIN (chest pain) (seriousness criterion hospitalization prolonged). The patient was hospitalized from sometime in 2021 to sometime in 2021 due to CHEST PAIN, MYOCARDITIS and VENTRICULAR TACHYCARDIA. At the time of the report, MYOCARDITIS (myocarditis) and VENTRICULAR TACHYCARDIA (NSVT episodes) was resolving and CHEST PAIN (chest pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, C-reactive protein: high (High) 4 (Values are expressed as the multiple of the upper limit of normal for each laboratory's reference range).. In 2021, Ejection fraction: abnormal (abnormal) 53%, inferolateral hypokinesis. In 2021, Electrocardiogram: abnormal (abnormal) Inferior, anterolateral STelevation. In 2021, imaging: abnormal (abnormal) Edema, delayed enhancement. In 2021, SARS-CoV-2 test: negative (Negative) negative. In 2021, Troponin: high (High) baseline-1327 (Values are expressed as the multiple of the upper limit of normal for each laboratory's reference range). and high (High) Peak-1433 (Values are expressed as the multiple of the upper limit of normal for each laboratory's reference range)..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MYOCARDITIS (myocarditis), VENTRICULAR TACHYCARDIA (NSVT episodes) and CHEST PAIN (chest pain) to be possibly related.    Discharged in stable condition. Treatment information not provided.  Company Comment : Based on current available information and the temporal association between product sue and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on current available information and the temporal association between product sue and the start date of the events a causal relationship cannot be excluded.",,,,,Y,,,,N,,,,"Test Date: 2021; Test Name: C-reactive protein; Result Unstructured Data: 4 (Values are expressed as the multiple of the upper limit of normal for each laboratory's reference range).; Test Date: 2021; Test Name: Lowest left ventricular ejection fraction; Result Unstructured Data: 53%, inferolateral hypokinesis; Test Date: 2021; Test Name: ECG; Result Unstructured Data: Inferior, anterolateral STelevation; Test Date: 2021; Test Name: MRI; Result Unstructured Data: Edema, delayed enhancement; Test Date: 2021; Test Name: SARS-CoV-2; Test Result: Negative  ; Result Unstructured Data: negative; Test Date: 2021; Test Name: troponin; Result Unstructured Data: baseline-1327 (Values are expressed as the multiple of the upper limit of normal for each laboratory's reference range).; Test Date: 2021; Test Name: troponin; Result Unstructured Data: Peak-1433 (Values are expressed as the multiple of the upper limit of normal for each laboratory's reference range).",UNK,,,,,,"USMODERNATX, INC.MOD20212",2,06/23/2021,,,,,myocarditis,G3,22,M,?,Limited data,VT,22yo male presented with chest pain unknown interval after 2nd dose. Severity indicators: VT.
1430395,Dyspnoea,24.0,Electrocardiogram ST segment elevation,24.0,Laboratory test abnormal,24.0,Myocarditis,24.0,Troponin,24.0,COVID19,PFIZER\BIONTECH,,2,SYR,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),06/27/2021,IN,14.0,14.0,,M,,"Patient received second dose of covid vaccine on 6/22/21, then developed SOB and CP on 6/25/21.  He was seen in the outpatient clinic and had an EKG which did not show significant ST elevation or LVH.  His troponin could not be drawn at that time d/t difficult access- he had labs done on 6/27/21 which were signficant for troponin of 2.1ng./mL.  He had a repeat EKG on 6/27/21 which did show subtle ST elevation in the inferior leads.  He was diagnosed with myocarditis- Cardiology was consulted.  He is being admitted to the hospital for observation overnight- will get an echocardiogram and serial troponins- results not yet known at the time of this report.  He is currently en route to the hospital.",,,,,Y,,,,U,06/22/2021,06/25/2021,3.0,"EKG 6/27/21- NSR, + ST elevation inferior leads Troponin 6/27/21- 2.1ng/mL",PVT,,"cetirizine 10mg po daily, vyvanse 50mg PO daily, adderall 10mg PO daily","Mild viral illness- cough, fatigue and diarrhea between vaccine doses one and two- never seen or evaluated, by patient report.  Some sinus congestion and HA around 6/25/21.",Obesity- BMI 51..9kg/m2 ADHD GERD,,,2,06/27/2021,,Y,,sulfa,myocarditis,G2,14,M,3,Trop 2.1->6.0 (peak 6.0); ST elevation,Viral etiology,14yo male presented with cardiac symptoms 3 days after 2nd dose. Workup: Trop 2.1->6.0 (peak 6.0). Confounders: Viral etiology.
1431066,Myocarditis,24.0,Pericardial effusion,24.0,Troponin I increased,24.0,,,,,COVID19,PFIZER\BIONTECH,EW0198,2,SYR,,COVID19 (COVID19 (PFIZER-BIONTECH)),06/28/2021,MD,17.0,17.0,,M,,"Patient with 1 day of chest pain, leading to ER visit that same day and admission to hospital with concern for myocarditis. Currently admitted to hospital awaiting further workup.",,,,,Y,2.0,,,N,06/24/2021,06/27/2021,3.0,"6/27 - Troponin I - 0.6 (normal range 0-0.1) 6/28 - Troponin I - 13.3 (normal range </= 0.06) 6/28 - EKG - ST elevations, concern for injury to heart muscle 6/28 - Echocardiogram - trivial valve insufficiency, trivial pericardial effusion",UNK,,None,None,None,,,2,06/28/2021,,,,No known allergies,myocarditis,G1,17,M,3,ST elevation; Pericardial effusion,Classic presentation,17yo male presented with chest pain 3 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1434274,Myocarditis,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,,UNK,,,COVID19 (COVID19 (PFIZER-BIONTECH)),06/29/2021,WA,15.0,15.0,,M,,Post COVID-19 immunization myocarditis,,,,,Y,4.0,,,,06/25/2021,06/26/2021,1.0,,UNK,,None known,None known,None,,,2,06/29/2021,,,,None known,myocarditis,G1,15,M,1,Limited data,Classic presentation,15yo male presented with cardiac symptoms 1 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1437261,Pneumonia,24.0,Pyrexia,24.0,Serositis,24.0,Tachycardia,24.0,,,COVID19,MODERNA,039B21A,2,IM,LA,COVID19 (COVID19 (MODERNA)),06/30/2021,MN,64.0,64.0,,F,,"I had been on weekly diflucan for toe fungus starting in late March.  I got the first Moderna shot April 13. On April 22 I had some chest tightness which I attributed to the Diflucan as it listed chest tightness as a side effect. On May 2nd the pain extended from the chest, neck, headache and all my teeth hurt and I ended up in the hospital for the first of 3 hospitalizations  Below is the summary of doctor?s notes on my hospitalizations.  They ran several tests to eliminate lupus, sjogrens, cancer, kidney issues, bacterial or fungus issues, etc.  It was not caused by the Diflucan side effect. They decided it might be viral.  Given the current report of some people getting pericarditis after the vaccine, my doctor and I felt we should report this incident.  Given the timing, it could have been the vaccine that caused the reaction.  I'm currently on prednisone for another month and colchicine for several more months and remain under the care of cardiology.   SUMMARY OF DOCTOR?S NOTES:   She presented to the ER 5/2/2021 with chest pain. When she presented, she had tachycardia with interior ST changes. CT showed no PE but there was a large pericardial effusion. Subsequently her blood pressure began dropping with narrowing pulse pressure and she was thought to have early tamponade physiology so was taken to the cath lab and pericardiocentesis was performed. She did well and was started on colchicine and ibuprofen.   5/14 When I saw her back, she was doing well. Since then, she has had back to back admissions:   5/24/2021-5/27/2021-CAP of LLL with bilateral pleural effusions and pericarditis treated with antibiotics but afterwards, felt to be viral. She was seen by Pulmonary at this hospital stay. Rheumatologist work up was started. ECHO was stable.  5/29 Second Moderna shot (was delayed 2 weeks due to concern about confusing the potential normal side effects with the pericarditis issues).    6/13/2021-6/15/2021-Serositis with tachycardia, cough and fever. Rheumatology did not see but was curb sided and recommended Prednisone (long taper) with clinic visit in the next 2 weeks. Limited ECHO was stable.     6/16 Patient is doing well. No chest pain. She is taking the Prednisone without issues. No GI upset and no loose stools.",,,,,Y,12.0,,,Y,04/13/2021,04/22/2021,9.0,"CT scans, chest xrays, echocardiograms and a multitude of blood tests.  The list is extensive and could be gotten from provider listed above.  No blood clots, eliminated several potential diseases as listed in the summary.  Identified pericarditits, pericardial effusion, pleural effusion, pneumonia",PVT,,"Diflucan, lisinopril, rosuvastatin, advil, tylenol, bayer one a day, omega, calcium daily",none,"high blood pressure, high cholesterol -- being controlled via medications",,,2,06/30/2021,,Y,Y,Shrimp,pericarditis,confounded,64.0,F,9,"Chest pain, EKG changes, Echo findings, Pericardial effusion","SLE/Lupus, Sjogren's syndrome, Cancer",I had been on weekly diflucan for toe fungus starting in late March.  I got the first Moderna shot April 13. On April 22 I had some chest tightness which I attributed to the Diflucan as it listed ches
1437909,Vascular graft,24.0,Vessel harvesting,24.0,Wound treatment,24.0,,,,,COVID19,MODERNA,028L20A,2,IM,LA,COVID19 (COVID19 (MODERNA)),06/30/2021,OH,49.0,49.0,,F,,"ONSET OF S/S: Approximately a week or two later I noted that when I would walk into work from our employee parking lot/garage that I would have onset of chest pressure, shortness of breath and pain radiating down both arms and occasionally my neck when it was at it's worse.  Initially, while I didn't feel like I was feeling stressed, I was concerned that I might be experiencing panic attacks.  Dismissing it as that I shared with my Husband my concerns in late February. At that point in time, we were seeing a decrease in cases and so I was hopeful that maybe my mental state and anxieties might resolve.  So I continued to dismiss the problem. Disease Progression:  Unfortunately, the symptoms continued to progress. It progressed to happening when I was leaving work or when it was required that I go anywhere in an real rush (a frequent occurrence). By early April, we went for a family vacation.  Almost every day as we walked into, around and out of the parks I would have to slow down and res to catch my breath and slow my heartrate which would spike up into the 140-160s.  By the end of the week it was happening multiple times each day. It was always initiated by an increase in activity or exertion.  We decided that it was not anxiety related and that she needed to see a doctor to pursue a diagnosis.   4/12/21: Due to already having an appointment set up with my OB/GYN prior to our vacation - that was the first appointment that I kept because I was hopeful or suspicious that my symptoms may really be menopausal in source. The hormone work-up did not reveal any abnormalities.  However, at that time they did send in a referral to  Dr., Cardiologist. 5/17/21: I met with Dr. at which an Echo and NM Stress test were ordered.   5/28/21: Echo & routine stress test were completed.  Insurance would not cover an actual NM Stress test so the order was changed to routine.  I failed the treadmill stress test within  4.42 minutes with the same symptoms I had been experiencing. Test was terminated due to worsening symptoms. , took approximately 10 minutes to recover. HR reached goal HR @ 157. At that time Dr. recommended starting a daily Aspirin tx and suggested that a possible heart cath may be needed. Dr. followed up these tests with a referral for a left heart cath, daily 81mg Aspirin and 12.5mg Metoprolol XR daily. During this almost 3 week time period my symptoms were getting increasingly worse and requiring less and less activity to instigate my symptoms.   6/15/21: Left heart catheterization procedure to evaluate the blood flow to the heart.  Impression and plan per Dr.   Impression:   Severe ostial RCA and left main disease with preserved LV systolic function.   Crescendo angina      Plan:   Findings were reviewed the patient and her family.   Ostial coronary disease raise the concern whether she had some type of aortitis but clinically there is no history for this and no prior chest irradiation.   Surgical intervention appears indicated as soon as possible and I have consulted Dr.   In the interim, continue aspirin, metoprolol. Initiate statin therapy.  (The remainder of the following record as documented by my husband and myself) They completed the procedure and it indicated two of the main blood vessels in her heart were constricted.  The vessel on the right side was 95% restricted and the vessel on the left was 65-70% restricted.  The doctors reported afterward that they had difficulty inserting the catheter.  They also indicated that they found no build-up of plaque in other vessels or other reasons for the vessels to be restricted.  They expressed surprise and confusion as to the cause of the damage to the vessels.  They walked through the risk factors and indicated that she had none of the traditional risk factors.  She never smoked.  She is not diabetic.  She is young and otherwise healthy.  They told us that they see this type of damage to the heart from people who had radiation therapy from treatment of Hodgkin?s Lymphoma when they were young.  They also indicated that this is something that can happen to Type 1 diabetics.  They expressed that this was very unusual and they did not know why she had this condition.  They felt there was a high risk of a heart attack due to the blockage and recommended that she be admitted to the hospital.  The proposed a course of treatment was traditional bypass surgery.  They felt due to the location and type of blockage that other procedures like a stent would not be feasible.   It was at this point in the consult room when the doctor shared the information above that I express my first question about whether this could be related either to a Covid infection (she was never diagnosed or had any symptoms) or due to the vaccine.  I asked this because the symptoms began after her second shot.  Because of her job we followed the news on the virus and vaccines closely.  Many reports indicated that the virus causes severe heart and lung damage.  Recently there were reports of inflammation of the heart associated with people who had recently been vaccinated.   When I proposed this connection, Dr said that the Myocarditis and Pericarditis reported to be associated with the vaccine did not present in this way.  He expressed that he did not think it was related.   Patient came out of the procedure and was admitted.  Later that evening Dr. came in to discuss the upcoming heart procedure.  He described the blockage and why it was critical that it be addressed.  He also expressed surprise that she was having this issue and did not have any of the normal symptoms of heart disease.  He described the surgery as a triple bypass to restore blood flow to the two sides of the heart affected by the blockage.  He indicated he would take a vein from her arm and a vein from her leg and bypass the affected areas of the restricted vessels.  It was not clear to me (we did not have any pictures or models to visualize the process) exactly how it would proceed but he said it is a very common procedure and of the bypass surgeries it is the easiest due to the location.  He did not expect any issues and indicated it was a 99% success rate.   In the conversation, he expressed multiple times that this was very unusual.  I asked if it was possible it could be Covid or vaccine related.  He did not believe it was related. 6/16/21 Wednesday patient spent the day being prepped for surgery.  Vein mapping, ABG, CXR completed. 6/17/21 Thursday morning, she went into surgery.  We received the updates with no indication of any issues.  After surgery Dr. came in for the post op consult.  He said that things did not go as planned.  They harvested the veins in preparation.  When they went in the ascending aorta was severely inflamed.  He said that normal thickness is a millimeter and that it is flexible.  Patient had a 6mm wall thickness and was very difficult to work with.  This caused them to only bypass 2 vessels.  He indicated he was concerned about attaching to the inflamed aorta and that it was very difficult to ensure the stitches went all the way through.  He was worried about the efficacy of the connection.  He also stated that the inflammation was unusual and that it was possible that if they had earlier diagnosed the inflammation as the cause of the restriction it might have been possible to avoid surgery and treating the inflammation would have cleared the restrictions on the vessels.  I asked again if this might be related either to Covid or to the vaccine.  This time he said that he did not know and that he would consult with others.  He also reported that he took a small part of the aorta out and had sent it to the lab for testing.  He did not indicate which tests they would do or what they were looking for specifically.    Operative Findings - per Dr. notes in MyChart:   1. The entire ascending aorta was noted to be significantly inflamed and thickened. The thickness of the aorta was noted to be approximately 5 to 6 mm in thickness. Because of the thickened aortic leaflets very hard to place an aortic cannula, antegrade catheter and placement of the proximal graft. Initially the plan was to do 2 bypasses to the left system 1 to the left anterior descending artery using the internal mammary artery and vein to the first obtuse marginal branch using a saphenous vein. Because of the inflammatory condition of the aorta it was decided to place only 1 bypass using the left internal mammary artery to the left system. This was done to avoid any unnecessary manipulation of the ascending aorta. The above-mentioned findings are consistent with aortitis.  2. The left anterior descending artery was noted with approximately 2 mm in diameter.  3. The distal right coronary artery was noted to be approximately 2.5 mm in diameter but slightly inflamed.  Patient made it to her ICU room (436) and late Thursday evening was extubated and went for a CT to see if they could see the inflammation.  That night she had to go on Bipap to help her oxygenation.   Per lab work - became very acidotic requiring Bipap post extubation that evening. 6/18/21: Friday, she continued Bipap to maintain oxygenation.  She had a heart rate issue late in the morning and had to have a pace maker attached.  Dr came back on Friday and said that he had talked to other doctors and they were going to refer patient to a Rheumatologist at OSU to evaluate if she has an autoimmune disease.   2 U RBCs for low Hgb. No s/s of active bleeding  6/19/21: Saturday went smoothly. She came off Bipap.  She was able to get up and walk out to the hall.   Chest Tubes, Cordis and foley removed. TR to SE6 stepdown unit.  Restarted on beta blocker 6/20/21: Sunday She went to the bathroom and got cleaned up.  The nurse changed the dressings on her incisions.   6/22/21: Echo completed. Ambulated in the hall.  Discharged home.",,,Y,,Y,7.0,,,N,01/27/2021,01/27/2021,0.0,"Too many results to report. Will obtain from medical team and provide at a later date. Per the medical team all of my chemistries, hematology, cardiac work-up labs were all negative. Auto-Immune work up in progress.",PVT,,"Cymbalta, Nexium",none,GERD,,,2,06/30/2021,,Y,,none,myocarditis,G2,49,F,0,Limited data,Cancer,49yo female presented with dyspnea 0 days after vaccination. Confounders: Cancer.
1464028,Troponin increased,24.0,Ultrasound Doppler,24.0,,,,,,,COVID19,MODERNA,0470B21A,1,IM,RA,COVID19 (COVID19 (MODERNA)),07/12/2021,CT,28.0,28.0,,M,,Acute Myocarditis - no etiology identified on discharge from hospital however few viral studies were pending.  Pt admitted with chest pain and elevated troponin.,,,,,,,,,Y,05/15/2021,07/08/2021,54.0,CXR  (7/8/2021) CT chest without contrast (7/8/2021) Echocardiogram  (7/8/2021) LE duplex (7/10/2021),PVT,,Sildenafil,None,,,,2,07/12/2021,,,,NKDA,myocarditis,G2,28,M,54,Limited data,Viral etiology,28yo male presented with chest pain 54 days after vaccination. Confounders: Viral etiology.
1464592,Troponin increased,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,EW0196,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),07/12/2021,AZ,17.0,17.0,,M,,Myocarditis with elevated Troponin and Low-normal Ejection Fraction,,,,,Y,2.0,,,N,07/08/2021,07/11/2021,3.0,"EKG, ECHO, Troponin, Labs",PHM,,none,none,none,,,2,07/12/2021,,,,none,myocarditis,G1,17,M,3,Limited data,Classic presentation,17yo male presented with cardiac symptoms 3 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1474640,Electrocardiogram ST segment abnormal,24.0,Fibrin D dimer,24.0,Myocarditis,24.0,Troponin,24.0,Troponin I increased,24.0,COVID19,MODERNA,046A21A,2,IM,LA,COVID19 (COVID19 (MODERNA)),07/15/2021,MD,23.0,23.0,,M,,"Developed sharp,constant left sided CP which was relieved with sitting forward 3 days after his second dose of Moderna Covid-19 vaccine. No palpitations, edema or SOB.   Dx: Probable Myocarditis",,,,,Y,4.0,,,N,03/26/2021,03/29/2021,3.0,"Trop I 2.620 ng/ml (0-.034).  Labs (3/30/2021): CK-404, ckmb-27, BNP-13.8, TSH, TnT- 3.182, TSH 1.8, D-dimer 0.4.  3/29/2021- EKG NSR with non-specific ST abnormalities 3/29/2021- CXR - unremarkable ECHO:There was no pericardial effusion or ""asynergy"" (EF 57%) CAG without significant stenosis (LMT, LAD, LCX, RCA, LVG cMRI 4/11/2021: 3 weeks after CP started. MRI No abnormality noted on cardiac morphology.Wall motion of left ventricular wall is maintained. No asynergy. No noted findings indicative of valvular heart disease. No abnormal high signal region can be pointed at T2-weighted image. No pathologic pericardial effusion was observed",MIL,,no,no,no,,,2,05/27/2021,,,,no,myocarditis,G3,23,M,3,EF 57%; Cardiac MRI+; Pericardial effusion; BNP 13.8,EF 57%,23yo male presented with cardiac symptoms 3 days after 2nd dose. Workup: EF 57%. Severity indicators: EF 57%.
1482907,Red blood cell sedimentation rate normal,24.0,Respiratory viral panel,24.0,Troponin I,24.0,White blood cell count,24.0,,,COVID19,PFIZER\BIONTECH,,2,,,COVID19 (COVID19 (PFIZER-BIONTECH)),07/18/2021,VA,,,,M,,"myocardial injury/acute myocarditis-like illness; This is a literature spontaneous report from a publication. This author reported similar events for 5 patients. This is the 1st of 5 reports.   Myopericarditis has been reported as a rare vaccination complication. There presented a case series of 7 patients hospitalized for acute myocarditis-like illness following COVID-19 vaccination. Six patients received mRNA (Moderna or Pfizer/BioNTech) and 1 received the adenovirus (Johnson & Johnson) vaccine. All patients presented 3-7 days post vaccination with acute onset chest pain and biochemical evidence of myocardial injury, by cardiac troponin I (Address withheld) (mean peak = 15.77ng/mL, median peak = 12.01ng/mL), or elevated high sensitivity troponin I (Address withheld) (peak=7000ng/L). All were hemodynamically stable and none had a pericardial friction rub or rash. Electrocardiogram (ECG) patterns varied from normal to ST segment elevation. Three patients underwent invasive coronary angiography and none had evidence of obstructive coronary artery disease. Echocardiograms showed left ventricular ejection fraction (LVEF) ranging from 35% to 62% with 5/7 having some degree of hypokinesis. Patients underwent cardiac magnetic resonance (CMR) between 3 and 37 days after vaccination, including multiplanar SSFP sequences, short axis T1 and T2 stacks, T1 mapping when available and multiplanar myocardial late gadolinium enhancement (LGE). Multi-focal subepicardial LGE was present in 7/7 patients and additional mid-myocardial LGE was demonstrated in 4/7 patients. There was corresponding myocardial edema in 3/7 patients. Two patients who underwent CMR> 7 days from presentation had no edema, with an additional patient's T2 images limited by artifact. One patient underwent endomyocardial biopsy without pathological evidence of myocarditis. None reported palpitations and there was no evidence of sustained arrhythmias. None had evidence of an active viral illness or autoimmune disease and 6/7 had PCR testing for acute COVID-19 infection during hospitalization, which was negative. Assessment of COVID-19 serology was obtained for 6/7 patients, with 4/6 showing presence of spike protein IgG antibodies.  Treatment varied and included beta-blocker and anti-inflammatory medication. Hospital length of stay was 3 plus or minus 1 days and all patients' symptoms resolved by hospital discharge. All cases were re-ported to the vaccine adverse event reporting system (VAERS) and the CDC.  A 39-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Pfizer-BioNTech COVID-19 (BNT162b2) vaccine), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient's medical history was not reported. Denied history of prior COVID-19 infection, Negative PCR. The patient's concomitant medications were not reported. The patient presented symptoms as Sudden onset 7/10 chest pain 2days after vaccine, associated with shortness of breath, Worse when lying flat and with inspiration. Days from administration to presentation is 3 days. Vital Signs at Presentation: Temperature (C): 36.6; Heart Rate (bpm): 93; Blood Pressure (mmHg): 116/76; Respirations (per min): 18; CXR (cardiac magnetic resonance) findings: No acute Process. EKG findings: ST changes: PR depression in II , AVF , V4-V6 T wave inversion V1 ; Rhythm: normal sinus rhythm (NSR). Echocardiogram: 3 days post vaccine: LVEF (left ventricular ejection fraction): 35-40%; LVIDd (left ventricular end-diastolic internal dimension): 4.9 cm; IVS: 1.1 cm; RWMA (regional wall motion abnormalities): Mild, Global LV HKN Mildly decreased RV Function; Diastolic function: Normal. Cardiac MRI (magnetic resonance imaging): 11 days post vaccine: LVEF: 56% (no regional wall motion abnormalities); LGE (late gadolinium enhancement): Subepicardial  LGE Along the anterior and lateral walls. No pericardial thickening or effusion; T1 mapping (Native T1 values obtained by the Modified Look-Locker Inversion recovery (MOLLI) pulse sequence): 1000ms; T2 (Images acquired by T2 mapping or SA T2FS sequences): No Definitive edema. WBC (white blood cell count): 9.01; cTnI, ng/mL (< 0.04 ng/ml); Presentation: 4.24, Peak: 11.01, Post Discharge: <0.01; BNP, pg/Ml: 22; ESR, peak, mm/hr: 8; CRP, peak, mg/dL: 5.1; ANA, screen: negative; SARS-CoV-2 Ab: Spike IgG: Positive, Nucleocapsid IgG: Negative; Respiratory viral panel: ND; Coronary angiography findings: No Evidence of coronary artery disease (CAD). Clinical Course: The patient hospitalized for 4 days and received treatment as beta-blocker (BB), angiotensin receptor blocker (ARB), Statin. The outcome of event was unknown.  Our series of 7 male COVID-19 vaccination recipients who presented with myocarditis-like illness supports a potential causal association with vaccination given the temporal relationship, clinical presentation and CMR findings. The clinical course of vaccine-associated myocarditis-like illness appears favorable, with resolution of symptoms in all patients. Given the potential morbidity of COVID-19 infection even in younger adults, the risk-benefit decision for vaccination remains highly favorable. Vaccine adverse event reporting remains of high importance and further studies are needed to elucidate the pathophysiological mechanism to potentially identify or prevent future occurrences.  No follow-up attempts are needed. No further information is expected; Information about batch number cannot be obtained.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of event Heart injury cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021768175 same product/event/, different patient;US-PFIZER INC-2021768174 same product/event/, different patient;US-PFIZER INC-2021768172 same product/event/, different patient;US-PFIZER INC-2021768173 same product/event/, different patient",,,,,Y,4.0,,,U,,,,"Test Name: Coronary angiography; Result Unstructured Data: Test Result:No Evidence of CAD; Test Name: ANA, screen; Test Result: Negative  ; Test Name: Nucleocapsid IgG; Test Result: Negative  ; Comments: Performed using Abbott ARCHITECT SARS-CoV-2 IgG; Test Name: Spike IgG; Test Result: Positive  ; Comments: Performed using Siemens Healthineers EXL SARS-CoV-2 IgG; Test Name: Blood Pressure; Result Unstructured Data: Test Result:116/76 mmHg; Test Name: Temparature; Result Unstructured Data: Test Result:36.6 Centigrade; Test Name: BNP; Result Unstructured Data: Test Result:22 pg/mL; Test Name: CXR findings; Result Unstructured Data: Test Result:No acute Process; Test Name: CRP, peak; Test Result:  5.1 mg/dl; Test Name: LVEF; Result Unstructured Data: Test Result:35-40 %; Test Name: LVEF; Result Unstructured Data: Test Result:56% (no regional wall motion abnormalities) %; Test Name: ST changes; Result Unstructured Data: Test Result:PR depression in II , AVF , V4-V6 T wave inversion; Comments: PR depression in II , AVF , V4-V6 T wave inversion V1; Test Name: Heart Rate; Result Unstructured Data: Test Result:93; Comments: bpm; Test Name: Respirations; Result Unstructured Data: Test Result:18; Comments: 18 Per Min; Test Name: LGE; Result Unstructured Data: Test Result:Subepicardial  LGE Along the anterior and lateral; Comments: Subepicardial  LGE Along the anterior and lateral walls. No pericardial thickening or effusion; Test Name: T1 mapping; Result Unstructured Data: Test Result:1000; Comments: ms; Test Name: T2; Result Unstructured Data: Test Result:No Definitive edema; Test Name: Rhythm; Result Unstructured Data: Test Result:NSR; Test Name: ESR; Result Unstructured Data: Test Result:8; Comments: peak; 8 mm/Hr; Test Name: Respiratory viral panel; Result Unstructured Data: Test Result:ND; Test Name: cTnI; Result Unstructured Data: Test Result:4.24 ng/ml; Comments: Presentation; Test Name: cTnI; Result Unstructured Data: Test Result:11.01 ng/ml; Comments: Peak; Test Name: cTnI; Result Unstructured Data: Test Result:<0.01 ng/ml; Comments: Post Discharge; Test Name: WBC; Result Unstructured Data: Test Result:9.01",UNK,,,,,,USPFIZER INC2021768011,2,07/07/2021,,,,,myocarditis,G2,?,M,?,EF 56%; ST elevation; Cardiac MRI+; CRP 5.1; BNP 22,Viral etiology,"Age unknown male presented with chest pain, dyspnea unknown interval after 2nd dose. Workup: EF 56%. Confounders: Viral etiology."
1482909,Troponin I,24.0,Troponin T,24.0,White blood cell count,24.0,,,,,COVID19,PFIZER\BIONTECH,,2,,,COVID19 (COVID19 (PFIZER-BIONTECH)),07/18/2021,VA,,,,M,,"myocardial injury/acute myocarditis-like illness; This is a literature spontaneous report from the Circulation, Myocarditis Temporally Associated with COVID-19 Vaccination (DOI: 10.1161/CIRCULATIONAHA.121.055891). This author reported similar events for 5 patients. This is the 4th of 5 reports.  Myopericarditis has been reported as a rare vaccination complication. There presented a case series of 7 patients hospitalized for acute myocarditis-like illness following COVID-19 vaccination. Six patients received mRNA (Moderna or Pfizer/BioNTech) and 1 received the adenovirus (Johnson & Johnson) vaccine. All patients presented 3-7 days post vaccination with acute onset chest pain and biochemical evidence of myocardial injury, by cardiac troponin I (Address withheld) (mean peak = 15.77ng/mL, median peak = 12.01ng/mL), or elevated high sensitivity troponin I (Address withheld) (peak=7000ng/L). All were hemodynamically stable and none had a pericardial friction rub or rash. Electrocardiogram (ECG) patterns varied from normal to ST segment elevation. Three patients underwent invasive coronary angiography and none had evidence of obstructive coronary artery disease. Echocardiograms showed left ventricular ejection fraction (LVEF) ranging from 35% to 62% with 5/7 having some degree of hypokinesis. Patients underwent cardiac magnetic resonance (CMR) between 3 and 37 days after vaccination, including multiplanar SSFP sequences, short axis T1 and T2 stacks, T1 mapping when available and multiplanar myocardial late gadolinium enhancement (LGE). Multi-focal subepicardial LGE was present in 7/7 patients and additional mid-myocardial LGE was demonstrated in 4/7 patients. There was corresponding myocardial edema in 3/7 patients. Two patients who underwent CMR> 7 days from presentation had no edema, with an additional patient's T2 images limited by artifact. One patient underwent endomyocardial biopsy without pathological evidence of myocarditis. None reported palpitations and there was no evidence of sustained arrhythmias. None had evidence of an active viral illness or autoimmune disease and 6/7 had PCR testing for acute COVID-19 infection during hospitalization, which was negative. Assessment of COVID-19 serology was obtained for 6/7 patients, with 4/6 showing presence of spike protein IgG antibodies.  Treatment varied and included beta-blocker and anti-inflammatory medication. Hospital length of stay was 3 plus or minus 1 days and all patients' symptoms resolved by hospital discharge. All cases were re-ported to the vaccine adverse event reporting system (VAERS) and the CDC.  A 20-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Pfizer-BioNTech COVID-19 (BNT162b2) vaccine), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included: History of prior COVID-19 infection. The patient's concomitant medications were not reported. The patient experienced myocardial injury/acute myocarditis-like illness on an unspecified date. Presenting Symptoms: Mid-sternal chest pain, with deep inspiration. The patient was hospitalized for myocardial injury/acute myocarditis-like illness for 4 days. Days from administration to presentation: 3 Days. On unknown date, negative COVID-19 PCR; Vital Signs at Presentation: Temperature (C): 37.9, Heart Rate (bpm): 112, Blood Pressure (mmHg): 121/78, Respirations (per min): 18; CXR findings: No evidence of acute cardiopulmonary disease; EKG findings: unknown results, ST changes: 1mm ST elevation V2-5, Rhythm: Sinus Tachycardia; Echocardiogram: 5 days post vaccine, LVEF: 50-55%, LVIDd: 4.34cm, IVS: 1.1cm, RWMA: Mild hypokinesis in the mid to distal anteroseptum and apex, Diastolic function: Normal; Cardiac MRI: 6 days post vaccine, LVEF: 52% (Subtle apical septal and apical lateral hypokinesis, LGE: Subepicardial LGE within the lateral, inferolateral, and anterolateral walls with global left ventricular apex. No pericardial thickening or effusion, T1 mapping: N/A, T2: Subtle inferior wall myocardial edema; WBC: 10.56; cTnI, ng/mL (< 0.04 ng/ml): Presentation: 0.48, Peak:8.36, Post Discharge: ND; hs-cTnI ng/L (<17 ng/L) unknown results; BNP, pg/Ml: 29; ESR, peak, mm/hr: 10; CRP, peak, mg/dL:8.2; ANA, screen: ND; SARS-CoV-2 Ab: Spike IgG: ND, Nucleocapsid IgG: ND; Respiratory viral panel: Negative; Coronary angiography findings: ND. Treatment(s): ibuprofen, famotidine. The outcome of event was unknown.  The clinical course of vaccine-associated myocarditis-like illness appears favorable, with resolution of symptoms in all patients. Given the potential morbidity of COVID-19 infection even in younger adults, the risk-benefit decision for vaccination remains highly favorable. Vaccine adverse event reporting remains of high importance and further studies are needed to elucidate the pathophysiological mechanism to potentially identify or prevent future occurrences.  Information about lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of event Heart injury cannot be excluded.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021768011 same product/event/, different patient",,,,,Y,4.0,,,U,,,,"Test Name: cTnI; Result Unstructured Data: Test Result:0.48 ng/ml; Comments: Presentation; Test Name: cTnI; Result Unstructured Data: Test Result:8.36 ng/ml; Comments: PEAK; Test Name: cTnI; Result Unstructured Data: Test Result:ND ng/ml; Comments: Post Discharge; Test Name: hs-cTnI; Result Unstructured Data: Test Result:unknown results ng/L; Test Name: WBC; Result Unstructured Data: Test Result:10.56; Test Name: Coronary angiography; Result Unstructured Data: Test Result:ND; Test Name: T1 mapping; Result Unstructured Data: Test Result:Not reported; Test Name: ANA; Result Unstructured Data: Test Result:ND; Test Name: Diastolic function; Result Unstructured Data: Test Result:Normal; Test Name: Blood Pressure; Result Unstructured Data: Test Result:121/78 mmHg; Test Name: Temperature (C); Result Unstructured Data: Test Result:37.9 Centigrade; Test Name: BNP; Result Unstructured Data: Test Result:29 pg/mL; Test Name: T2; Result Unstructured Data: Test Result:Subtle inferior; Comments: Subtle inferior wall myocardial edema; Test Name: CXR findings; Result Unstructured Data: Test Result:No evidence of; Comments: No evidence of acute cardiopulmonary disease; Test Name: CRP; Test Result:  8.2 mg/dl; Test Name: Echocardiogram; Result Unstructured Data: Test Result:5 days post vaccine; Test Name: RWMA; Result Unstructured Data: Test Result:Mild hypokinesis; Comments: Mild hypokinesis in the mid to  distal anteroseptum  and apex; Test Name: LVEF; Result Unstructured Data: Test Result:50-55 %; Test Name: LVEF; Result Unstructured Data: Test Result:52% %; Comments: (Subtle  apical septal and  apical lateral  hypokinesis); Test Name: LVIDd; Result Unstructured Data: Test Result:4.34cm; Test Name: EKG findings; Result Unstructured Data: Test Result:Not reported; Test Name: ST changes; Result Unstructured Data: Test Result:1mm ST elevation V2-5; Comments: 1mm ST elevation V2-5; Test Name: Heart Rate; Result Unstructured Data: Test Result:112; Comments: (bpm); Test Name: IVS; Result Unstructured Data: Test Result:1.1cm; Test Name: Respirations; Result Unstructured Data: Test Result:18; Comments: (per min); Test Name: LGE; Result Unstructured Data: Test Result:Subepicardial LGE; Comments: Subepicardial  LGE within the  lateral,  inferolateral, and  anterolateral  walls with global  left ventricular  apex. No  pericardial  thickening or  effusio; Test Name: Cardiac MRI; Result Unstructured Data: Test Result:6 days post; Test Name: Rhythm; Result Unstructured Data: Test Result:Sinus Tachycardia; Test Name: ESR; Result Unstructured Data: Test Result:10; Comments: mm/hr; Test Name: Respiratory viral panel; Result Unstructured Data: Test Result:Negative; Test Name: PCR COVID-19; Test Result: Negative",UNK,,,,Medical History/Concurrent Conditions: COVID-19 (History of prior COVID-19 infection: Yes),,USPFIZER INC2021768174,2,07/07/2021,,,,,myocarditis,G2,?,M,?,EF 52%; ST elevation; Cardiac MRI+; CRP 8.2; BNP 29,Viral etiology,Age unknown male presented with chest pain unknown interval after 2nd dose. Workup: EF 52%. Confounders: Viral etiology.
1489813,SARS-CoV-2 test,24.0,Troponin,24.0,,,,,,,COVID19,PFIZER\BIONTECH,ER8735,1,,RA,COVID19 (COVID19 (PFIZER-BIONTECH)),07/21/2021,MN,64.0,,,M,,"extreme pain in his head, back, shoulder, arms, and lungs feeling crushed; extreme pain in his head, back, shoulder, arms, and lungs feeling crushed; extreme pain in his head, back, shoulder, arms, and lungs feeling crushed; extreme pain in his head, back, shoulder, arms, and lungs feeling crushed; extreme pain in his head, back, shoulder, arms, and lungs feeling crushed; heart attack; Myocarditis; Heart racing; 20% loss of memory; light chest pain/pressure; foggy; severe headache; light chest pain/pressure; ill; horrible cough; Dizziness; High temperature; tiredness; This is a spontaneous report  received from a contactable consumer (patient) reported for himself. This 64-year-old male patient received bnt162b2 (PFIZER BIONTIC COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in right shoulder on 20Apr2021 at 12:25 (Batch/Lot Number: ER8735) as single dose for covid-19 immunisation. There was no medical history or concomitant medications. There was no additional vaccines administered on same date of the Pfizer suspect. The patient received the first dose and after he had a horrible reaction and he had to go to the hospital. By 03May2021 he was in the ER and they were saying he had a heart attack; they were going to do emergency surgery to place a stent in his heart; but when they did the tests they found that a virus had caused the heart attack; he had myocarditis. Add then he had various medical care to keep him alive those two days. The doctor confirmed that he had myocarditis from a virus. He was still on mediation for his heart. The patient also mentioned his memory comes and goes now. Mentions the beta blocker his is prescribed is Metoprolol 25mg. Adds he was instructed to take one half of a 25mg tablet and then move up to 25mg, but he blacked out for a day when he took the 25mg, so he had to go back to one half of 25mg. Adds his heart races really fast and he has to have this medication to control it. He is also taking 81mg ASPIRIN. He was taking Atorvastatin 20mg once daily, but the other doctor told him to stop it because it is not doing him any good. The patient states he kept a journal of his symptoms after the vaccination on 20Apr2021. From 20Apr2021 to 22Apr2021, for two days he felt tired, slept all night on 21Apr2021, awake for two hours then back to sleep. From 22Apr2021 to 27Apr2021, he felt fine. On 28Apr2021 he was tired. On 29Apr2021, tired, dizzy, horrible cough, fever of 100 / high temperature. On 30Apr2021, the patient took off work, bad cough, resting, dizzy, ill. On 02May2021, ill, temperature. On 03May2021, ill, temperature 100, when he got out of bed at 05:00AM he had extreme pain in his head, back, shoulder, arms, and lungs feeling crushed so he went to the emergency room. The did two COVIDs tests that were negative. Blood tests that showed the heart attack need for a stent; but when they got in there with the camera it showed he had a viral attack on his heart that caused the blood flow to slow; EKG abnormal, mentions an MRI; and troponin level off the charts. The priest came in to talk to him and he had a horrible cough that has now gone away. He was in the hospital overnight and discharged 04May2021 at 15:00. After that he noticed he feels light chest pain/pressure all the time on 04May2021; the first week he was foggy on 04May2021 and had severe headache on 04May2021 and noticed about 20% loss of memory. The patient mentioned he made medical heart parts at work and he went back to work on 10May2021 but he just sat at his bench and examined the parts. He thought the vaccine activated his really good immune system and caused it to attack his heart. He had another EKG and the doctor said his right ventricle is damaged in his heart last week. Mentions he has had at least 30 different blood tests. Everyday for three weeks he thought he was going to die but his doctor did give him some hope. The event was hospitalized for myocarditis from a virus, heart attack and extreme pain in his head, back, shoulder, arms, and lungs feeling crushed from 03May2021 to 04May2021 at 15:00. Treatment received for myocarditis from a virus and heart attack. The outcome of tiredness, light chest pain/pressure was not recovered, of horrible cough was recovered. The outcome of other events was unknown. Heart racing results in Physician Office visit with follow up.  Follow-up attempts are completed. No further information is expected.",,,,,Y,1.0,,,N,04/20/2021,04/20/2021,0.0,Test Name: Blood test; Result Unstructured Data: Test Result:heart attack need for a stent; Comments: had at least 30 different blood tests; Test Date: 20210429; Test Name: Body temperature; Result Unstructured Data: Test Result:fever of 100; Test Date: 20210503; Test Name: Body temperature; Result Unstructured Data: Test Result:100; Test Name: EKG; Result Unstructured Data: Test Result:Abnormal; Test Name: EKG; Result Unstructured Data: Test Result:his right ventricle is damaged in his heart; Comments: another EKG; Test Name: MRI; Result Unstructured Data: Test Result:unknown results; Test Name: Covid-19; Test Result: Negative  ; Test Name: Covid-19; Test Result: Negative  ; Test Name: Troponin; Result Unstructured Data: Test Result:troponin level off the charts,OTH,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none,,USPFIZER INC2021849261,2,07/20/2021,,Y,Y,,myocarditis,G2,64,M,0,Limited data,Viral etiology,"64yo male presented with chest pain, fever 0 days after 1st dose. Confounders: Viral etiology."
1490272,Myocarditis,24.0,Pain,24.0,Troponin increased,24.0,,,,,COVID19,PFIZER\BIONTECH,,UNK,SYR,,COVID19 (COVID19 (PFIZER-BIONTECH)),07/21/2021,TX,13.0,13.0,,M,,"Presented with pressure-like chest pain, elevated troponins and diffuse ST elevations on EKG consistent with perimyocarditis.  Troponins continue to up-trend during first day of admission (highest ~15). Started on scheduled ibuprofen for pain and inflammation. Pain resolved by day 2 of admission and troponins were down-trending. Echo with normal biventricular function. Discharged home on ibuprofen PRN and cardiology follow-up.",,,,,Y,2.0,,,Y,07/16/2021,07/18/2021,2.0,"EKG: NSR, diffuse ST elevation Echo: normal biventricular function Troponins: highest ~ 15, down-trending by day two of admission.",PVT,,none,"1 week of cough, congestion, loss of smell/taste about 2-3 weeks prior to presentation to hospital with chest pain after vaccine.",none,,,2,07/21/2021,,Y,,none,myocarditis,G1,13,M,2,ST elevation,Classic presentation,13yo male presented with chest pain 2 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1490549,Pneumonia,24.0,SARS-CoV-2 test positive,24.0,,,,,,,COVID19,MODERNA,046A21A,2,SYR,RA,COVID19 (COVID19 (MODERNA)),07/21/2021,TX,47.0,47.0,,F,,"A few days after the shot I felt bad. About a month afterwards, I got pneumonia and went to the ER. During a chest x-ray, they found that my heart was enlarged. They sent me home and two weeks later I went to work. I started having chest pains, but I thought that I pulled a muscle at work. I went to the ER and was told about the inflammation of my heart and they thought I was having a heart attack. I also tested positive COVID  and was rushed to another hospital that was better staffed to treat people like myself. I was diagnosed with a leaky valve, arrhythmia, and myocarditis.",,,,,Y,4.0,,,N,04/13/2021,04/14/2021,1.0,"Heart Ultrasound, COVID19 test, and blood work",PUB,,None,None,Mild Asthma,,vsafe,2,07/21/2021,,Y,Y,Latex,myocarditis,G2,47,F,1,Limited data,COVID-19 positive,47yo female presented with chest pain 1 days after vaccination. Confounders: COVID-19 positive.
1498145,Vomiting,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),07/23/2021,MA,18.0,18.0,,M,,"Patient presented to ED with fever, vomiting.  Found to have elevated troponins with myocarditis.  ECHO was normal, treated with indomethacin and colchicine and will follow up with Cardiology in a couple of weeks.",,,,,,,,,U,06/04/2021,07/16/2021,42.0,"7/16/21 - CRP result 144, troponins up to 1.41",UNK,,none,"Febrile viral infection, COVID negative",,,,2,07/23/2021,,,Y,No known allergies,myocarditis,G2,18,M,42,CRP 144,Viral etiology,18yo male presented with fever 42 days after vaccination. Confounders: Viral etiology.
1499676,Troponin I normal,24.0,White blood cell count normal,24.0,,,,,,,COVID19,MODERNA,002C21A,2,IM,RA,COVID19 (COVID19 (MODERNA)),07/24/2021,WA,26.0,26.0,,M,,"During cardiac workup for unrelated symptoms, low normal/borderline decreased heart function seen on echo (LVEF 50.7%).  Began treatment with diltiazem.  Began noticing SOB with mild exertion (walking <100 yards) and heartrate stayed above 100bpm despite medication.  Mildly elevated blood pressure.  Followup cardiac MRI performed 7/6 corroborated echo findings (LVEF 52%) and showed patchy areas of subacute pericarditis and myocarditis inflammation with changes to tissue noticed.  Visited urgent care with pericardial chest pain 7/21, received indocin as short term replacement for nabumetone NSAID treatment.  Currently waiting on stress test scheduled for 9/16.",,,,,,,,,U,04/24/2021,05/27/2021,33.0,"Echo (5/27/2021) - discovered decreased heart function Cardiac MRI (7/6/2021)   Following lab tests performed 7/21/2021: WBC 7.0K/uL RBC 5.14 10*6 Hemoglobin 15.6 GM/DL Hematocrit 45% MCV 87 MCH 30 MCHC 35% RDW 13.9 Platelet count 187 10*3 Neutrophils, absolute 4.3K/uL Lymphocytes, absolute 2.1K/uL Monocytes, absolute 0.4K/uL Eosinophils, absolute 0.2K/uL Basophils, absolute 0.1K/uL Sodium 137MEQ/L Potassium 3.9MEQ/L Chloride 102MEQ/L Carbon Dioxide 27MEQ/L Anion Gap 8 Glucose 99mg/dL BUN 13 mg/dL Creatinine 0.86mg/dL GFR above 60ML/MIN Troponin I <0.02ng/mL D-dimer, quant <200ng/mL CRP 2.5mg/L  Chest X-Ray (7/21/2021) - no acute cardiopulmonary findings",PVT,,"Fluoxetine, hydroxyzine, docusate sodium, methylphenidate, nabumetone, metamucil, cranberry concentrate, Humira, omeprazole, vitamin D",none,"Ankylosing spondylitis, GERD, anxiety with panic attacks, major depressive disorder, ADHD, tendinitis, PTSD",,,2,07/24/2021,,Y,Y,none,myocarditis,G3,26,M,33,EF 52%; Cardiac MRI+; CRP 2.5,EF 52%,26yo male presented with chest pain 33 days after vaccination. Workup: EF 52%. Severity indicators: EF 52%.
1499689,Swelling face,24.0,Tachypnoea,24.0,Thrombectomy,24.0,Troponin increased,24.0,,,COVID19,PFIZER\BIONTECH,EW0185,1,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),07/24/2021,WA,35.0,35.0,,M,,"DX: Myocarditis Onset of S/S 06/02/2021   S/S:Dyspnea on exertion, Fever/chills,Tachypnea Found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation.  35 year old man with medical history notable for likely untreated hypertension and tobacco use disorder who presented with reported fever, confusion, shortness of breath, and facial swelling, initially treated for allergic reaction/angioedema without effect, progressed to respiratory failure, found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation resulting in death.     Regarding cardiac picture, patient with abnormal ECG, mildly reduced EF on echo (though could be due to untreated hypertension or to respiratory failure/critical illness), borderline troponin (need to check reference range). ED note initially mentions concern for myocarditis due to vaccine causing heart failure and subsequent respiratory failure, but appears this piece was written prior to MRI showing basilar stroke. Death note has myocarditis listed as a cause of death (among many), though a bit unclear if this was intentionally listed or just reflects a list of all hospital problems.     Also had a CT of his head which showed scattered foci of gas within intraorbital soft tissues along with mild proptosis; unclear etiology for this (perhaps a fall with facial injuries prior to arriving at hospital?)    Awaiting additional physician notes/imaging reports.",Y,,,,Y,,,,U,05/11/2021,06/03/2021,23.0,"Temp: 36.9 C Resp: 40 HR: 141 BP: 185/136 O2: 97 CXR: abnormal  06/03/2021 EKG: abnormal 06/03/2021  sinus tachycardia,  left atrial enlargement, right axis deviation,  poor R wave progression nonspecific ST  abnormalities. prolonged QT at 575 ECHO: abnormal  06/03/2021  EF is mildly reduced, 40-45% without any  significant pericardial effusion.   Respiratory Viral Panel: negative  06/03/2021 Urine Tox: neg proBNP: abnormal 5507 pg/mL  Troponin: abnormal 2 ng/mL",PVT,,N/A: Data collected from report pulled. Limited details available in report.,N/A: Data collected from report pulled. Limited details available in report.,"N/A: Data collected from report pulled. Limited details available in report.  Report mentions cardiovascular disease, HTN,",,,2,07/24/2021,,,Y,N/A: Data collected from report pulled. Limited details available in report.,myocarditis,G2,35,M,23,Pericardial effusion,Viral etiology,"35yo male presented with dyspnea, fever 23 days after vaccination. Confounders: Viral etiology."
1501224,Pneumothorax,24.0,Skin candida,24.0,Thoracic operation,24.0,Type 1 diabetes mellitus,24.0,,,COVID19,PFIZER\BIONTECH,EL9265,1,SYR,RA,COVID19 (COVID19 (PFIZER-BIONTECH)),07/25/2021,AL,15.0,15.0,,M,,"Received 1st dose of Pfizer Covid Vaccine and started becoming increasingly manic within about an hour. Complained of stomach discomfort. Became increasingly anxious and manic and was only able to sleep for two hours (received at 4pm, slept from 12am to 2am). Awake and manic the day following. Complained of stomach pain. Eating normally with no other symptoms. Started complaining of being cold and chills. Applied rotating heated blankets until he feel asleep about 10pm. Woke up at 2am. Manic and anxious. Stomach started swelling more and becoming rigid.  Gave him Miralax. No change in swelling. Increased stomach pain. Gave him a suppository. Immediate small bowel movement. After two more hours and no change in swelling, gave a second suppository. Immediate small bowel movement. Stomach becoming distended and complaining of increased pain. Took him to the ER. Pain amplified on the way. Admitted to PICU after EKG in ER. Quickly declined and went into respiratory failure. Right lung had no air exchange and left lung collapsed. Myocarditis, pleural effusion, kidney damage and new onset Type I diabetes. Unexplained pneumonia. No growth from fluid in lung.",,,Y,,Y,32.0,,Y,N,05/14/2021,05/14/2021,0.0,"5-16-21 through 6-17-21 New onset diabetes Type I, Acute Kidney Injury, Adverse Drug Event, Candidal intertrigo, Acute hypoxemic respiratory failue CRP Elevated, Glycosuria, Hyperglycemia, Hypomagnesemia, Leukocytosis, Pleural Effusion, Empyema Lung, Pneumonia VATS on 5-20-21.  Right Lung had no air exchange, Left lung collapsed, heart enlarged, myocarditis, heart failure, heart injury, Two chest tubes and PICC placed.",PVT,,"Sertraline, Risperidone, Buspirone, Aripiprazole, CoQ10, Norditropin, Flintstone Complete",None,Prader Willi Syndrome,,,2,07/25/2021,Y,Y,Y,None,myocarditis,G1,15,M,0,Limited data,Classic presentation,15yo male presented with cardiac symptoms 0 days after 1st dose. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1511080,Chest pain,24.0,Fatigue,24.0,Palpitations,24.0,,,,,COVID19,PFIZER\BIONTECH,,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),07/28/2021,GA,19.0,19.0,,M,,"Got heart inflammation, probably pericarditis based on the symptoms though that is usually paired with myocarditis. Also had some heart palpitations and a much more noticeable heartbeat accompanied with chest pain. Symptoms started the morning after getting the vaccine. Fatigue for 1 day, mostly recovered by day 2, fully recovered from all symptoms by day 3. No fever.   Going to assume the heart was affected because the injection was in the left arm (near the heart). Might have caused a higher density of cytokines to be near heart tissue and cause inflammation.   Also I didn't go to a doctor because no insurance, figured I would rather take my chances with a heart attack. Cause I would be guaranteed to have a heart attack after seeing that medical bill.",,,,,,,,,Y,06/25/2021,06/26/2021,1.0,,PHM,,,,asthma,,,2,07/28/2021,,,,,myocarditis,G1,19,M,1,Limited data,Classic presentation,"19yo male presented with chest pain, fever 1 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile."
1515244,Upper respiratory tract infection,24.0,,,,,,,,,COVID19,JANSSEN,,UNK,,,COVID19 (COVID19 (JANSSEN)),07/30/2021,TX,27.0,27.0,,F,,Patient received J&J vaccine in May. Returned from tour of duty with the army sometime in July. Became ill on 7/22 with URI symptoms. Tested Covid Positive on 7/23. Rapidly deteriorated and developed fulminant myocarditis requiring mechanical ventilation and VA ECMO. Also with failing kidneys and liver.,,,Y,,Y,,,,N,05/24/2021,07/22/2021,59.0,,PVT,,,Unknown,None,,,2,07/30/2021,,,,No known allergies,myocarditis,G3,27,F,59,Limited data,ECMO; Fulminant,27yo female presented with cardiac symptoms 59 days after vaccination. Severity indicators: ECMO; Fulminant.
1515531,Myocarditis,24.0,Troponin,24.0,,,,,,,COVID19,PFIZER\BIONTECH,,UNK,,,COVID19 (COVID19 (PFIZER-BIONTECH)),07/30/2021,NY,17.0,17.0,,M,,Myocarditis,,,,,,,,,Y,07/05/2021,07/06/2021,1.0,Troponin 0.04,PVT,,,,,,,2,07/30/2021,,Y,,Adhesive,myocarditis,G1,17,M,1,Trop 0.04,Classic presentation,"17yo male presented with cardiac symptoms 1 days after vaccination. Workup: Trop 0.04. Diagnosed with acute myocarditis, classic post-vaccine profile."
1549179,Troponin increased,24.0,,,,,,,,,COVID19,PFIZER\BIONTECH,,2,,,COVID19 (COVID19 (PFIZER-BIONTECH)),08/12/2021,PA,14.0,14.0,,M,,3 days after 2nd vaccine my son had stabbing chest pain. We was transported by ambulance from a local ER to hospital with high traponin levels.  He was diagnosed with Myocarditis from the vaccine.,,,,,,,,,N,06/30/2021,07/03/2021,3.0,Troop on levels  Cardiac MRI Ecco Cardiogram  EKG,PHM,,Zertek,,Asthma,,,2,08/12/2021,,,,No,myocarditis,G1,14,M,3,Cardiac MRI+,Classic presentation,14yo male presented with chest pain 3 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1591514,Dyspnoea,24.0,SARS-CoV-2 test negative,24.0,,,,,,,COVID19,MODERNA,052E21A,1,SYR,LA,COVID19 (COVID19 (MODERNA)),08/20/2021,MA,30.0,30.0,,M,,"It looks like Myocarditis, where I got shortness of breath while I sleeping 3 times on the first time of onset. I did the proning technique and continue sleeping. The second day of onset, I got shortness of breath one time and I resolved it by proning again afterwards. Both instances happened at night (11PM to 12PM) during my sleep. I did COVID-19 test twice and it was confirmed NOT the COVID-19.",,,,,,,,,U,08/15/2021,08/18/2021,3.0,COVID-19 test negative on 8/17 and 8/19.,PHM,,Acetylcysteine 200mg,,Follicular Lymphoma Stage IV.,,,2,08/20/2021,,,,,myocarditis,G2,30,M,3,Limited data,Cancer,30yo male presented with dyspnea 3 days after vaccination. Confounders: Cancer.
1592056,Oropharyngeal pain,24.0,Pericarditis,24.0,Vomiting,24.0,,,,,COVID19,PFIZER\BIONTECH,EW0175,2,SYR,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),08/20/2021,NV,59.0,59.0,,F,,"Within 2 hours, I became nauseous; I had a lot of nausea. I had three times of vomiting; loss of appetite; chills and a very sore throat; very swollen glands and chest pain. They were so severe I doubled over. I made an appt with - myocarditis and pericarditis. I was sent to get a heart Catherization  - femoral artery - right side that week. At a medical center.  It showed no blockages but helped to diagnose me. I am on medications for this now. Midodrine and I'm also getting a med but they have to determine what it will be:  I have a lot of doctors and they are trying to decided  how to proceed. Hospital did one part of it and the saliva collections was mailed to me for this test:  Amalodyis genetic thing  I have been tested for this and results have not come back yet. They would be me on something else besides  Humira  if I test positive but if I don't they may put me on Humira. I also am on Salt tablets because I dehydrate easily. Naproxen - I take once a day and that is 500 mg.  Can't do much. in the day I am in bed by 07:00 pm. I have a lot of fatigue. They symptoms are definitely interfering with my life. I get occasional nausea and I get occasional chest pain when I exert myself. I get breathless when I am lying down. I have been to ER twice - For the chest pain and feeling like I am going to pass out - it's hard to describe - it feels like my body is electrical and I get breathless and I can't feel my body. I get dissociation and I had that symptoms immediately after both vaccines and lasted a whole wee after both vaccines: the feeling of not being in reality. I want to get the Booster.  Note: I had chest pains with the Arava when I was on that Feb. and then I got off of it on March 16th - because the side affects were so severe. I had a terrible pain in my back. And neck pain. And then the COVID vaccines - severe muscle aches and very fatigued. I couldn't do anything I was on the sofa. And then those symptoms subsided. But the fatigue ahs continued.  It's hard to tell. A week after my vaccines (both) when my initial side affects were gone - I had complete relief from my autoimmune symptoms - it almost like it had rebooted my body. I had no pain. At all! No fatigue and my joints and my hands - they visibly had reduced swelling. I had a liaison on vaccine that had started to fade away. It felt like I had gotten a treatment for my autoimmune disease of some sort because my symptoms for that window of time after each vaccine (COVID PFIZER) were alleviated.",,,,,,,,,U,04/26/2021,04/26/2021,0.0,"Called emergency services- ER- 1st time  - shortness of breath - and for severe chest pain: shoulders and down my arms and tension in my neck and jaw; it felt better to bend over - They discovered I had very high potassium - contributing factor to why I was getting so sick. Potassium is a new thing - I have never had high Potassium before. Took blood and did EKG; chest x-ray; Diagnosed with: Myocarditis and Pericarditis and sent me home. August 2nd, 2021 - 2nd time I was driven to ER- (I had gone to Neurologist first and that doctor sent me to ER since my Potassium was so high) and that is also the same hospital-2nd time  - Potassium was high at this visit, too.",OTH,,Prednisone - 5 mg; Vit D 5000 a day; Multi-Vitamin; Propalis - made from bees - anti-viral; NAC Acetyl - immune support; Folic Acid; Hydrocodone - 4 times a day; Salagen - for  Shogran's syndrome; Zanadine - PRN; Klonopin - three times a w,no,Psoatic arthritis - since 35 - went out of remission in the beginning of 2020; Fibromyalgia; Degenerative disc disease; Shogran's Sydrome; Rheumatoid Arthritis; Heart disease - after the vaccines for COVID,Flu vaccine - 2005: I had severe chest pain and nausea; severe muscle pains; swollen glands and chills -  was in ER the whole ni,vsafe,2,08/20/2021,,Y,Y,Fentanyl; codeine; Demerol; Methotrexate; Arava,myocarditis,G2,59,F,0,Limited data,Viral etiology; Rheumatoid,59yo female presented with chest pain 0 days after vaccination. Confounders: Viral etiology; Rheumatoid.
1592526,Troponin,24.0,Ultrasound abdomen abnormal,24.0,Vaccination complication,24.0,Vomiting,24.0,,,COVID19,PFIZER\BIONTECH,FC3180,2,SYR,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),08/20/2021,CA,15.0,15.0,,F,,"Pt admitted to medical facility 8-17-21 with fever, HTN, local shot site reaction, chest pain, and vomiting; elevated liver enymes, troponins, and D-dimer.  Dx: covid vax related myocarditis in obese, anxious teen with liver disease.  Treated with steroids, IVIG, clonidine, zofran, and benadryl.  Four normal EKGs, Echo with ejection fraction 64%, BP stablized, patient improved, discharged home 8-20-21.",,,Y,,Y,4.0,,,U,08/14/2021,08/17/2021,3.0,"AST 56  ALT 118  serial troponins 0.6, 1.28, and 1.0  WSR 25  Platlets normal, CXR normal, all on 8-17-21.  EKGs normal,  Echo cardiogram normal, Abd US enlarged Fatty Liver, all over next day or two.",PHM,,none,Overweight (~100 Kg);  Fatty Liver Disease;  Anxiety,Overweight (~100 Kg);  Fatty Liver Disease;  Anxiety,,,2,08/20/2021,,,,none,myocarditis,G3,15,F,3,EF 64%,EF 64%,"15yo female presented with chest pain, fever 3 days after vaccination. Workup: EF 64%. Severity indicators: EF 64%."
1636617,Painful respiration,24.0,Troponin increased,24.0,,,,,,,COVID19,PFIZER\BIONTECH,EW0187,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),08/26/2021,CA,12.0,12.0,,M,,"Pt is a previously healthy 12 Y 4 M  male who received his second COVID Pfizer vaccine on 8/19/21 presenting with acute onset chest pain on the morning of 8/21. He describes it as sharp, worse with inspiration, and on the left side of chest, 10/10 at worse and now at 0/10. Initial troponin was 1.99 with a normal EKG/Echo. He was admitted to local HCF and was treated with acetaminophen, ibuprofen, and toradol; but around 1700-1800, his chest pain got worse. Repeat troponin was significantly increased to 19.5. Regional cardiology recommended he be transferred to a facility with specialty.  Pt was transferred to another HCF on 8/22 Suspect myopericarditis 2/2 covid vaccine, less likely myocarditis 2/2 viral illness as no sign/sx of infection. Also endorsed passive SI to multiple team members, to be assessed by psychology.   Neuro: - pain: ibuprofen 600mg TID with meals, pepcid 20mg PO qHS while on ibuprofen. - discharge with total 2 week course ibuprofen and pepcid   CV: - Chest pain resolves with doses of ibuprofen. - Echo and EKG normal on 8/21/21. - Troponin peaked at 23.67, downtrended and was 0.91 at discharge.",,,,,Y,3.0,,,Y,08/18/2021,08/21/2021,3.0,Results as of 8/26/2021 09:08  8/21/2021 08:52 TROPONIN I: 1.99 (H)  8/21/2021 15:09 TROPONIN I: 2.37 (H)  8/21/2021 21:22 TROPONIN I: 19.51 (H)  8/22/2021 09:08 TROPONIN I: 19.73 (H)  8/22/2021 19:40 TROPONIN I: 22.17 (H)  8/23/2021 02:25 TROPONIN I: 23.67 (H)  8/23/2021 08:24 TROPONIN I: 15.96 (H)  8/23/2021 14:05 TROPONIN I: 14.02 (H)  8/23/2021 19:45 TROPONIN I: 11.45 (H)  8/24/2021 02:20 TROPONIN I: 6.91 (H)  8/24/2021 08:14 TROPONIN I: 3.65 (H)  8/25/2021 04:30 TROPONIN I: 0.91 (H),PVT,,None,None,"Cough, variant asthma",,,2,08/26/2021,,,,nka,myocarditis,G2,12,M,3,Trop 0.91->23.67 (peak 23.67),Viral etiology,12yo male presented with chest pain 3 days after vaccination. Workup: Trop 0.91->23.67 (peak 23.67). Confounders: Viral etiology.
1645372,Palpitations,24.0,Pyrexia,24.0,,,,,,,COVID19,MODERNA,026L20A,1,OT,RA,COVID19 (COVID19 (MODERNA)),08/28/2021,NY,51.0,51.0,,F,,"Myocarditis; Sick; Fever of 102-103 degrees F; Felt like she had pressure in her chest; Palpitations; Very fatigued; Shortness of breath; Cold chills; This spontaneous case was reported by an other health care professional and describes the occurrence of MYOCARDITIS (Myocarditis) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Family history included Breast cancer since an unknown date.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced ILLNESS (Sick), PYREXIA (Fever of 102-103 degrees F) and CHEST DISCOMFORT (Felt like she had pressure in her chest). In February 2021, the patient experienced DYSPNOEA (Shortness of breath), CHILLS (Cold chills), PALPITATIONS (Palpitations) and FATIGUE (Very fatigued). On an unknown date, the patient experienced MYOCARDITIS (Myocarditis) (seriousness criterion medically significant) and STRESS (Stress). In February 2021, CHILLS (Cold chills) had resolved. On 17-Feb-2021, PYREXIA (Fever of 102-103 degrees F) had resolved. On 28-Feb-2021, ILLNESS (Sick) had resolved. At the time of the report, MYOCARDITIS (Myocarditis), DYSPNOEA (Shortness of breath), CHEST DISCOMFORT (Felt like she had pressure in her chest), PALPITATIONS (Palpitations), FATIGUE (Very fatigued) and STRESS (Stress) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: high (High) Fever of 102-103 degrees F. In July 2021, Electrocardiogram abnormal: abnormal (abnormal) abnormal electrocardiogram. On an unknown date, Echocardiogram: abnormal (abnormal) diagnosed with myocarditis. On an unknown date, Electrocardiogram ambulatory: abnormal (abnormal) diagnosed with myocarditis.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  About 3-4 weeks ago the patient wanted to be checked out before she went for a magnetic resonance imaging for possible breast cancer. The patient did not get any medication for the myocarditis. Patient was not going to get a booster.  Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.",,,,,,,,,U,01/18/2021,02/01/2021,14.0,Test Date: 20210215; Test Name: Body temperature; Result Unstructured Data: Fever of 102-103 degrees F; Test Name: echocardiogram; Result Unstructured Data: diagnosed with myocarditis; Test Date: 202107; Test Name: Electrocardiogram abnormal; Result Unstructured Data: abnormal electrocardiogram; Test Name: Holter monitor; Result Unstructured Data: diagnosed with myocarditis,UNK,,,Breast cancer,Comments: No medical history was reported.,,"USMODERNATX, INC.MOD20212",2,08/27/2021,,,,,myocarditis,G2,51,F,14,Limited data,Cancer,"51yo female presented with dyspnea, fever 14 days after 2nd dose. Confounders: Cancer."
1645384,Systemic lupus erythematosus,24.0,Thrombosis,24.0,Vasculitis,24.0,,,,,COVID19,MODERNA,,1,OT,,COVID19 (COVID19 (MODERNA)),08/28/2021,,66.0,,,F,,"blood vessels are bursting; respiratory lung disease; myocarditis; Inflammation marker was extremely high; oxygen was saturated; blood cells seems to be clotting; aspiration; loss of appetite; pulmonary edema; Chron's Disease; Fluid overload; Retaining fluid; shortness of breath; prolong severely debilitating vasculitis; swelling; Could not walk; abdominal pain; dizziness; eyes burning; anemic; Cough; Weakness/ chronic weakness/ Debiliated; could no longer work; Could not sit up; Brain fog; Diarrhea; Pain/achiness; rash/rash on entire body; fatigue/chronic fatigue; joint pain; hypoxia; cardiogenic shock,; Cirrhosis; distorted heart function; ARDS; cardiac arrest; multiorgan failure; acute kidney injury; chest pain; diagnosis of lupus; hematoma; This spontaneous case was reported by a consumer and describes the occurrence of SYSTEMIC LUPUS ERYTHEMATOSUS (diagnosis of lupus), HYPOXIA (hypoxia), CARDIOGENIC SHOCK (cardiogenic shock,), HEPATIC CIRRHOSIS (Cirrhosis), CARDIAC DISORDER (distorted heart function), ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS), CARDIAC ARREST (cardiac arrest), MULTIPLE ORGAN DYSFUNCTION SYNDROME (multiorgan failure), ACUTE KIDNEY INJURY (acute kidney injury), CHEST PAIN (chest pain), HAEMATOMA (hematoma), PURPURA (blood vessels are bursting), LUNG DISORDER (respiratory lung disease), MYOCARDITIS (myocarditis), INFLAMMATION (Inflammation marker was extremely high), OXYGEN SATURATION (oxygen was saturated), THROMBOSIS (blood cells seems to be clotting), ASPIRATION (aspiration), DECREASED APPETITE (loss of appetite), PULMONARY OEDEMA (pulmonary edema), CROHN'S DISEASE (Chron's Disease), FLUID OVERLOAD (Fluid overload), FLUID RETENTION (Retaining fluid), DYSPNOEA (shortness of breath), VASCULITIS (prolong severely debilitating vasculitis), SWELLING (swelling), GAIT DISTURBANCE (Could not walk), ABDOMINAL PAIN (abdominal pain), DIZZINESS (dizziness), EYE IRRITATION (eyes burning), ANAEMIA (anemic), COUGH (Cough), ASTHENIA (Weakness/ chronic weakness/ Debiliated), IMPAIRED WORK ABILITY (could no longer work), SITTING DISABILITY (Could not sit up), FEELING ABNORMAL (Brain fog), DIARRHOEA (Diarrhea), PAIN (Pain/achiness), RASH (rash/rash on entire body), FATIGUE (fatigue/chronic fatigue) and ARTHRALGIA (joint pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Atrial fibrillation and Urinary retention.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jun-2021, the patient experienced SYSTEMIC LUPUS ERYTHEMATOSUS (diagnosis of lupus) (seriousness criteria hospitalization and medically significant). On an unknown date, the patient experienced HYPOXIA (hypoxia) (seriousness criteria hospitalization, medically significant and life threatening), CARDIOGENIC SHOCK (cardiogenic shock,) (seriousness criteria hospitalization, disability, medically significant and life threatening), HEPATIC CIRRHOSIS (Cirrhosis) (seriousness criteria hospitalization, medically significant and life threatening), CARDIAC DISORDER (distorted heart function) (seriousness criteria hospitalization and life threatening), ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) (seriousness criteria hospitalization, medically significant and life threatening), CARDIAC ARREST (cardiac arrest) (seriousness criteria hospitalization, medically significant and life threatening), MULTIPLE ORGAN DYSFUNCTION SYNDROME (multiorgan failure) (seriousness criteria hospitalization, medically significant and life threatening), ACUTE KIDNEY INJURY (acute kidney injury) (seriousness criteria hospitalization, medically significant and life threatening), CHEST PAIN (chest pain) (seriousness criteria hospitalization and life threatening), HAEMATOMA (hematoma) (seriousness criteria hospitalization prolonged and life threatening), PURPURA (blood vessels are bursting) (seriousness criteria hospitalization, disability and life threatening), LUNG DISORDER (respiratory lung disease) (seriousness criteria hospitalization and life threatening), MYOCARDITIS (myocarditis) (seriousness criteria hospitalization, medically significant and life threatening), INFLAMMATION (Inflammation marker was extremely high) (seriousness criterion hospitalization), OXYGEN SATURATION (oxygen was saturated) (seriousness criterion hospitalization), THROMBOSIS (blood cells seems to be clotting) (seriousness criteria hospitalization, disability and medically significant), ASPIRATION (aspiration) (seriousness criteria hospitalization and medically significant), DECREASED APPETITE (loss of appetite) (seriousness criterion hospitalization), PULMONARY OEDEMA (pulmonary edema) (seriousness criteria hospitalization, disability and medically significant), CROHN'S DISEASE (Chron's Disease) (seriousness criteria hospitalization and medically significant), FLUID OVERLOAD (Fluid overload) (seriousness criterion hospitalization), FLUID RETENTION (Retaining fluid) (seriousness criterion hospitalization), DYSPNOEA (shortness of breath) (seriousness criterion hospitalization), VASCULITIS (prolong severely debilitating vasculitis) (seriousness criterion hospitalization), SWELLING (swelling) (seriousness criterion hospitalization), GAIT DISTURBANCE (Could not walk) (seriousness criteria hospitalization and disability), ABDOMINAL PAIN (abdominal pain) (seriousness criterion hospitalization), DIZZINESS (dizziness) (seriousness criterion hospitalization), EYE IRRITATION (eyes burning) (seriousness criterion hospitalization), ANAEMIA (anemic) (seriousness criterion hospitalization), COUGH (Cough) (seriousness criterion hospitalization), ASTHENIA (Weakness/ chronic weakness/ Debiliated) (seriousness criterion hospitalization), IMPAIRED WORK ABILITY (could no longer work) (seriousness criteria hospitalization and disability), SITTING DISABILITY (Could not sit up) (seriousness criteria hospitalization and disability), FEELING ABNORMAL (Brain fog) (seriousness criterion hospitalization), DIARRHOEA (Diarrhea) (seriousness criterion hospitalization), PAIN (Pain/achiness) (seriousness criterion hospitalization), RASH (rash/rash on entire body) (seriousness criterion hospitalization), FATIGUE (fatigue/chronic fatigue) (seriousness criterion hospitalization) and ARTHRALGIA (joint pain) (seriousness criterion hospitalization). At the time of the report, SYSTEMIC LUPUS ERYTHEMATOSUS (diagnosis of lupus), HYPOXIA (hypoxia), CARDIOGENIC SHOCK (cardiogenic shock,), HEPATIC CIRRHOSIS (Cirrhosis), CARDIAC DISORDER (distorted heart function), ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS), CARDIAC ARREST (cardiac arrest), MULTIPLE ORGAN DYSFUNCTION SYNDROME (multiorgan failure), ACUTE KIDNEY INJURY (acute kidney injury), CHEST PAIN (chest pain), HAEMATOMA (hematoma), PURPURA (blood vessels are bursting), LUNG DISORDER (respiratory lung disease), MYOCARDITIS (myocarditis), INFLAMMATION (Inflammation marker was extremely high), OXYGEN SATURATION (oxygen was saturated), THROMBOSIS (blood cells seems to be clotting), ASPIRATION (aspiration), DECREASED APPETITE (loss of appetite), PULMONARY OEDEMA (pulmonary edema), CROHN'S DISEASE (Chron's Disease), FLUID OVERLOAD (Fluid overload), FLUID RETENTION (Retaining fluid), DYSPNOEA (shortness of breath), VASCULITIS (prolong severely debilitating vasculitis), SWELLING (swelling), GAIT DISTURBANCE (Could not walk), ABDOMINAL PAIN (abdominal pain), DIZZINESS (dizziness), EYE IRRITATION (eyes burning), ANAEMIA (anemic), COUGH (Cough), ASTHENIA (Weakness/ chronic weakness/ Debiliated), IMPAIRED WORK ABILITY (could no longer work), SITTING DISABILITY (Could not sit up), FEELING ABNORMAL (Brain fog), DIARRHOEA (Diarrhea), PAIN (Pain/achiness), RASH (rash/rash on entire body), FATIGUE (fatigue/chronic fatigue) and ARTHRALGIA (joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Colonoscopy: chron's disease (abnormal) Chron's Disease. In 2021, Inflammatory marker test: high (High) Extremely high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant product usage were not reported by the reporter. Treatment included Chemotherapy, CPR, PEA, ECMO Machine.  Patient was reported as dead and later was revived after 6 minutes of CPR.  Company Comment: This case concerns a 66 -year-old patient who was diagnosed with Lupus and Crohns disease after the second dose of Moderna vaccine. Very limited information regarding these events has been provided at this time.  Additionally, other events have been reported, based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  Further information is not expected.   This case was linked to MOD-2021-293826 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: Follow up received on 23-AUG-2021, contains No New information.; Sender's Comments: This case concerns a 66 -year-old patient who was diagnosed with Lupus and Crohns disease after the second dose of Moderna vaccine. Very limited information regarding these events has been provided at this time.  Additionally, other events have been reported, based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  Further information is not expected.",,,Y,,Y,,Y,Y,U,03/26/2021,06/11/2021,77.0,Test Date: 2021; Test Name: Colonoscopy; Result Unstructured Data: Chron's Disease; Test Date: 2021; Test Name: Inflammation marker; Result Unstructured Data: Extremely high,UNK,,,Atrial fibrillation; Hypertension; Urinary retention,,,"USMODERNATX, INC.MOD20212",2,08/24/2021,,Y,Y,,myocarditis,G3,66,F,77,Limited data,ECMO; Cardiac arrest; Cardiogenic shock,"66yo female presented with chest pain, dyspnea 77 days after 2nd dose. Severity indicators: ECMO; Cardiac arrest; Cardiogenic shock."
1661275,Myocarditis,24.0,Platelet count,24.0,Polymerase chain reaction,24.0,SARS-CoV-2 antibody test,24.0,Serum ferritin,24.0,COVID19,PFIZER\BIONTECH,,1,,,COVID19 (COVID19 (PFIZER-BIONTECH)),09/01/2021,VA,,,,F,,"fulminant myocarditis; This is a literature report associated with BNT162b2 mRNA COVID-19 vaccination in two patients. This author reported similar event for two patients. This is second of two reports.   A 34-year-old female without prior medical history presented 9 days after her first vaccine dose. On day 4 after vaccine, she developed fevers, cough, chest pain, nausea, and vomiting. She presented to another institution with hypotension and sinus tachycardia, an echocardiogram showed severely reduced LVEF of 15%. Cardiac catheterization showed no obstructive coronary artery disease. She was transferred for initiation of VA-ECMO. On admission, she was in severe shock requiring multiple vasopressors. CRP, ferritin and CK-MB were elevated at 5.6 mg/dL, >30,000 ng/mL, and 42.4 ng/mL, respectively. VA-ECMO and RRT were initiated. Treatment was initiated with methylprednisolone 1000 mg daily and continued for 3 days followed by a slow taper over, with IVIG 30 mg daily for 4 days, and anakinra 100 mg daily. Lactic acid 13 mmol/ L on admission normalized within 24 h of ECMO onset, INR improved from 4.5 to 1.7. Interleukin-6 level was mildly elevated at 17 pg/mL and interleukin-2 soluble receptor alpha was 1067 U/mL (NV less than 710). Thrombocytopenia was noted at 106x10 9 /L which persisted for several days. ALI was noted with ALT and AST at 14,477 and 6086 u/L which steadily improved thereafter. PCR for SARS-CoV2 and other common respiratory viruses was negative. SARS-CoV2 spike protein IgG antibody was positive (64 arbitrary units/ml), and IgG anti-nucleocapsid was negative, consistent with immunization due to vaccine without prior infection. Vasopressors were weaned off, LVEF was documented at 50% by transthoracic echocardiography, VA-ECMO was discontinued. She was treated with prednisone 1 mg/kg and anakinra with prednisone tapered first (by reducing 0.1 mg every week) and tapering anakinra planned after prednisone is discontinued. An endomyocardial biopsy performed on day 13 of hospital admission, after recovery of cardiac function and near resolution of the systemic hyperinflammation, showed cardiomyocytes with minute foci of cytoplasmic vacuolization and rare interstitial lymphocytic infiltrate, which is consistent with healing myocarditis, but did not meet conventional diagnostic criteria for acute myocarditis. A cardiac catheterization at the same time showed preservation of cardiac output and normal filling pressures. A cardiac magnetic resonance, performed 45 days after the initial presentation, showed LVEF of 35%, diffuse elevation of native T1 values, small pericardial effusion with enhancement of the pericardium anterior and anterolaterally and small patchy areas of enhancement following delayed imaging after gadolinium in the mid-wall of the anterior wall, consistent with myopericarditis. Genetic testing for 121 genes showed no variants associated with genetic disorders. Guideline-directed heart failure treatment was also initiated. She was discharged from the hospital after 73 days. In summary, both cases presented features of fulminant myocarditis with a temporal association with the BNT162b2 mRNA Covid-19 vaccination, in absence of other apparent causes, and with unique features of systemic hyperinflammation associated with refractory shock. These cases identify the need for awareness of a potential, albeit extremely rare, link of BNT162b2 mRNA Covid-19 vaccination associated with fulminant myocarditis as part of a severe systemic hyperinflammatory syndrome, requiring mechanical cardiac support and, most importantly, immunosuppressive therapy. The degree of the inflammatory biomarkers and multiorgan dysfunction seen in the two cases described, as in some patients with Covid-19, is indeed out of proportion to with hemodynamic failure and shock and it is not rapidly resolved by cardiac mechanical support, reflecting a significant degree of vasoplegia. The optimal immunosuppressive treatment for systemic hyperinflammation associated with fulminant myocarditis is unknown. They chose a combination of high dose methylprednisolone, IVIG and anakinra (Table 1) as a strategy used across a variety of immunologic and rheumatologic diseases characterized with inappropriate macrophage activation. Table 1 Key biomarkers at admission and immunomodulating therapy: Patient #2: Presentation included: Symptoms: Fever, cough, chest pain, nausea and vomiting. Vaccine type was BNT162b2 mRNA Covid-19. Timing was 9 days after 1st dose. Hemodynamics included Hypotension and tachycardia. ECG : Non-specific changes. Echocardiogram: LVEF 15%. Biomarkers included: CRP : 5.6 mg/dl; Interleukin: 17.2 pg/ml [12 h after therapy]; Ferritin : greater than 30,000 ng/ml; INR : 4.5; D-dimer : greater than 20 ug/ml; Lactic acid : 13 mmol/l; CK-MB : 42 ng/ml; SARS-CoV2 spike IgG : 64 a.u./ml; SARS-CoV2 NC IgG : negative. Immunosuppressive therapy included: Methylprednisolone : 1000 mg daily for 3 days, followed by a slow prednisone taper over several weeks; Immunoglobulins : 30 mg daily for 4 days; Anakinra : 100 mg daily. Outcome was Recovering, minimal symptoms, LVEF 35%, delayed enhancement after gadolinium at cardiac magnetic resonance; discharged from the hospital after 73 days.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The event myocarditis is considered possibly related to suspect BNT162b2 mRNA COVID-19 vaccination, based on temporal association and in absence of other apparent causes, and with unique features of systemic hyperinflammation associated with refractory shock.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202101116136 Same article/ drug/event and different patient",,,,,Y,73.0,,,N,,,,"Test Name: ALT; Result Unstructured Data: Test Result:14477 IU/l; Comments: ALI was noted  u/l; Test Name: IgG anti-nucleocapsid; Test Result: Negative  ; Test Name: AST; Result Unstructured Data: Test Result:6086 IU/l; Comments: u/l ALI was noted; Test Name: endomyocardial biopsy; Result Unstructured Data: Test Result:showed cardiomyocytes with minute foci of cytoplas; Comments: performed on day 13 of hospital admission, showed cardiomyocytes with minute foci of cytoplasmic vacuolization and rare interstitial lymphocytic infiltrate, which is consistent with healing myocarditis, but did not meet conventional diagnostic criteria for acute myocarditis; Test Name: CK-MB; Result Unstructured Data: Test Result:42 ng/ml; Test Name: CK-MB; Result Unstructured Data: Test Result:42.4 ng/ml; Comments: elevated; Test Name: Lactic acid; Result Unstructured Data: Test Result:13 mmol/L; Comments: on admission normalized within 24 h of ECMO onset; Test Name: Cardiac catheterization; Result Unstructured Data: Test Result:Showed no obstructive coronary artery disease; Comments: showed no obstructive coronary artery disease; Test Name: Cardiac catheterization; Result Unstructured Data: Test Result:showed preservation of cardiac output and normal f; Comments: showed preservation of cardiac output and normal filling pressures, on day 13 of hospital admission; Test Name: CRP; Test Result:  5.6 mg/dl; Comments: elevated; Test Name: LVEF; Test Result:  15 %; Test Name: LVEF; Test Result:  50 %; Comments: documented by transthoracic echocardiography; Test Name: ECG; Result Unstructured Data: Test Result:Non-specific changes; Test Name: D-dimer; Result Unstructured Data: Test Result:greater than 20 ug/ml; Test Name: Interleukin-6; Result Unstructured Data: Test Result:17.2 pg/mL; Comments: [12 h after therapy]; Test Name: Interleukin-6; Result Unstructured Data: Test Result:17 pg/mL; Comments: mildly elevated; Test Name: interleukin-2 soluble receptor alpha; Result Unstructured Data: Test Result:1067 IU/ml; Comments: u/ml  (NV <710); Test Name: INR; Result Unstructured Data: Test Result:4.5; Test Name: INR; Result Unstructured Data: Test Result:1.7; Comments: improved; Test Name: cardiac magnetic resonance; Result Unstructured Data: Test Result:showed LVEF of 35%, diffuse elevation of native T1; Comments: performed 45 days after the initial presentation, showed LVEF of 35%, diffuse elevation of native T1 values, small pericardial effusion with enhancement of the pericardium anterior and anterolaterally and small patchy areas of enhancement following delayed imaging after gadolinium in the mid-wall of the anterior wall, consistent with myopericarditis; Test Name: thrombocytes; Result Unstructured Data: Test Result:106 x10 9/l; Comments: Thrombocytopenia was noted persisted for several days; Test Name: PCR; Test Result: Negative  ; Comments: PCR for SARS-CoV2 and other common respiratory viruses was negative; Test Name: SARS-CoV2 NC IgG; Test Result: Negative  ; Test Name: SARS-CoV2 spike IgG; Result Unstructured Data: Test Result:64; Comments: a.u./ml; Test Name: SARS-CoV2 spike protein IgG antibody; Test Result: Positive  ; Comments: (64 arbitrary units/ml); Test Name: Ferritin; Result Unstructured Data: Test Result:greater than 30000 ng/ml; Comments: elevated",UNK,,,,"Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none, Comment: without prior medical history",,USPFIZER INC202101116531,2,08/31/2021,,Y,,,myocarditis,G3,?,F,?,EF 15%; Cardiac MRI+; Pericardial effusion; CRP 5.6,ECMO; Fulminant; EF 15%,"Age unknown female presented with chest pain, fever unknown interval after 1st dose. Workup: EF 15%. Severity indicators: ECMO; Fulminant; EF 15%."
1666411,Heart rate increased,24.0,Intensive care,24.0,Myocarditis,24.0,Syncope,24.0,,,COVID19,PFIZER\BIONTECH,,2,,,COVID19 (COVID19 (PFIZER-BIONTECH)),09/02/2021,,71.0,71.0,,M,,Case of Myocarditis. Symptoms of dizziness which led to fainting. Heart rate out of control reaching over 200 bpm. Rushed to ER and admitted in ICU for a couple of days.,,,Y,,Y,3.0,,,Y,05/19/2021,06/25/2021,37.0,"Chest xray (showed heart enlarged), electrocardiogram (appeared to be atrial fibrillation).",PVT,,"losartan, terazosin, soltalol, potassium chloride","History of ventricular tachycardia, irregular heartbeat controlled by medication at the time of second dose of vaccine.",irregular heartbeat,,,2,09/02/2021,,,Y,nka,myocarditis,G3,71,M,37,Limited data,VT,71yo male presented with cardiac symptoms 37 days after 2nd dose. Severity indicators: VT.
1689697,Urticaria,24.1,White blood cell count normal,24.1,,,,,,,COVID19,PFIZER\BIONTECH,301308A,2,IM,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),09/10/2021,MN,17.0,17.0,,M,,"Tolerated administration of vaccine, but developed full-body hives (urticaria) on 9/8/21 (4 days later). He visited urgent care, where he had allergy testing obtained, which is negative thus far, and negative/normal CBC, BMP, ESR, CRP, and troponin. He was prescribed Zyrtec, prednisone, and an EpiPen PRN and discharged home. Started steroid (1 dose), but had an episode of syncope after getting out of the shower. EMS was called, and they documented BP 80's/50's. He was given IVF and brought to Emergency Department, where he was admitted for observation. Hives resolved, he had normal BP and hemodynamics throughout his stay. EKG showed sinus tachycardia, and ECHO was normal with no sign of effusion, pericarditis or myocarditis.",,,,,Y,1.0,,,Y,09/04/2021,09/08/2021,4.0,"Labs 9/8/21: WBC - 5.3,  Hgb - 15.4,  Platelets - 352,  Sodium - 137,  Potassium 3.8, Chloride - 106, Calcium - 9.3, BUN - 9, Creatinine - 0.98, Glucose - 102, Troponin - <0.015, ESR - 9, CRP - 7.9 (normal value <8)  SARS-CoV-2 RNA PCR: Negative  EKG 9/8/21: Sinus tachycardia, otherwise normal ECG  Echocardiogram 9/9/21:  1. Normal intracardiac anatomy. 2. Normal chamber sizes, wall thickness, septal position, and systolic function. 3. Normal venous connections (RUPV not well visualized), coronary artery origins, and left aortic arch with normal branching.",PHM,,Tylenol,None,None,,,2,09/10/2021,,,Y,Benadryl causes hives Amoxicillin causes hives,myocarditis,G1,17,M,4,CRP 7.9,Classic presentation,17yo male presented with cardiac symptoms 4 days after vaccination. Diagnosed with acute myocarditis consistent with classic post-vaccine profile.
1692252,Sinus rhythm,24.0,Troponin,24.0,Troponin I,24.0,White blood cell count,24.0,,,COVID19,PFIZER\BIONTECH,,1,,,COVID19 (COVID19 (PFIZER-BIONTECH)),09/11/2021,FL,,,,M,,"perimyocarditis within 4 days of receiving a dose of BNT162b2 vaccine; This is a literature report. This author reported similar events for eight patients. This is the fourth of eight reports.  The authors describe clinical characteristics of 8 adolescents who presented over the course of 36 days to (Hospital) with perimyocarditis within 4 days of receiving a dose of BNT162b2 vaccine. A 15-year-old male with Marfan syndrome and aortic root dilation presented to the ED with sudden onset of retrosternal chest pain, fatigue, and abdominal pain for 1 day. He denied fever, shortness of breath, or recent illness. The patient had a history of SARS-CoV-2 infection in January 2021 with mild symptoms. He had received the first dose of the BNT162b2 vaccine 3 days prior to admission. In the ED, his troponin was 7.2 ng/ mL and ECG demonstrated normal sinus rhythm with no other changes. Chest X-ray was normal. The peak troponin level was 11.8 ng/mL. Pain resolved while he was still in ED. The patient was asymptomatic at the time of admission. TTE showed patent foramen ovale, mild mitral valve prolapses with mild-to-moderate mitral regurgitation, mild aortic root dilation (unchanged), and qualitatively low normal LVSF. Cardiac MRI (magnetic resonance imaging) was significant for focal edema at the basal inferolateral segments, normal biventricular size and global systolic function, and stable aortic root dilation. The patient had 12- and 8-beat runs of irregular polymorphic ventricular tachycardia. The runs occurred within 1 minute of each other, and the patient was asymptomatic at the time. He remained hemodynamically stable. Infectious workup was negative, including adenovirus plasma PCR, CMV antibodies, enterovirus plasma PCR, EBV titers, Leptospira IgM, Parvovirus B19 PCR, and RPP (Respiratory viral panel). Body mass index (kg/m2) 16.8, Past medical history (PMH) Marfan syndrome, History of prior COVID-19 infection: Yes, Days between vaccine and symptom onset 2, Length of stay (hours) 71, Laboratories: White blood cell count (Ref: 5-10) 6.6, Peak troponin-I (Ref: 0.00-0.08 ng/mL) 11.80, Discharge troponin-I (Ref: 0.00-0.08 ng/mL) 0.28, CKMB (creatine kinase myocardial band, Ref:0-3.5ng/mL) N/A, CPK (creatine phosphokinase Ref: 33-145 IU/L) 312, d-dimer (Ref: 0.27-0.41 mmg/mL) less than 0.19, COVID-19 testing: SARS-CoV-2 PCR Negative, SARS-CoV-2 spike IgM Negative, SARS-CoV-2 nucleocapsid IgG Negative, EKG (electrocardiogram): EKG findings Normal sinus Rhythm, Imaging: Chest radiograph (cardiopulmonary findings) Negative, Left ventricular ejection fraction on ECHO (echocardiogram) 57, Pericardial effusion present No, Cardiac MRI performed Yes, Left ventricular ejection fraction on MRI 61, Myocardial edema on MRI (yes/no) Yes, Late gadolinium enhancement on MRI (yes/no) Yes, treatment: no intravenous immunoglobulin; nonsteroidal anti-inflammatory drugs.  Herein described is the first case series from a single institution of 8 adolescent males with a diagnosis of perimyocarditis in the setting of recent BNT162b2 vaccination with no other identifiable cause. Pediatricians should consider myocarditis in the differential diagnosis of patients presenting with chest pain after receiving the BNT162b2 vaccine and be aware of the clinical implications and the need to report this potential adverse event. Currently, the association between perimyocarditis and the BNT162b2 vaccine is unproven but recent reports suggest there may be causality. This case series raises additional questions regarding appropriate recommendations for COVID-19 vaccination in adolescents with a prior history of perimyocarditis, of SARS CoV-2 infection (clinically or by serology), and of multisystem inflammatory syndrome associated with SARS-CoV-2 (MISC). It also poses the issue of whether patients who experience perimyocarditis post-BNT162b2 vaccine should receive booster SARS-CoV-2 vaccines in the future.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: A contributory role of BNT162B2 to the event perimyocarditis cannot be excluded based on the plausible temporal relationship, product safety profile and lack of reported alternative explanation at this time. This case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : PFIZER INC-202101133568 Same article/drug/event; different patient",,,,,Y,,,,U,,,,"Test Name: adenovirus plasma PCR; Test Result: Negative  ; Test Name: cpk; Result Unstructured Data: Test Result:312 IU/l; Test Name: creatine phosphokinase-MB; Result Unstructured Data: Test Result:Unknown ng/ml; Test Name: Leptospira immunoglobulin M; Test Result: Negative  ; Test Name: BMI; Result Unstructured Data: Test Result:16.8; Comments: 16.8 kg/m2; Test Name: Chest radiograph (cardiopulmonary findings); Test Result: Negative  ; Test Name: Chest radiograph (cardiopulmonary findings); Result Unstructured Data: Test Result:normal; Test Name: CMV antibodies; Test Result: Negative  ; Test Name: Transthoracic echocardiogram; Result Unstructured Data: Test Result:patent foramen ovale; Comments: showed patent foramen ovale, mild mitral valve prolapse with  mild-to-moderate mitral regurgitation, mild aortic root dilation  (unchanged), and qualitatively low normal LVSF; Test Name: Left ventricular ejection fraction on ECHO; Result Unstructured Data: Test Result:57; Test Name: Left ventricular ejection fraction on MRI; Result Unstructured Data: Test Result:61; Test Name: electrocardiogram; Result Unstructured Data: Test Result:normal Sinus rhythm; Comments: normal sinus rhythm with no other changes; Test Name: enterovirus plasma PCR; Test Result: Negative  ; Test Name: EBV titers; Test Result: Negative  ; Test Name: d-dimer; Result Unstructured Data: Test Result:less than 0.19 ug/ml; Test Name: Hemodynamic test; Result Unstructured Data: Test Result:remained hemodynamically stable; Test Name: Cardiac MRI; Result Unstructured Data: Test Result:significant for focal edema at the basal inferolat; Comments: significant for focal edema at the basal inferolateral segments, normal biventricular size and global systolic function, and stable aortic root dilation. The patient had 12- and 8- beat runs of irregular polymorphic ventricular tachycardia (Figure 1B). Myocardial edema, left ventricular ejection fraction 61, late gadolinium enhancement; Test Name: Parvovirus B19 PCR; Test Result: Negative  ; Test Name: RPP; Test Result: Negative  ; Test Name: SARS-CoV-2 nucleocapsid immunoglobulin G (IgG); Test Result: Negative  ; Test Name: SARS-CoV-2 spike IgM; Test Result: Negative  ; Test Name: SARS-CoV-2 PCR; Test Result: Negative  ; Test Name: sinus rhythm; Result Unstructured Data: Test Result:normal; Test Name: Troponin; Result Unstructured Data: Test Result:7.2 ng/ml; Test Name: Troponin; Result Unstructured Data: Test Result:11.8 ng/ml; Test Name: Discharge troponin-I; Result Unstructured Data: Test Result:0.28 ng/ml; Test Name: peak troponin-I; Result Unstructured Data: Test Result:11.80 ng/ml; Test Name: White blood cell count; Result Unstructured Data: Test Result:6.6",UNK,,,,Medical History/Concurrent Conditions: Aortic dilatation; Marfan's syndrome; SARS-CoV-2 infection (with mild symptoms),,USPFIZER INC202101137432,2,09/09/2021,,,Y,,myocarditis,G3,?,M,?,Trop 7.2; Cardiac MRI+; Pericardial effusion,VT,"Age unknown male presented with chest pain, dyspnea, fever unknown interval after 1st dose. Workup: Trop 7.2. Severity indicators: VT."
1704121,Patent ductus arteriosus,24.1,Troponin increased,24.1,Ventricular hypokinesia,24.1,,,,,COVID19,PFIZER\BIONTECH,,UNK,,,COVID19 (COVID19 (PFIZER-BIONTECH)),09/16/2021,WA,26.0,26.0,,M,,Myocarditis with EF 40% diagnosed 9/15,,,,,Y,2.0,,,U,09/12/2021,09/13/2021,1.0,"TTE with EF 40% and global hypokinesis, cardiac CT angiography with patent vessels, Troponin elevation peaking at 32, chest pain",PVT,,erythromycin ointment left eye qid,denies,overweith with BMI 25,,,2,09/16/2021,,,,nkda,myocarditis,G3,26,M,1,EF 40%,EF 40%,26yo male presented with cardiac symptoms 1 days after vaccination. Workup: EF 40%. Severity indicators: EF 40%.
1705028,X-ray,24.1,,,,,,,,,COVID19,PFIZER\BIONTECH,EW0198,1,SYR,LA,COVID19 (COVID19 (PFIZER-BIONTECH)),09/16/2021,NV,18.0,18.0,,M,,"Red swelling after the first dose in the upper left  High fever after the second dose from 9:00 pm (approximately 5 hours after vaccination) on 7/5/21 till 12:30 pm on 7/7/21 Chest pains at 12:30 pm on 7/7/21. Went to the ER at 1:30 pm. Diagnosed with a heart attack with heart attack symptoms at 1:40 pm Many tests occurred, some being a Hospital Echo and X-Ray The procedure that occurred is the Cardia Catheterization Procedures  Diagnosed with myocarditis Hospitalized for three days and two nights Medication: Colchicine (colchicine 0.6mg oral capsule)/ 1 cap by mouth/ once daily for one month Ibuprofen (ibuprofen 600mg oral tablet)/ 1 tab by mouth/ three times daily for one month PredniSONE (predniSONE 10mg oral tablet)/40mg PO daily x3 days/30 mg PO daily x3 days/20mg PO daily x3/10mg PO daily x3 days No physical activities or work for one month after discharge 2 months later, chest pains occur sometimes",,,Y,,Y,3.0,,Y,N,07/05/2021,07/07/2021,2.0,"Many tests occurred, some being a Hospital Echo and X-Ray The procedure that occurred is the Cardia Catheterization Procedures  Diagnosed with myocarditis",PHM,,,,,,,2,09/16/2021,,Y,Y,,myocarditis,G1,18,M,2,Limited data,Classic presentation,"18yo male presented with chest pain, fever 2 days after 2nd dose. Diagnosed with acute myocarditis consistent with classic post-vaccine profile."
1708522,Pyrexia,24.1,SARS-CoV-2 antibody test positive,24.1,Troponin increased,24.1,Ventricular extrasystoles,24.1,,,COVID19,PFIZER\BIONTECH,,2,,,COVID19 (COVID19 (PFIZER-BIONTECH)),09/17/2021,MI,16.0,16.0,,M,,developed low grade fever and myalgia after the vaccine and then presented on the 3-4th day post vaccine with chest pain radiating to left arm worsening with laying flat.EKG was normal troponin was elevated. PVCs were noted on telemetry.Normal function on echocardiogram with trace pericardial effusion.cardiac MRI showed delayed enhancement of the subepicardial area and signs of myocarditis of LV.pain decreased and troponing initiallytrended up then started to drop on 9/17/21 and pt was discharged on steroids and aspirin.SARS AB positive- resp panel was negative.,,,,,Y,3.0,,,N,09/12/2021,09/13/2021,1.0,"troponin 0.4 ng/ml( normal less than 0.05)at presentation 9-15-21-repeat 1.24ng /ml on  9-16-21. Last troponin 0.73 on discharge 9/17-2021. Normal EKG no ST T changes Normal LV function on echocardiogram with trace pericardial effusion Cardiac MRI 9-16-21 Myocarditis of the left ventricle and also delay enhancement, subpericardial could be just to myocarditis, rather than ischemia,, of the left ventricle lateral wall. positive SARS Covid 2 spike Ab on 9-16-21 negative respiratory viral panel 9-16-21",PVT,,unknown,None,None,,,2,09/17/2021,,Y,Y,NKDA,myocarditis,G2,16,M,1,Trop 0.4->0.73 (peak 0.73); Cardiac MRI+; Pericardial effusion,Viral etiology,"16yo male presented with chest pain, fever 1 days after vaccination. Workup: Trop 0.4->0.73 (peak 0.73). Confounders: Viral etiology."
1712137,Ventricular extrasystoles,24.1,Ventricular tachycardia,24.1,,,,,,,COVID19,MODERNA,,1,,LA,COVID19 (COVID19 (MODERNA)),09/18/2021,MA,57.0,57.0,,F,,Superventricular Tacacardia Wore Holter monitor for 15 days 85 events in total 3 significant with heart rate over 200  Myocarditis Perscibed Metatropol to lower heart rate  Sudden onset no prior heart issies,,,,,,,,,U,05/10/2021,05/13/2021,3.0,"Holter Monitor Completed June 16 2021  Skip navigation to main contentMenu   S EVENT MONITOR SCAN AND ANALYSIS - DetailsPrinter friendly page--New window will open About this test  Details Past Results Graph of Past Results Study Result Narrative Zio XT 13-day Holter patch monitor  Ventricular tachycardia (4 beats or more): Number of episodes = 2  Atrial fibrillation: None found  Supraventricular tachycardia (4 beats or more): Number of episodes = 85  Pauses (3 seconds or longer): None found  AV block (2nd degree Mobitz II, or 3rd degree): None found     Findings: Patient had a min HR of 53 bpm, max HR of 207 bpm, and avg HR of 76 bpm. Predominant underlying rhythm was Sinus Rhythm. 2 Ventricular Tachycardia runs occurred, the run with the fastest interval lasting 19 beats with a max rate of 171 bpm (avg 142 bpm); the run with the fastest interval was also the longest. 85 Supraventricular Tachycardia runs occurred, the run with the fastest interval lasting 5 beats with a max rate of 207 bpm, the longest lasting 20.1 secs with an avg rate of 99 bpm. Isolated SVEs were rare (<1.0%), SVE Couplets were rare (<1.0%), and SVE Triplets were rare (<1.0%). Isolated VEs were rare (<1.0%, 139), VE Couplets were rare (<1.0%, 1), and VE Triplets were rare (<1.0%, 1).       Physician interpretation: Patient triggered events correlated with sinus rhythm and occasional PACs/PVCs. There were 2 episodes of a wide-complex tachycardia that appears most consistent with nonsustained ventricular tachycardia (differential including an SVT with aberrancy), longest episode lasted 19 beats/8.3 seconds. There were also occasional atrial runs consistent with paroxysmal SVT, longest lasting 33 beats/3.1 seconds and appears most consistent with an atrial tachycardia.  Component Results Heart rate range Your Value 53-207 bpm Standard Range bpm Heart rate (average) Your Value 76 bpm Standard Range bpm Ventricular tachycardia - number of episodes Your Value 2 Ventricular tachycardia - heart rate range Your Value 59-171 bpm Standard Range bpm Ventricular tachycardia - heart rate (average) Your Value 128 bpm Standard Range bpm Longest ventricular tachycardia episode start Your Value June 16, 2021 22:30:20 ET Longest ventricular tachycardia episode end Your Value June 16, 2021 22:30:28 ET Longest ventricular tachycardia episode - duration Your Value 8.3 Longest ventricular tachycardia episode - number of beats Your Value 19 beats Standard Range beats Longest ventricular tachycardia episode - heart rate range low Your Value >=85 Longest ventricular tachycardia episode - heart rate range high Your Value >=171 Longest ventricular tachycardia episode - heart rate (average) Your Value 142 Ventricular tachycardia with fastest heart rate start Your Value June 16, 2021 22:30:20 ET Ventricular tachycardia with fastest heart rate end Your Value June 16, 2021 22:30:28 ET Ventricular tachycardia with fastest heart rate - duration Your Value 8.3 sec Standard Range sec Ventricular tachycardia with fastest heart rate - number of beats Your Value 19 beats Standard Range beats Ventricular tachycardia with fastest heart rate - heart rate range low Your Value >=85 Ventricular tachycardia with fastest heart rate - heart rate range high Your Value >=171 Ventricular tachycardia with fastest heart rate - heart rate (average) Your Value 142 Supraventricular tachycardia - number of episodes Your Value 85 Supraventricular tachycardia - heart rate range Your Value 79-207 bpm Standard Range bpm Supraventricular tachycardia - heart rate (average) Your Value 116 bpm Standard Range bpm Longest supraventricular tachycardia episode start Your Value June 18, 2021 18:28:28 ET Longest supraventricular tachycardia episode end Your Value June 18, 2021 18:28:49 ET Longest supraventricular tachycardia episode - duration Your Value 20.1 sec Standard Range sec Longest supraventricular tachycardia episode - number of beats Your Value 33 beats Standard Range beats Longest supraventricular tachycardia episode - heart rate range low Your Value >=97 bpm Standard Range bpm Longest supraventricular tachycardia episode - heart rate range high Your Value >=103 bpm Standard Range bpm Longest supraventricular tachycardia episode - heart rate (average) Your Value 99 bpm Standard Range bpm Supraventricular tachycardia with fastest heart rate start Your Value June 20, 2021 12:21:51 ET Supraventricular tachycardia with fastest heart rate end Your Value June 20, 2021 12:21:53 ET Supraventricular tachycardia with fastest heart rate - duration Your Value 1.9 sec Standard Range sec Supraventricular tachycardia with fastest heart rate - number of beats Your Value 5 beats Standard Range beats Supraventricular tachycardia with fastest heart rate - heart rate range low Your Value >=135 bpm Standard Range bpm CV LHS SVT_F_EPI_BPM_H Your Value >=207 bpm Standard Range bpm Supraventricular tachycardia with fastest heart rate - heart rate (average) Your Value 164 bpm Standard Range bpm Isolated SVE frequency Your Value Rare Isolated SVE count Your Value 3,365 episodes Standard Range episodes SVE Couplets Frequency Your Value Rare SVE Couplets Counts Your Value 389 episodes Standard Range episodes SVE Triplets Frequency Your Value Rare SVE Triplets Counts Your Value 133 episodes Standard Range episodes Isolated VE Frequency Your Value Rare Isolated VE Counts Your Value 139 episodes Standard Range episodes VE Couplets Frequency Your Value Rare VE Couplets Counts Your Value 1 episodes Standard Range episodes VE Triplets Frequency Your Value Rare VE Triplets Counts Your Value 1 episodes Standard Range episodes Enrollment Period Start Your Value June 15, 2021 13:33:10 ET Enrollment Period End Your Value June 28, 2021 10:11:03 ET General Information   Collected on 06/15/2021 1:33 PM  Resulted on 07/19/2021 5:13 PM  Result Status: Final result  This test result has been released by an automatic process. In the interests of patient-centered care, My Chart is making your test results available to you in a timely fashion. It may be the case that you see your test results before your provider. Keep in mind that test results do not provide a definitive diagnosis. If you have questions, please reach out to the provider who ordered the test.",PHM,,Celexa,,,,,2,09/18/2021,,Y,,Yeast allergy Poatsium allergy in Medication,myocarditis,G3,57,F,3,Limited data,Heart block; VT,57yo female presented with cardiac symptoms 3 days after vaccination. Severity indicators: Heart block; VT.
1735422,Myocarditis,24.1,SARS-CoV-2 test positive,24.1,Ventricular fibrillation,24.1,,,,,COVID19,PFIZER\BIONTECH,,1,IM,UN,COVID19 (COVID19 (PFIZER-BIONTECH)),09/25/2021,SC,27.0,27.0,,F,,"Patient meeting case definition for MIS-A with evidence of myocarditis. She is 27 weeks pregnant, Estimated fetal weight 1116g  Patient proceeded to progress to cardiogenic shock requiring inotropes and vasopressors.  Her hospital course has been complicated by a ventricular fibrillation related cardiac arrest and acute respiratory failure from which she recovered and was successfully extubated.  She was treated with aspirin 162 mg, 2.5 mg/kg of IVIG, 400 mg of Tocilizumab, 6 mg twice daily of dexamethasone followed by 1 mg/kg of methylprednisolone.",,,Y,,Y,6.0,,,N,09/05/2021,09/18/2021,13.0,"SARS-CoV-2 virus RNA, 9/19/2021, 9/22/2021: Positive Covid 2 IgG spike protein, 9/20/2021: Positive, 22.9 AU per mL CT angiogram of her chest, 9/19/2021: Notable for mild atelectasis but no pulmonary infiltrates",PVT,,Ferrous Sulfate,COVID-19,Anemia History of pre-term delivery,,,2,09/25/2021,,,,No known allergies,myocarditis,G3,27,F,13,Limited data,Inotropes; VF; Cardiac arrest; Cardiogenic shock,27yo female presented with cardiac symptoms 13 days after vaccination. Severity indicators: Inotropes; VF; Cardiac arrest; Cardiogenic shock.
1740551,White blood cell count,24.0,,,,,,,,,COVID19,MODERNA,,1,OT,,COVID19 (COVID19 (MODERNA)),09/28/2021,MN,44.0,,,M,,"Acute myocarditis; Malaise; Dry cough; Myalgias; Headache; This literature-non-study case was reported in a literature article and describes the occurrence of MYOCARDITIS (Acute myocarditis) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   LITERATURE REFERENCE: Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. Rep. 2021;5(8):1-6     The patient's past medical history included Smoker (former smoker). Concurrent medical conditions included Obstructive sleep apnoea syndrome, Asthma and Obesity (BMI 30.9 kg/m2). Concomitant products included ALBUTEROL [SALBUTAMOL] and FLUTICASONE; SALMETEROL for an unknown indication.   On 01-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYOCARDITIS (Acute myocarditis) (seriousness criteria hospitalization prolonged and medically significant). On an unknown date, the patient experienced MALAISE (Malaise), COUGH (Dry cough), MYALGIA (Myalgias) and HEADACHE (Headache). The patient was hospitalized from 05-May-2021 to 09-May-2021 due to MYOCARDITIS. The patient was treated with COLCHICINE on 06-May-2021 for Chest pain, at an unspecified dose and frequency. On 06-Jun-2021, MYOCARDITIS (Acute myocarditis) had resolved. At the time of the report, MALAISE (Malaise), COUGH (Dry cough), MYALGIA (Myalgias) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Angiocardiogram: abnormal (abnormal) showed very mild coronary artery disease. On 05-May-2021, C-reactive protein: 63.5 mg/l (High) 63.5 mg/L (reference range: =8.0?mg/L). On 05-May-2021, Cardiac ventriculogram left: 40% (abnormal) showed a mildly reduced ejection fraction of 40% with global hypokinesis that was most severe at the apex. On 05-May-2021, Echocardiogram: abnormal (abnormal) Showed a decreased left ventricular ejection fraction.Demonstrated borderline enlarged left ventricle with an estimated ejection fraction of 4045%, mild-moderate generalized left ventricular hypokinesis, slightly worse at the apex, borderline enlarged right ventricle with mildly-moderately decreased systolic function, and no significant valve disease.. On 05-May-2021, Electrocardiogram: abnormal (abnormal) Electrocardiogram showed ST-segment elevation in the lateral limb and precordial leads. On 05-May-2021, Eosinophil count (0.03-0.48): 0.04  10(9)/l (normal) 0.04  10(9)/L. On 05-May-2021, Left ventricular end-diastolic pressure: 29?mmhg (High) markedly elevated at 29?mmHg. On 05-May-2021, Magnetic resonance imaging heart: acute myocarditis (abnormal) was compatible with acute myocarditis with patchy linear mid-myocardial enhancement of the septum and inferior walls at the base to mid-ventricle, sub-epicardial/mid-myocardial enhancement of the lateral wall at the mid-ventricle and apical lateral wall. There was associated myocardial oedema involving most of the myocardium and mild pericardial enhancement. On 05-May-2021, N-terminal prohormone brain natriuretic peptide: 1059 pg/ml (High) 1059 pg/mL (reference range: =51?pg/mL). On 05-May-2021, Physical examination: minimal lower extremity swelling (abnormal) showed minimal lower extremity swelling. On 05-May-2021, Red blood cell sedimentation rate (2-2): 12 mm/h (High) 12 mm/h. On 05-May-2021, Troponin T: 847 ng/l (High) 847 ng/L (reference range: =15?ng/L). On 05-May-2021, Vital signs measurement: normal (normal) temperature of 36.9 degrees Celsius, heart rate of 79 beats per minute, blood pressure of 90/72, respiratory rate of 12 breaths per minute, and oxygen saturation of 95%. On 05-May-2021, White blood cell count (3.4-9.6): 9.7  10(9)/l (High) 9.7  10(9)/L. On 06-May-2021, Echocardiogram: normal (normal) Repeat Transthoracic echocardiogram showing normalization of ejection fraction, and no regional wall motion abnormalities. On 06-May-2021, Troponin T: 675?ng/l (High) decreased to 675?ng/L the day after admission. On an unknown date, Chest X-ray: mild pulmonary oedema (abnormal) showed findings consistent with mild pulmonary oedema. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative (COVID-19 nasal swab testing using polymerase chain reaction was negative).     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered MYOCARDITIS (Acute myocarditis), MALAISE (Malaise), COUGH (Dry cough), MYALGIA (Myalgias) and HEADACHE (Headache) to be possibly related.    Patient was in his usual state of health prior to getting the second dose of mRNA-1273 SARS-CoV-2 Vaccine. There was no family history of cardiovascular or autoimmune disease.  Endomyocardial biopsy was not performed as the patient experienced mild symptoms, had no haemodynamic or electrical instability, and responded promptly to initial management.  The patient was started on supportive therapy for the symptoms, including a brief course of intravenous diuretics for mild symptoms of congestion. Angiotensin-converting enzyme inhibitor and a beta-blocker therapy were commenced to treat systolic dysfunction. The patient was also initiated on colchicine to treat mild persistent chest pain, which was thought to be related to pericardial inflammation that resolved 4-5?days after presentation.   The patient was discharged home after 5 days of monitoring without evidence of electrical or haemodynamic instability and with Class I symptoms. One month later, repeat echocardiogram showed normalization of the left ventricular ejection fraction (56%) and size, no regional wall motion abnormalities, and normal longitudinal peak systolic strain. The patient remained asymptomatic and off diuretics.  This case concerns a 44-year-old male patient with a history of Obstructive sleep apnoea syndrome, Asthma and Obesity, who experienced the serious expected event Myocarditis. The event occurred approximately 4 days after the second and most recent dose of mRNA-1273 Moderna vaccine. The event was considered related to the study drug per the reporter's assessment. The event is consistent with the current understanding of the mechanism of action of the study medication. The benefit-risk relationship of mRNA-1273 Moderna vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 22-Sep-2021: Follow up received by safety on 22-Sep-2021 included an Email with FTA received from team and does not contain any new information.; Sender's Comments: This case concerns a 44-year-old male patient with a history of Obstructive sleep apnoea syndrome, Asthma and Obesity, who experienced the serious expected event Myocarditis. The event occurred approximately 4 days after the second and most recent dose of mRNA-1273 Moderna vaccine. The event was considered related to the study drug per the reporter's assessment. The event is consistent with the current understanding of the mechanism of action of the study medication. The benefit-risk relationship of mRNA-1273 Moderna vaccine is not affected by this report.",,,,,Y,5.0,,,Y,05/01/2021,05/05/2021,4.0,"Test Date: 20210505; Test Name: Emergent coronary angiogram; Result Unstructured Data: showed very mild coronary artery disease; Test Date: 20210505; Test Name: Left ventriculogram; Result Unstructured Data: showed a mildly reduced ejection fraction of 40% with global hypokinesis that was most severe at the apex; Test Name: Chest X-ray; Result Unstructured Data: showed findings consistent with mild pulmonary oedema; Test Date: 20210505; Test Name: C-reactive protein; Result Unstructured Data: 63.5 mg/L (reference range: =8.0?mg/L); Test Date: 20210505; Test Name: Transthoracic echocardiogram; Result Unstructured Data: Showed a decreased left ventricular ejection fraction. Demonstrated borderline enlarged left ventricle with an estimated ejection fraction of 4045%, mild-moderate generalized left ventricular hypokinesis, slightly worse at the apex, borderline enlarged right ventricle with mildly-moderately decreased systolic function, and no significant valve disease.; Test Date: 20210506; Test Name: Transthoracic echocardiogram; Result Unstructured Data: Repeat Transthoracic echocardiogram showing normalization of ejection fraction, and no regional wall motion abnormalities; Test Date: 20210505; Test Name: Electrocardiogram; Result Unstructured Data: Electrocardiogram showed ST-segment elevation in the lateral limb and precordial leads; Test Date: 20210505; Test Name: Eosinophils; Result Unstructured Data: 0.04  10(9)/L; Test Date: 20210505; Test Name: Left ventricular end-diastolic pressure; Result Unstructured Data: markedly elevated at 29?mmHg; Test Date: 20210505; Test Name: Cardiac magnetic resonance imaging; Result Unstructured Data: was compatible with acute myocarditis with patchy linear mid-myocardial enhancement of the septum and inferior walls at the base to mid-ventricle, sub-epicardial/mid-myocardial enhancement of the lateral wall at the mid-ventricle and apical lateral wall. There was associated myocardial oedema involving most of the myocardium and mild pericardial enhancement; Test Date: 20210505; Test Name: NT-proBNP; Result Unstructured Data: 1059 pg/mL (reference range: =51?pg/mL); Test Date: 20210505; Test Name: Physical exam; Result Unstructured Data: showed minimal lower extremity swelling; Test Date: 20210505; Test Name: Sedimentation rate; Result Unstructured Data: 12 mm/h; Test Name: COVID-19 PCR test; Test Result: Negative  ; Result Unstructured Data: Negative (COVID-19 nasal swab testing using polymerase chain reaction was negative); Test Date: 20210505; Test Name: Peak troponin T, 5th generation; Result Unstructured Data: 847 ng/L (reference range: =15?ng/L); Test Date: 20210506; Test Name: Peak troponin T, 5th generation; Result Unstructured Data: decreased to 675?ng/L the day after admission; Test Date: 20210505; Test Name: Vital signs; Result Unstructured Data: temperature of 36.9 degrees Celsius, heart rate of 79 beats per minute, blood pressure of 90/72, respiratory rate of 12 breaths per minute, and oxygen saturation of 95%; Test Date: 20210505; Test Name: White blood cell count; Result Unstructured Data: 9.7  10(9)/L.",UNK,,Albuterol [Salbutamol]; Fluticasone; Salmeterol,Asthma; Obesity (BMI 30.9 kg/m2); Obstructive sleep apnoea syndrome.,Medical History/Concurrent Conditions: Smoker (former smoker).,,"USMODERNATX, INC.MOD20213",2,09/28/2021,,,,,myocarditis,G3,44,M,4,Trop 675.0->847.0 (peak 847.0); EF 40%; Cardiac MRI+,EF 40%,"44yo male presented with chest pain 4 days after 2nd dose. Workup: Trop 675.0->847.0 (peak 847.0), EF 40%. Severity indicators: EF 40%."
1790502,Muscle contusion,24.0,Supraventricular tachycardia,24.0,,,,,,,COVID19,MODERNA,012L20A,1,OT,RA,COVID19 (COVID19 (MODERNA)),10/16/2021,FL,38.0,,,F,,"arrythmia under control with medication; after second dose patient went into SVT; bruising from her deltoid to the bottom of her latissimus dorsi; anemic; periodic chest pain for a couple of months; This spontaneous case was reported by a physician and describes the occurrence of ARRHYTHMIA (arrythmia under control with medication) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARRHYTHMIA (arrythmia under control with medication) (seriousness criterion medically significant), SUPRAVENTRICULAR TACHYCARDIA (after second dose patient went into SVT), MUSCLE CONTUSION (bruising from her deltoid to the bottom of her latissimus dorsi), ANAEMIA (anemic) and CHEST PAIN (periodic chest pain for a couple of months). At the time of the report, ARRHYTHMIA (arrythmia under control with medication) was resolving, SUPRAVENTRICULAR TACHYCARDIA (after second dose patient went into SVT), MUSCLE CONTUSION (bruising from her deltoid to the bottom of her latissimus dorsi) and ANAEMIA (anemic) outcome was unknown and CHEST PAIN (periodic chest pain for a couple of months) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Cardiac stress test: negative (Negative) Negative and negative (Negative) Negative. On an unknown date, Echocardiogram: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided. There was no diagnosis of myocarditis or pericarditis and no medical history of arrhythmia. Patient had seen a cardiologist.  Company Comment: This case concerns a 38-year-old, female patient with no previous relevant medical history reported, who experienced the unexpected events of arrhythmia and supraventricular tachycardia. The events occurred on an unknown number of days after the second dose of mRNA-1273. The rechallenge was not applicable since the events happened after the second dose. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a 38-year-old, female patient with no previous relevant medical history reported, who experienced the unexpected events of arrhythmia and supraventricular tachycardia. The events occurred on an unknown number of days after the second dose of mRNA-1273. The rechallenge was not applicable since the events happened after the second dose. The benefit-risk relationship of mRNA-1273 is not affected by this report.",,,,,,,,,N,,,,Test Name: multiple EKGs; Test Result: Negative  ; Result Unstructured Data: Negative; Test Name: Stress test; Test Result: Negative  ; Result Unstructured Data: Negative; Test Name: echo; Test Result: Negative  ; Result Unstructured Data: Negative,UNK,,,,,,"USMODERNATX, INC.MOD20213",2,10/15/2021,,,,,myocarditis,G3,38,F,?,Limited data,VT,38yo female presented with chest pain unknown interval after 2nd dose. Severity indicators: VT.
1793549,Red blood cell sedimentation rate increased,24.1,Troponin I increased,24.1,White blood cell count increased,24.1,,,,,COVID19,MODERNA,039D21A,1,IM,LA,COVID19 (COVID19 (MODERNA)),10/16/2021,WA,37.0,37.0,,M,,"Patient states that he received his first dose of the Moderna vaccination on October 10.  The next day he began having myalgias, chills, and headache.  2 days later, he developed chest pain and shortness of breath.  He had a fever to 103 deg F at home.  Chest pain is described as tightness, located in the midsternal region with some radiation to the neck.  He reports this is worse with bending forward.  The pain has been constant.   He feels as though he is unable to take a deep breath.  He had COVID in 1/2021 - with positive COVID-19 test on 1/18/2021. He presented to the ED and was noted to have elevated WBC and cardiac troponin.  CTA chest was negative for pulmonary embolism.  He was diagnosed with acute myocarditis. There was improvement in the chest discomfort, albeit still present, at the time of discharge.  Symptomatic treatment recommended.",,,,,Y,1.0,,,U,10/10/2021,10/11/2021,1.0,"CT angiogram chest 10/13/2021 --Multifocal, predominantly linear bibasilar opacity, likely atelectasis. --Mild stranding of the left anterior chest wall/left axillary region subcutaneous tissues, as may be seen in the setting of cellulitis, with several prominent likely reactive left axillary lymph nodes.  Troponin I   1.052 ng/mL (0 - 0.028 ng/mL) WBC 16.07 K/uL (4-12) Sed rate 25 mm/hr (0-15) CRP 11.7 mg.dL (0-1.0)",PHM,,dabigatran metoprolol tartrate hydrochlorothiazide testosterone cypionate,none,atrial fibrillation Factor V Leiden DVT,,,2,10/16/2021,,,,Penicillin,myocarditis,G2,37,M,1,Trop 1.052->1.052 (peak 1.052); CRP 11.7,COVID-19 positive,"37yo male presented with chest pain, dyspnea, fever 1 days after 1st dose. Workup: Trop 1.052->1.052 (peak 1.052). Confounders: COVID-19 positive."
1795077,Myocarditis,24.1,Oxygen saturation decreased,24.1,Pericarditis,24.1,Peripheral swelling,24.1,SARS-CoV-2 test negative,24.1,COVID19,MODERNA,052E22A,1,IM,LA,COVID19 (COVID19 (MODERNA)),10/18/2021,NJ,63.0,63.0,,F,,"I am a 63-year-old woman, who was in good health with no preexisting conditions.  I took the first injection Moderna COVID19 vaccine shot on Friday. September 24, 2021 due to the mandate to keep my job as a substitute teacher.  I started feeling bad and my breathing deteriorated each day to the point where I was out of breath.  On Wednesday, September 29, 2021, I went to urgent care.   After initial check-up, they called the ambulance and I was transported to the Emergency Room and immediately placed on high flow oxygen.  One more day delay and I would have died due to lack of oxygen. At the hospital, on Thursday, September 30, 2021, the doctor removed ONE Liter (Quart) of fluid from my right lung, the next day the doctor removed ONE and ONE THIRD liters of fluid from my left lung.  The fluid was a rusty reddish color.   At the hospital, all kinds to tests were performed, heart test, cancer test, COVID19 test and bacterial tests, all results were negative.  By Saturday, I was off oxygen and was released from the hospital on Monday, October 4, 2021.  By the end of the week, I again started feeling out of breath.  On Monday, October 11, the doctor ordered a chest X-ray.  The x-ray was read on Tuesday morning.  The Doctor immediately called me and told me to go to Emergency Room at Medical Center.  On Wednesday, October 13, 2021, surgery was performed on me to install draining tubes from both of my lungs.  More than a liter of fluid was removed from each of my lungs.  Again, more tests were performed on me to find the root cause and none were found.  On Friday, October 15, I was released from the hospital with tubes from my lungs.    On Sunday, October 17, 2021, the visiting nurse came to my house and drained 25 ml from my right lung and 75 ml from my left lung. The nurse is scheduled to come three times a week to remove the fluid. I am currently suffering from swelling in my feet, myocarditis and pericarditis and unable to work in this condition, as a result of the Moderna vaccine.",,,Y,,Y,9.0,,,U,09/24/2021,09/25/2021,1.0,Acute hypoxemic respiratory failure,PVT,,Vitamins,None,None,,,2,10/18/2021,,,,None,myocarditis,G2,63,F,1,Limited data,Cancer,63yo female presented with cardiac symptoms 1 days after vaccination. Confounders: Cancer.
1828901,Tachycardia,24.1,Troponin increased,24.1,Ventricular arrhythmia,24.1,,,,,COVID19,PFIZER\BIONTECH,,2,,,COVID19 (COVID19 (PFIZER-BIONTECH)),10/29/2021,WA,17.0,17.0,,F,,"Patient reported symptomatic (non-severe) case of COVID-19 August 2021 and recovered fully.  She reported receiving Pfizer COVID vaccine 9/3/21 and second dose 9/15/21.  She present to the emergency department of my hospital 10/23/21 with chest pain and dyspnea for 48h.  Was feeling completely well prior to onset of chest discomfort.  Symptoms were mild.  No sick contacts or family members.  ED evaluation remarkable for normal exam, no hypoxia, normal blood pressure.  EKG with diffuse ST elevation.  Troponin elevated at 20.  CTA chest negative for PE or pneumonia.  SARS-CoV-PCR positive but thought to be persistent positive rather than reinfection because of lack of clinical symptoms, recent COVID-19 and recent vaccination.  Cardiologist consulted, thought acute coronary syndrome unlikely based on age and lack of risk factors.  STAT Echo resulted depressed EF 40-45%.  Simultaneously she had become increasingly tachycardic and EKG appeared more ischemic.  Cardiac cath lab was activated and she was about to be transported when she suffered cardiac arrest.  Initial rhythm was VT.  Received ACLS protocol CPR x 65 minutes including multiple cardioversion, amiodarone, lidocaine, magnesium and other antiarrhythmics.  Unfortunately she was not able to be resuscitated and died.  Cause of death possible acute myocarditis.",Y,10/23/2021,,,Y,1.0,,,N,09/15/2021,10/21/2021,36.0,"See above.  CBC, BMP.  Troponin elevated at 20.  CRP significantly elevated.  CTA chest negative for PE.  EKG with ST elevations.  Echocardiogram with depressed EF 40-45%.  SARS-CoV-2 positive.",UNK,,none,COVID-19 August 2021,none,,,2,10/29/2021,,,,none,myocarditis,G3,17,F,36,Trop 20.0->20.0 (peak 20.0); EF 40%; ST elevation,VT; Cardiac arrest; EF 40%,"17yo female presented with chest pain, dyspnea 36 days after 2nd dose. Workup: Trop 20.0->20.0 (peak 20.0), EF 40%. Severity indicators: VT; Cardiac arrest; EF 40%."
1829441,Biopsy heart,24.1,Blood culture negative,24.1,Cardiac failure,24.1,Cardiac imaging procedure abnormal,24.1,Cardiac index,24.1,COVID19,PFIZER\BIONTECH,E18982,1,IM,UN,COVID19 (COVID19 (PFIZER-BIONTECH)),10/29/2021,CA,63.0,63.0,,M,,"He first felt nauseated for three days after his first dose of the Pfizer vaccine for COVID-19 six weeks prior. As his symptoms resolved soon after the first dose of the vaccine, he received the second dose as recommended two weeks later. Approximately 5 days later, he began experiencing fevers and chills. This later progressed to cough and shortness of breath. He denied any sick contacts during that time period. Due to the severity of symptoms, he went to urgent care. In spite of a negative work-up, his symptoms persisted. This prompted four additional visits to urgent care. Negative studies included stool studies, influenza viral PCR, COVID-19 PCR, upper respiratory viral panel PCR, and blood cultures. His last visit to urgent care prompted a referral to his local emergency department after an electrocardiogram was performed.    On that day, he was found to have an electrocardiogram concerning for a STEMI in the setting of signs and symptoms of heart failure. Fifth generation troponin was 5,816 ng/L and N-terminal pro B type natriuretic peptide was 15,646 pg/mL. Echo revealed an ejection fraction of 35%, biventricular hypertrophy, and apical hypokinesis. Right and left heart catheterization revealed elevated filling pressures, a cardiac index of 1.8 L/min/M^2, and no obstructive coronary artery disease. An intra-aortic balloon pump was placed. Dopamine and dobutamine were initiated. Endomyocardial biopsy was performed revealing lymphocytes, eosinophils, and giant cells confirming the diagnosis of giant cell myocarditis. Treatment ensued soon after consisting of high dose steroids followed by a long steroid taper, tacrolimus, and mycophenolate mofetil. Soon after these interventions were initiated, his condition improved and both the intra-aortic balloon pump and vasoactive agents were successfully withdrawn. Prior to discharge, cardiac magnetic resonance imaging was performed revealing mildly depressed right and left ventricular systolic function and areas of linear and transmural subepicardial delayed enhancement involving the inferior and septal apical walls compatible with myocarditis. Extensive work-up for the etiology of myocarditis was negative.",,,Y,,Y,11.0,,,N,02/07/2021,02/12/2021,5.0,"COVID vaccine date:  1/17/21 and 2/7/21 Patient reported symptoms began 2/12/21 Multiple visits to urgent care Endomyocardial biopsy 3/18/21: ""Myocarditis with eosinophils and giant cells. """,UNK,,Wellbutrin Calcitriol Metformin Betamethasone,None,Psoriasis and Pre-diabetes mellitus type 2,,,2,10/29/2021,,,Y,Penicillin,myocarditis,G3,63,M,5,Trop 5816.0; EF 35%,Dobutamine; EF 35%,"63yo male presented with dyspnea, fever 5 days after 2nd dose. Workup: Trop 5816.0, EF 35%. Severity indicators: Dobutamine; EF 35%."
